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General Introduction 
Genetic Predisposition of Cancer 
It is generally accepted that cancer is a result of uncontrolled proliferation of cells with 
multiple genetic aberrations One pathway of tumongenesis occurs at the somatic cell level. 
This means that somatic cells, which are genetically "normal" at constitution, transform 
into an abnormal or deregulated state and generate cancerous growth (Cairns, 1981). In 
1914 Boven postulated the hypothesis that specific chromosomal aberrations are associated 
with the development of cancer (Boven, 1914). The first molecular proof for this observa-
tion was the detection of a t(9,22) chromosome, the so-called Philadelphia chromosome, in 
peripheral lymphocytes of patients with chronic myeloid leukemia (CIVIL) (Nowell & 
Hungerford, 1960) 
A second pathway of tumongenesis may find its beginning at the germ cell level This 
implies that a genetic instability is brought about in all somatic cells at birth. This gene-
tically predisposed form of tumongenesis was first postulated by Knudson (1971) as the 
two-hit hypothesis, and assumes that a second genetic event at the homologue chromosome 
is necessary to transform the phenotypically normal somatic cell into a tumor cell 
Recently, the process of tumongenesis has been recognized as being a multistep process, 
in which several genetic changes are involved, rather than being the consequence of a 
single change in the DNA sequence of a somatic cell (Harris. 1991). Furthermore, since 
cells in many primary tumors show the same abnormal karyotype, the majority of human 
cancers are thought to develop from single transformed cells with a clonal unicellular origin 
(Fialkow, 1979) The classical cascade of events in carcinogenesis involves initiation, 
promotion, and tumor progression In tumor initiation, a carcinogen-induced genetic change 
gives a selective growth advantage to susceptible cells These initiated cells are less respon-
sive to signals maintaining normal tissue architecture and regulating the homeostatic growth 
and maturation of cells During tumor promotion, unrestrained proliferation of cells 
increases the possibility of additional genetic changes These random somatic changes will 
then lead to cellular heterogeneity within malignant tissues (Heppner, 1984, Nicolson, 
1987) During tumor progression, a further increase of genomic instability can cause other 
chromosomal aberrations, gene amplification, and altered gene regulation and expression 
(Sandberg, 1990) 
Genes involved in Cancer 
The molecular approach of cancer has led to the study and identification of several 
genes involved in tumor development and progression (Croce, 1991, Solomon et al, 1991) 
The two major groups of genes in tumongenesis are (a) the proto-oncogenes, and (b) the 
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tumor suppressor genes 
Proto-oncogenes were first identified as the cellular homologues of activated viral on-
cogenes that constitute a stable part of the genome of acutely transforming retrovirusses 
The general importance of cellular proto-oncogenes in malignancy is evident by their 
activation by means of retroviral transfection, point mutations, amplification or chromoso-
mal translocations in both viral induced and naturally occurring malignancies They act 
dominantly in producing the malignant phenotype as a result of abnormal activation and/or 
aberrant expression of their gene product (Bishop, 1991) Many proto-oncogenes encode 
proteins that are involved in signaling pathways and are therefore thought to be critical to 
the control of cell proliferation and differentiation For example, proto-oncogenes that 
encode growth factors (e g c-sis), growth factor receptors (e g c-fms, c-kit), transducers 
of growth factor responses (e g c-src, c-ras, c-abl), and transcription factors (e g N-myc, 
c-jun) have all been described (Cantley et al, 1991) 
The second and perhaps more heterogeneous group of genes in tumongenesis has been 
shown to have onco suppressor activity Loss of gene function is required to initiate or 
progress the disease However, both copies of such genes have to be inactivated and so the 
causal mutations are recessive at the cellular level The study of retinoblastoma has 
provided insight into the genetic mechanisms of these suppressor genes Knudson's model 
(1971) has been made more specific by the finding that the two target loci are the two 
copies of the chromosome 13ql4-associated retinoblastoma (Rb) gene, and that the critical 
mutations serve to inactivate Rb function Mutation or loss of the p53 gene is the com-
monest alteration at the gene level yet found in many types of human cancers (Hollstein et 
al, 1991) The p53 protein is found in the nucleus and has many attributes of a transcription 
factor, including the ability to bind to a specific DNA sequence and the presence of a 
transcription-activating domain (Kern et al, 1991) Recently, the biological function of p53 
has been described as a cell cycle control protein at the level of Gl to S phase transition, 
acting as a checkpoint control for DNA damage In tumor cells, that have lost the wild-type 
function of p53, show gene amplification, which can be considered as a form of genetic 
instability (Livingstone et al, 1992) These cells are more susceptible to the killing effect of 
DNA damaging agents because they replicate through the damage (Lane, 1992, Vogelstein 
and Kmzler, 1992) 
Methods to Study Chromosomal Aberrations 
Changes in the cellular DNA content and the proliferative fraction of malignancies are 
regarded as prognostic parameters For the study of genetic aberrations during tumor 
development and progression, several techniques can be applied Therefore, these techni-
ques have found their way in tumor pathology, to improve the clinical diagnosis of malig-
nancy, and to increase our understanding of the multistep process involved in tumongenesis 
(Fearon & Vogelstem, 1990) 
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Λ Cytometry 
Cytometry may be defined as the quantitative measurement of individual cells and 
cellular constituents In recent years, cytometry is applied to an increasing extend in clinical 
pathology Flow cytometry (FCM) and image cytometry are the two major technical 
approaches in this respect Both techniques help to characterize biological properties of 
tumors Since these determinations can be performed in interphase nuclei, there is no need 
to culture cells and therefore every tissue type or cell population is accessible for analysis. 
In image cytometry, cells or tissues are fixed onto glass slides and are analyzed for 
parameters, such as shape, size, texture, and DNA content, using an imaging system. 
Although the number of cells that can be analyzed is much less than in FCM, a few 
hundred cells per tumor, the procedure may generate much more information per cell 
In FCM the total DNA content of a large population of cells can be quantitated The 
estimation of tumor cell ploidy has been described to be of prognostic significance (Dressier 
& Bartow, 1989) However, the technique is limited in the detection of a minimal DNA 
difference An increase in DNA content of about 4% can be seen as a split peak in 
heterogeneous cell populations (Vindelov et al, 1983) FCM includes the possibility of flow 
sorting, in which the malignant and the non-malignant cells can be separated by means of 
combination with immunohistochemical procedures For example. Beck et al (1990) have 
developed a FCM procedure to distinguish epithelial, primary tumor cells from non-
epithelial cells in mixed tumor cell populations on the basis of their intermediate filament 
expression patterns 
In general, in adult solid tumors, aneuploidy has been found to correlate with increasing 
tumor grade and stage and with worse prognosis, whereas a high S-phase fraction also in 
non-aneuploid TCCs predicts a more aggressive tumor behavior. FCM analyses of 
transitional cell carcinomas (TCCs) of the urinary bladder have shown that tumor stage is 
strongly correlated with the DNA ploidy. Low grade/low stage TCCs often appear to have 
a (near-) diploid DNA index, while the more advanced stages of TCC show more often an 
aneuploid DNA content (Tnbukait, 1984, Smeets et al, 1987) 
2 Karyotyping 
The development of chromosome banding techniques some 25 years ago has provided an 
efficient tool for chromosome analyses (Caspersson et al 1968) Until recently, conven­
tional karyotyping was practically the only way to obtain information on specific chromo­
somal aberrations in tumors So far, about 70% of the data concerning chromosomal 
abnormalities of cancer have come from studies on hematological malignancies, despite the 
fact that they comprise only 10% of all cancers (Milelman et al, 1991) These karyotyping 
studies are used in determining diagnostic and prognostic parameters, since well established 
knowledge of chromosome aberrations in several hematological malignancies exists 
In the case of solid tumors, chromosome banding techniques are often hampered by 
technical difficulties, such as (1) interior quality of metaphase chromosome spreads from 
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solid tumor cell samples, (2) low number of mitotic cells in primary tumors, (3) selective 
outgrowth of certain fast growing subpopulations, and (4) loss of genetic material, both due 
to culturing of the cells (Teyssier, 1989) 
Also the stage at which changes become apparent differs between hematological malig-
nancies and solid tumors The clinical and biological appearance of leukemia becomes 
apparent at an early stage of the disease, at which the primary karyotypic changes are 
observed Hematologic malignancies are often diagnosed at an early stage and are then 
characterized by single or few chromosomal abnormalities, most often reciprocal trans-
locations that represent the primary chromosomal changes On the contrary, many of the 
solid tumors are diagnosed and studied at later stages, when they display complex and 
heterogeneous patterns of chromosomal aberrations, involving both structural and numerical 
changes, as well as polyploidization The primary chromosomal changes are masked by 
secondary changes related to tumor progression, ageing, metastasis, resistance to therapy 
etc (Nowell, 1986, Sandberg, 1990, Mitelman et al, 1991) 
Cytogenetic analysis of TCCs of the urinary bladder has revealed several specific 
chromosomal changes, i e iso(5q ), +7, -9, or -9q- and possibly lip- (Ramaekers & 
Hopman, 1993) Whether there is a correlation between the cytogenetic changes and 
biological behavior of the tumor needs to be determined in more detail 
3 Allelorypmg 
Another powerful tool to study genetic imbalances in genomic tumor DNA can be 
performed by restriction fragment length polymorphism (RFLP) analysis For this purpose, 
labelled polymorphic DNA probes are used as markers to identify individuals heterozygous 
for specific chromosomal loci Alleles present in tumor DNA from heterozygous individuals 
can be compared with those present in the corresponding constitutional DNA isolated from 
normal blood cells to detect allele loss or loss of heterozygosity (LOH) Such LOH in the 
vicinity of putative onco-suppressor gene loci has been used as support for Knudson's two 
hit hypothesis of carcinogenesis (Knudson, 1989), involving loss of gene function by 
homozygous inactivation of tumor suppressor genes Using RFLP analysis, allelic losses in 
the vicinity of onco-suppressor gene loci have now been observed in a high proportion of 
several human solid tumor types, such as breast cancer (17p, 17q, Salo et al, 1991), colon 
cancer (5q, 17p, 18q, Vogelstem et al, 1988), and bladder cancer (9q, l ip , 17p, Tsai et al, 
1990) This approach requires however relatively large numbers of polymorphic DNA 
markers, which must then also be informative for the patient under investigation (Cavenee 
et al, 1983, Bishop, 1987) Although amplifications of specific DNA sequences can be 
detected, it is difficult to distinguish between two and three copies of a specific DNA 
segment Furthermore, since this analysis is done on Southern blots from tumor DNA, no 
information is obtained at the single-cell level Also contamination with DNA from non-
neoplastic cells may hamper the interpretation Therefore, the analysis of genomic DNA 
from tumor samples for chromosomal gain and loss by this method remains laborious and is 
10 
unlikely to be applied in a routine setting 
4 In situ Hybridization 
In situ hybridization (ISH) may be defined as the method for a direct detection of 
specific nucleic acid sequences in cells and tissues in which simultaneously morphological 
analysis can be performed ISH was originally described in 1969 using 32P-labeled probes 
(Pardue & Gall, 1969, John et al, 1969) Improvements in recombinant DNA technology 
and isotopie labelling procedures allowed the demonstration of single copy genes on meta-
phase chromosomes (Gerhard et al, 1981) Subsequent development of non-radioactive 
detection methods increased the safety and simplicity of the procedure while also equivalent 
sensitivity could be achieved without using radioactive labels (Hopman et al, 1988; Raap et 
al, 1990) Since chromosomes are generally organized into distinct domains in interphase 
nuclei, ISH can be applied to detect chromosome aberrations in non-mitotic cells. There-
fore, this technique is often called "interphase cytogenetics" (Cremer et al, 1986). In 
particular for solid tumors interphase cytogenetics is of great importance, because it has the 
potential to link the more morphologically-orientated techniques to the more molecular 
techniques, such as RFLP analyses 
Several non-radioactive methods have been developed for in situ DNA-DNA hybrid 
detection A chromosome-specific DNA probe can chemically be modified with 2-acetyl-
aminofluorene (Landegent et al, 1984) or mercury-(II)-acetate (Hopman et al, 1986), or 
enzymatically be modified by a nick translation reaction using deoxyundine triphosphate 
labeled with biotin (Langer et al, 1981), digoxygenin (Kessler, 1990), or fluorescein 
(Wiegant et al, 1992 ) These haptens can be subsequently detected by affinity-cytochemical 
techniques, using specific monoclonal or polyclonal antibodies Therefore, fluorochromes, 
such as FITC, TRITC, Texas Red, or AMCA, as well as enzymes, such as horse radish 
peroxidase or alkaline phosphatase, can be applied (for review see Raap et al, 1989) By 
using multiple-labeled probes the number of probes that can be detected simultaneously has 
been extended (Nederlof et al, 1990) 
The clinical application of ISH depends on the availability of probes that bind speci-
fically to regions of genetic or cytogenetic interest The probes now in use fall into three 
general classes 
(1) Probes for repeated DNA sequences specific for only one chromosome type All 
human chromosomes have been shown to carry DNA sequences that are tandemly repeated 
several hundred to several thousand times in the centromenc region. Most of these 
sequences are of the alpha-satellite (tandemly repeats of about 171 bp monomers) or the 
satellite-Ill (5 bp monomers) families The specificity of probes for these regions comes 
from the fact that there is significant variation in the repeated monomers among chromo-
some types Chromosome specific repeat sequence probes have now been isolated and 
cloned for human chromosomes 1, 3-12, 15-20, X, and Y These probes are used primarily 
for chromosome counting, since their target sequences can be detected as dot-like signals, 
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reflecting the number of the individual target chromosomes. 
(2) Whole chromosome probes which comprise elements with DNA sequence homology 
along the length of a target chromosome. These probes, typically made from chromosome-
specific recombinant DNA libraries, are useful for analysis of both structural and numerical 
aberrations in metaphase spreads The phage DNA chromosome libraries were produced 
from flow-sorted chromosomes (Pinkel, 1988). Subcloning of the phage inserts into 
Plasmids reduces the amount of vector DNA associated with each human insert. These 
probes are referred to as "chromosome painting" probes, since they are used to stain (paint) 
whole chromosomes 
(3) Probes for specific loci. These are typically single copy gene probes, homologous to 
specific targets ranging in size from 15 to >500 kb, so that the signals are bright and 
reliable DNA sequences cloned into large insert phages, cosmids, or yeast artificial 
chromosomes have proven to be useful as specific locus probes (Tkachuk et al, 1991). 
The application of these probes in tumor pathology for the detection of numerical and 
structural chromosome aberrations in both metaphase spreads and interphase nuclei will be 
discussed in Chapter 1 
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Scope of this Thesis 
The general purpose of this study was the application of nonradioactive ISH techniques to 
the analysis of interphase nuclei of single cell suspensions and tissue sections from hemato-
logical malignancies and TCC of the urinary bladder Furthermore, procedures were 
developed to facilitate the detection of chromosomal abnormalities in these tumors 
Genetic alterations in these cancers have been identified by classical karyotyping proce-
dures However, in case the tumor cells are cultured to obtain more and better metaphase 
spreads as compared to the direct analysis, a potential danger exists in the loss of genetic 
material and the selection of certain fast-growing subpopulations In diagnostic pathology the 
FCM analysis of these lesions has become an accepted screening method for the determina-
tion of the DNA content and proliferative capacity of malignant cells in solid tumors These 
parameters can be used as prognostic and diagnostic indicators 
As mentioned before in this chapter, interphase cytogenetics using chromosome-specific 
repetitive DNA probes may be applied as an alternative approach for these two classical 
techniques, especially in the case of solid tumors 
The aim of the study described in this thesis was to use mainly probes for repetitive DNA 
sequences in combination with ISH, and to make this approach suitable for application in a 
more or less routine setting The findings of the ISH methods were compared with those 
obtained by other techniques, such as conventional karyotyping and RFLP analyses 
Chapter 1 reviews the techniques of interphase cytogenetics and its clinical applications 
and results in tumor pathology 
In the first part of the thesis the ISH technique is applied to interphase cells of hemato-
logical tumors since these tumor cells could be easily analyzed at the single cell level, and 
routine karyotyping could be applied to virtually all cases In Chapter 2 a panel of centro-
mere associated DNA probes has been applied to detect numerical chromosome aberrations 
in interphase nuclei These findings were correlated to conventional karyotyping data 
Chapter 3 describes a new application of ISH on agar cultures, where a numerical chromo-
some aberration can be used as a marker for progenitor cells In Chapter 4 this new method 
has been applied to investigate in vitro cultured progenitor cells and single cells of patients 
with AML in order to illustrate the usefulness of the technique to study behaviour of AML 
during preleukemic phase active disease, remission, and under in vitro culture conditions 
The second part of the thesis demonstrates the usefulness of interphase cytogenetics for 
the detection of chromosomal abenations in solid cancers Therefore, the transitional cell 
carcinoma of the urinary bladder was chosen as a model While cytogenetic analyses of these 
malignancies have been used to piovide a basic knowledge of genetic alterations in bladder 
cancer ISH procedures have been applied to further screen for numerical (Chapter 5) and 
structural (Chapter 6) chromosomal abenations Chapter 6 describes the application of the 
ISH technique to concerniate on stiuctuial chiomosome 1 aberrations Finally Chapter 7 
compares the interphase cytogenetic technique on frozen tissue sections to RFLP analysis of 
the same tumors 
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Introduction 
The prognosis of malignant or premalignant lesions is in many cases correlated with the 
quantitative and structural aberrations in the genomic content of the disease. Therefore, 
techniques such as flow cytometry (FCM), karyotyping and molecular techniques have been 
developed for the detection and characterization of such genetic changes, which may be 
central to the initiation and progression of neoplasms. 
The FCM technique quantitates the total DNA content of a tumor cell population, but it 
gives no information with respect to specific chromosome aberrations and has limitations in 
the detection of minor quantitative DNA changes. 
Chromosome analysis of cancer cells by karyotyping (metaphase cytogenetics), on the 
other hand, facilitates the identification of small deviations in chromosome content and 
chromosome structure. However, karyotyping is often only possible after tissue culturing, 
which may result in a selective growth of cells with the highest mitotic index and loss of 
chromosomal material. Furthermore, such analyses are often hampered by the small number 
of recognizable metaphases, the lack of chromosome spreading, poor banding quality, and a 
condensed or fuzzy appearance of the chromosomes. 
The multiple molecular techniques, such as DNA sequencing, Southern and Northern 
blotting, RFLP analysis and PCR. make it possible to study genes, their copy number, 
structure and the regulation of their expression. These techniques have identified different 
genes involved in cancers, like proto-oncogenes and tumor suppressor genes. Although the 
sensitivity of these molecular techniques is high, partially as a result of the large amount of 
starting material, no information is obtained on the single cell level, and heterogeneity 
within a population of cells is often difficult to detect. 
The non-radioactive in situ hybridization (ISH) procedure has been developed to 
overcome the limitations of FCM, karyotyping and molecular genetics. The use of 
chromosome specific DNA probes in combination with the ISH technique enables the 
detection of numerical and structural chromosome aberrations in both metaphase spreads 
and interphase nuclei. The term "interphase cytogenetics" refers to the cytogenetic analysis 
by means of ISH applied to non-mitotic cells, and was originally introduced by Cremer et 
al (1986). 
About twenty years ago, the technique of in situ hybridization was developed using 
radioactive probes (Pardue & Gall, 1969; John et al. 1969). The radioactive ISH has, 
nowadays, reached a very high sensitivity. The detection of DNA sequences of single copy 
genes (Harper et al, 1981), viral genomes (Brigati et al, 1982; Burns et al, 1986), or 
mRNA molecules in individual cells (Cogían et al, 1985) or tissue slides (Angerer et al, 
1985; Burns et al, 1987; McGee et al, 1987; Denijn et al, 1990) has been described. 
The radioactive procedure has the disadvantages of long exposure times for detection, 
biological hazard and limited spatial resolution. Therefore, modifications of nucleic acids 
with haptens or other labels, which allow a non-radioactive detection (e.g. by fluoro-
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chromomes, enzymes, or colloidal gold particles) have been developed (Raap et al, 1989). 
Moreover, the non-radioactive ISH allows the detection of two, three, or even more 
different DNA targets as well as mRNAs by using differently labelled probes followed by 
different immunocytochemical detection systems (Landegent et al, 1985; Hopman et al, 
1986, Nederlof et al, 1989, 1990; Lichter et al, 1990). Also the combination of immunocy-
tochemistry and in situ hybridization is feasible (Denijn et al, 1990). 
Methodological Aspects 
To employ the ISH procedure in Pathology practice and to apply it to single cell 
suspensions paraffin sections and rrozen sections of solid tumors, the next general 
methodological outline is followed 
1) selection of probes; 2) modification of the probe by non-isotopic, enzymatic or chemical 
labelling; 3) fixation of the biological material, and pretreatment of tissue material on the 
slides for ISH; 4) specific hybridization of the modified probe with denatured target DNA, 
and 5) immunocytochemical detection of the hybridized probe 
DNA Probes 
The eukaryotic DNA contains many repeated base-pair sequences, with highly repetitive 
DNA (satellite DNA) usually localized near centromeres. Some satellite DNAs have a 
heptanucleotide sequence repeated more than ten thousand times. Another category of 
repetitive DNA sequences is represented by the genes for rRNA and histones A third 
category comprises single-copy DNA, consisting of sequences that occur only once (or a 
few times) in a haploid genome (Jelinek & Schmid, 1982) 
Several types of DNA probes can be used to detect numerical and structural chromosome 
aberrations 
DNA probes recognizing highly repetitive sequences, mostly in the centromeric and 
telomeric region (Table 1), are now routinely applicable in pathology practice (Figures 1 
and 2), also since their number is constant during the entire cell cycle. 
Probes recognizing entire chromosomes or large single copy genes are also being 
developed In order to obtain cyto-staining of individual human chromosomes using 
commercially available genomic DNA libraries, a suppression of hybridization signals from 
ubiquitous repeated sequences, such as the Alu and Kpnl elements, is necessary. This can 
be achieved by using total human DNA in a reannealing procedure, and is therefore also 
referred to as Chromosome In Situ Suppression (CISS) hybridization (Cremer et al, 1988). 
This principle is also used to facilitate the selective hybridization of unique sequence 
subsets from cosmid DNA clones in ISH experiments (Landegent et al, 1987; Fuscoe et al 
1989) As a result, a more or less homogeneous hybridization signal on individual human 
chromosomes from pter to qter can be obtained (Figure IE), which can also be recognized 
in the interphase nuclei as chromosome domains (Figure IF and I) Large single copy genes 
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Table 1. Chromosome specific repetitive DNA probes 
Chromosome 
1 
ІрЗб 
3 
6 
7 
8 
9 
10 
11 
12 
15 
16 
17 
18 
Χ 
Y 
Name 
Probe 
pUCl 77 
ρ 1-79 
ρα3 5 
р308 
p7tl 
D8Z2 
pHUR98 
DlOZl 
pLCllA 
ρα12Η8 
D15Z1 
pHUR195 
pl7H8 
Ll 84 
pBAMX5 
DYZ5 
Inseit 
(kb) 
1 77 
0 90 
2 10 
3 00 
0 68 
2 55 
0 16 
0 95 
0 85 
1 35 
1 80 
1 20 
2 70 
0 68 
200 
2 10 
Repetitive 
Sequence 
sat.lll 
unknown 
alphoid 
alphoid 
alphoid 
alphoid 
sat III 
alphoid 
alphoid 
alphoid 
sat III 
sat II 
alphoid 
alphoid 
alphoid 
sat III 
Reference 
Cooke et al, 1979 
Buroker et al, 1987 
Waye et al, 1989 
Jabs étal, 1984 
Waye et al, 1987 
Donlon et al, 1986 
Moyzis et al, 1987 
Devileeetal, 1988 
Waye et al, 1987 
Looijenga et al, 1990 
Higgins étal , 1985 
Moyzis et al. 1987 
Waye et al, 1986 
Devi lee et al, 1986 
Willard et al, 1983 
Cooke et al, 1982 
can be detected in the interphase nucleus if the target covers about 10 30 kb of unique 
sequences The application of these probes in pathology is still in a developmental stage, 
and the number of papers is limited (Cremer et al, 1988, Pinket et al, 1988, Arnoldus et al, 
1991) 
Probe modifications 
To detect the molecular hybrids of probe and target sequences, a reporter molecule has 
to be introduced into the DNA piobe This can be done by the enzymatic incorporation of 
biotin, digoxygenin, BrdUTP, and recently FITC-dUTP, or by a chemical modification 
with e g an acelylaminofluorene (AAF) group, mercury ions, or a sulphone group (for 
review see Raap et al, 1989) 
Recently, also the chemical synthesis of oligonucleotide probes containing functional 
groups (ι e primary aliphatic amines or sulfhydryl groups) has been described, thus in 
principle allowing the application of nucleotide oligomers in non-radioactive ISH by 
coupling haptens such as biotin or reporter molecules like fluorochromes or enzymes (Raap 
et al, 1989) These modified oligonucleotide probes will become of great importance as 
their automated synthesis makes them available to laboratories not familiar with DNA 
recombinant technology 
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Detection Systems 
In most cases the haptens, or the modified probe, are detected by affinity cytochemical 
techniques, using monoclonal or polyclonal antibodies directed to the introduced haptens. 
Indirect immunocytochemical procedures use fluorochromes such as fluorescein (FITC), 
rhodamin (TRITC), Texas Red, or AMCA (amino-methylcoumarin acetic acid). For routine 
light microscopy enzymes such as peroxidase with or without amplification, alkaline 
phosphatase, or the avidin/biotinylated-anti-avidin system are applied, resulting in a 
precipitation of enzyme substrates with different colours. 
The simultaneous hybridization of two or more differently labeled probes (e g. biotin, 
digoxygenin and AAF) can be visualized using fluorochromes, such as FITC, TRITC and 
AMCA In principle, the peioxidase and alkaline phosphatase can also be applied in 
precipitation reactions to detect two different nucleic acids by routine light microscopy 
(Hernngton et al, 1989) The localization and resolution of the signals is however not so 
good as compared with the use of fluorochromes. In Figures 1 and 2 we show some 
examples of the use of fluorochromes or enzymatic detection systems 
Processing of Biological Material for ISH in Pathology 
In Pathology, fresh tumor material obtained after surgery or by fine-needle aspiration 
biopsies is divided for different diagnostic approaches, such as immunocytochemistry, histo-
or cytological diagnosis, flow cytometry, or in situ hybridization. Most of the fixatives used 
in pathology, such as ethanol 70% in flow cytometry, or formaldehyde in some immuno-
histological procedures, do not hamper an ISH reaction To accomplish a good penetration 
of the DNA probes and subsequently for the antibodies, proteolytic enzymes such as 
proteinase К and pepsin are applied in different ISH protocols, to reverse the effect of the 
fixative, thus increasing the accessibility ot the target DNAs (Hopman et al, 1988a, Raap et 
al, 1990) by removing the cytoplasm and part of the nuclear proteins (Hopman et al, 
1988b) In general, to obtain optimal hybridization signals, cells with a higher DNA 
content and larger nuclei need a milder pepsin pretreatment than cells with smaller nuclei. 
For sections of routinely processed tumor material a higher concentration of pepsin has to 
be used (Hopman et al, 1991) As a result ol sectioning of the nuclei in paraffin blocks or 
frozen material, an underestimation of the real copy number can be the result. Therefore, 
we correlated chromosome copy numbers as detected in single cell suspensions isolated 
from fresh tumor material with the number as detected in paraffin sections of the same 
tumor Comparison of the ISH data shows that an aneuploidy can easily be detected (Figure 
2) The surplus value of ISH on paraffin sections as compared to ISH on isolated tumor 
cells can be summarized as follows 1) chromosome heterogeneity (e g tetraploidization) 
can be detected within a tumor, 2) focal tumor cell aieas with chromosome aberrations can 
be recognized in the sections and be correlated with the histologic appearance; 3) discri­
mination between stromal, inflammatory cells and tumor cells is possible, 4) no selection of 
cells occurs as a result of the cell disaggregation procedure 
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Pitfalls and Criteria Гог Evaluation 
The estimation of chromosome ploidy in single cells as well as in sections may be 
incorrect for different reasons. Cells in which the chromosome copy number is under­
estimated can always be detected as a result of inefficient hybridization and colocalization 
of spots. An overestimation of ISH signal numbers can be made when the morphology of 
the cells is disrupted. Furthermore, the overlap of nuclei, the inhomogeneous fluorescent 
intensity of ISH signals, minor binding sides, and spots in paired arrangement (split spots), 
can interfere with the estimation of the real chromosome copy number of a cell. 
Applications 
The probes and methods described above have been applied to several types of human 
malignancies. In the following a summary of the most relevant data is given. 
Hematological tumots 
In hematological oncology chromosome banding techniques play an important role in 
determining diagnosis and prognosis since well established knowledge of chromosome 
aberrations in hematological malignancies exist. Therefore, it is to be expected that also 
interphase cytogenetics will be implemented rapidly for diagnosis and monitoring of 
leukaemia and lymphomas. 
Recently, some studies were published, comparing the interphase cytogenetic procedure 
using non-radioactive ISH with conventional cytogenetic analyses of cell lines derived from 
solid tumors, in neoplastic cells from bone marrow and peripheral blood (Nederlof et al, 
1989; Anaslasi et al, 1990; Kibbelaar et al, 1991; Poddighe et al, 1991). These studies 
demonstrated that repetitive DNA probes can be applied routinely in a ISH procedure and 
are useful in addition to conventional cytogenetic techniques for the detection of both 
numerical as structural chromosome aberrations on interphase nuclei and metaphase 
spreads. 
With the ISH method it is also feasible to detect low numbers of host cells in sex-
mismatched bone marrow transplant recipients (Van Dekken et al, 1989). Figure 1-0 shows 
results of a double-target ISH experiment using an X and Y specific probe, in which the 
appearance of a male cell in a female population, with a sensitivity in the order of 0.01%, 
can be detected. As compared to karyotyping this simple and fast method has furthermore 
the advantage that it does not require metaphase spreads, but can be applied on interphase 
nuclei. 
Although cenlromeric DNA probes are already useful to detect numerical chromosome 
aberrations, it is also possible to detect structural aberrations with these centromeric probes 
(Nederlof et al, 1989; Poddighe et al, 1991). We demonstrated that the use of double-target 
ISH experiments on interphase nuclei of bone marrow cells (Figure 1K-N) can characterize 
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marker chromosomes and translocations between chromosomes. 
To monitor patients for residual disease for which one or more cytogenetic hallmarks 
are known, interphase cytogenetics is also exquisitely suited. For example, chronic 
myelogenous leukaemia (CML) is genetically characterized by a fusion of the ber and abl 
genes on chromosomes 22 and 9, respectively. This translocation can be detected by e.g. 
Southern blot analysis and/or other molecular genetic approaches such as in vitro ampli-
fication by polymerase chain reaction (PCR). However, these techniques give no infor-
mation about individual cells. A two-color fluorescence ISH approach with probes 
recognizing the ber and abl oncogenes was applied to demonstrate the bcr-abl fusion in 
interphase nuclei of individual blood and bone marrow cells (Tkachuk et al, 1990; Arnoldus 
et al, 1990). 
Urological rumors 
Bladder cancer. In order to detect numerical chromosome aberrations in transitional cell 
carcinomas (TCCs). several studies have used the hybridization of centromere specific 
DNA probes for chromosome 1, 7, 9, 11, 15, 17, and 18 (Hopman et al, 1988b, 1989, 
1991) to single-cell suspensions of these tumors. 
The results showed that in bladder tumors, which had a DNA index of approximately 1.0 
as measured by FCM, aneuploidy could be frequently detected. Most strikingly, a mono-
somy for chromosome 9 was found in low-grade TCCs. 
Tumors with a DNA index of 1.2 to 3.2, exhibited an even more profound hetero-
geneity when evaluating within one tumor or between different tumors with the same DNA-
content. This phenomena is demonstrated by double-target ISH experiments in Figure 1J, 
showing an imbalance between chromosomes 1 and 18. Analysis of the total tumor cell 
populations by ISH has shown that minor cell fractions with extremely high chromosome 
copy numbers can be detected in these tumors. These cells may possibly originate from 
polyploidization. In high grade and/or invasive FCM aneuploid/tetraploid tumors chromo-
some 9 frequently appeared to be disomic, while the other chromosomes confirmed the 
tetraploidization. 
One of the chaiactenstic numerical aberrations which we detected in low-grade 
noninvasive TCCs included, next to the monosomy for chromosome 9, a trisomy for 
chromosome 1. Since the localization of many of the DNA targets will result in aberrant 
ISH spot numbers only when a complete loss or gain of the centromere or deletions 
including part of the centromere are involved, we hybridized low-grade noninvasive TCCs 
with a probe for the centromenc and telomeric region, as well as a library of DNA probes 
for chromosome 1 in single- and double-target hybridizations to detect selective loss or gain 
of the p- or q-arm. In this ISH study we determined frequent imbalance between the 
presence of centromere and telomere regions of chromosome 1. In some diploid cases three 
centromeric regions were found, while only two telomeric regions were detected. In those 
cases three domains for the library probe for chromosome 1 were seen (Figure 1G-I), 
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whereas in the tetraploid cases a selective loss of heterochromatin was observed (to be 
published). 
We also detected numerical chromosome aberrations in paraffin sections of TCCs 
(Hopman et al, 1991). As an example, we show a TCC with a DNA index of 1.0, in which 
the main population contained a trisomy for chromosome 1 in single-cell suspensions. In 
the tumor areas, cell populations with spot numbers ranging from 1 to 4 were detected 
(Figure 2C). The inflammatory cells in the paraffin sections of this tumor mainly showed 
two spots for chromosome 1 (Figure 2D). Comparison of the ISH data from isolated tumor 
cells in suspension and paraffin sections show that aneuploidy can easily be detected. Figure 
2E demonstrates a paraffin section of a TCC with a DNA index of 3.2. While in isolated 
cells, the average spot number for the chromosome 1 probe ranged from 6 to 9, in the 
paraffin sections this range was broader and no evident major peak could be detected. On 
basis of these comparative studies we conclude that a fast screening method for detection of 
numerical chromosome aberrations in routinely processed tumor material has become 
available. Hybridization with different probes on the same tumor areas in parallel sections 
or double-target ISH will enable to study chromosome ratios and therefore the specific loss 
of chromosomes. 
Figure 1. Single-target and double-target in situ hybridization on interphase nuclei and metaphase 
spreads In A and B, interphase nuclei and metaphase spreads of human lymphocytes are hybridized 
with probes for chromosomes I (TR1TC fluorescence signals in B) and 18 (FITC fluorescence signaL· 
in B). The naming of the DNA m A is performed with DAPI. In С and D, interphase nuclei and 
metaphase spreads of human lymphocytes are hybridized with telomeric probe pi. 79 for chromosome 1 
(see arrows) In E and F, a phage probe library for chromosome ¡2 is hybridized on a metaphase 
spread (E) and interphase nuclei (F) of human lymphocytes. F shows the two domains of chromosome 
12 in the interphase nuclei; this probe mature has a preferential hybridization affinity to the 
centromere In G, H and I, interphase nuclei of flow cytometrically diploid transitional cell carcinoma 
of the urinary bladder are hybridized with a centromere probe pUCl 77 ( trisomy. G), a telomere 
probe pi. 79 (disomy, H), and a phage probe library (two and three domains, I) for chromosome 1. In 
J, double-target ISH using probes for chromosome 1 (FITC, green ISH spots) and chromosome 18 
(TRITC, red spots) demonstrates the chromosome heterogeneity in the tumour cells of bladder. In K, L, 
M and N, double-target ISH was performed with the probe for chromosome 1 (FITC, green ISH spots) 
and the probe for chromosome 16 (TRITC, red ISH spots) on bone marrow cells of a patient suffering 
chronic myeloid leukaemia Colocalization of red and green spots, resulting in yellow/white signals in 
M and N, indicating the translocation product t(I;l6). In O, the arrow shows a male cell in a female 
blood cell population, showing chimerism after bone marrow transplantation. In P, the combination of 
immunohislochemistry and the ISH technique is demonstrated and shown to discriminate between 
epithelial (keratin positive. Alkaline phosphatase/fasl blue T24 cells, which are trisomtc for the 
chromosome I probe) and non-epithelial (keratin negative Molt4 cells, which are tetrasonuc for the 
chromosome 1 probe) cells 
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Prostate cancer. The analysis of prostate tumors by ISH was reported by Van Dekken 
et al (1990). These authors found two typical chromosomal aberrations in adenocarcinomas 
of the prostate, i.e. a monosomy for chromosome 10 and a loss of the Y-chromosome. This 
Y-chromosome loss is possibly age-related, while the monosomy for chromosome 10 may 
correlate to the metastatic behavior of this carcinoma type, since in the literature a 
del(10q24) has been reported in such cases (Sandberg et al, 1988). 
Renal cell carcinoma. Clinical evaluation of patients with renal cell carcinoma results in 
a TNM classification with a predictive value for prognosis after surgical treatment. This 
allows a rough subdivision of patients into groups with different survival rates. Additional 
techniques have been explored for their ability to obtain a more precise classification of 
patients Recently, Beck et al (manuscript in preparation) applied the ISH technique, using 
specific centromeric probes for chromosomes 1 and 7, to detect genetic events involved in 
the progression of this renal cell carcinoma. It is concluded that the group of renal cell 
carcinomas with a diploid DNA content as measured by flow cytometry can be subdivided 
into two subpopulations on basis of ISH. One group with an euploid spotnumber for 
chromosomes 1 and 7, and another group with an aberrant number of spots for these 
probes. Whether or not this refinement in diagnosis is of clinical importance remains to be 
evaluated. 
Breast tumors 
Devilee et al (1988) detected numerical aberrations for the target sites of chromosome 1 
and/or chromosome 18 in seven studied primary breast tumors. Although all had a single 
peak in DNA flow measurements, six of the cases appeared to be heterogeneous with 
respect to the chromosome 1 and 18 content per nucleus, whereas no shift in DNA content 
was observed in the flow cytometer. Moreover, this finding is observed in more solid 
tumor types, since a minimal DNA difference of about 4% from DI = 1.0 is required for 
obtaining a split peak in flow cytometry. 
Tesm tumors 
One approach in the prevention of testicular germ cell cancer is to diagnose the 
neoplasia at an early stage, i.e. carcinoma in situ (CIS) or even earlier. So-called atypical 
germ cells morphologically resemble neoplastic cells in seminoma. The hyperdiploid DNA 
content, as measured by flow cytometry, is one of the markers of seminomas, next to 
numerical aberrations of chromosome 1. Giwercman et al (1990) developed a noninvasive 
procedure using the nonradioactive ISH assay with a probe for chromosome 1 on prepa-
rations of semen. In a blind study they identified samples from both patients with isolated 
CIS changes and patients in whom CIS was accompanied by a tumor, based on the 
percentage of the hyperdiploid cells present in such preparations. It was concluded that for 
detection of aneuploid cells in semen, ISH may be a more sensitive technique than flow 
cytometry, and may become a valuable and fast tool for diagnosis of testicular CIS and 
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thereby for prevention of testicular cancer 
Walt et al (1989) used the ISH procedure with the probe for chromosome 1 to deter-
mine whether such aberrations can be detected in atypical germ cell nuclei in paraffin-
embedded seminiferous tubules as well One-third of intratubular nuclei, containing atypical 
germ cells, consistently showed three hybridization signals in contrast to two signals 
regularly observed in normal intestine and spermatogonia Therefore, also cytogenetic 
studies of precancerous cells can be performed directly on paraffin embedded tissue which 
will now allow retrospective studies 
Van Dekken et al (1990) applied the ISH to assess the presence of numerical chromo-
some aberrations in nuclei isolated from a fresh seminoma, using a panel of 12 centromeric 
probes Compared with the FCM analysis they found for almost all of these probes an 
aneuploid number of fluorescent spots 
Neurological tumors 
Cytogenetic studies of brain tumors have revealed numerical chromosome aberrations, 
such as a polysomy for chromosome 7 and losses for chromosomes 10, 22 and the sex 
chromosomes in glioma cells (both oligodendroglioma and glioblastoma cells), as well as 
monosomy for chromosome 22 in meningiomas Until now, these cytogenetic aberrations 
are only observed by karyotyping 
Cremer et al (1988) have documented structural and quantitative changes in two glioma 
cell lines, including the loss and gain of entire individual chromosomes, and of chromo-
somal subregions They have been able to characterize both minor and predominant 
karyotypic features in each cell line The target sequences in chromosomes 1, 4, 7, 18 and 
22, clearly highlighted numerical and/or structural aberrations, using library probes in the 
CISS hybridization technique They observed in both cell lines an under-representation of 
chromosome 22 and an over-representation of chromosome 7, in agreement with previous 
studies on gliomas In addition, these authors observed also an under-representation for 
chromosome 4 
Recently, Arnoldus et al (1991) has screened for these chromosomal aberrations using 9 
centromeric DNA probes on a procedure for interphase cytogenetics by ISH on brain 
tumors Apart from a discrepancy in the frequency of appearance of chromosomal 
aberrations as compared to the literature they found the similar cytogenetic aberrations 
Hydatidiform moles and hydropic abortions 
The differential diagnosis of complete (CM) and partial (PM) hydatidiform moles and 
hydropic abortions (HA) can be difficult when based on histology alone Therefore, van de 
Kaa et al (1991) performed the ISH technique on paraffin sections of hydatidiform moles 
(Figure 2F-H) and hydropic abortions using probes for chromosome 1, X and Y, to 
discriminate between maternal and trophoblast cells Using the ISH technique it was 
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Figure 2. Results of the ISH procedures on routinely processed cytological and histological material. 
The ISH signals are immunologically detected with peroxidase/DAB for light microscopy. In A, 
metaphase spreads and interphase nuclei of human lymphocytes are hybridized with the repetitive 
probe for chromosome 1, demonstrating two ISH spots per nucleus. In B, a breast tumour in a 
cytological preparation from pleural fluid demonstrates an aneuploid ISH spotnumber for chromosome 
1; the arrows indicate so-called iso-chromosomes. С and D show a flow cytometrically diploid 
transitional cell carcinoma of the human bladder, with two or three spots (see arrows) per nucleus for 
chromosome 1 (C). In D the tumour cells (three spots per nucleus) can be discriminated from the non-
tumour cells, such as stromal cells (see arrow). In E a tetraploid tumour of the bladder is hybridized 
with a probe for chromosome I, resulting in 3 to 9 ISH spots per nucleus. The arrow points to a 
metaphase nucleus, with 9 spots for chromosome 1. F, G and H show a case of hydropically 
degenerated abortion, with three copies of chromosomes I (F) and X (G), and none for chromosome Y 
(H), confirming triploidy as detected by cytometrical analysis. 
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demonstrated that it can be established whether a hydatidiform mole is diploid or triploid, 
which can be of great value in the differential diagnosis between complete and partial 
moles. Furthermore, as a result of the discrimination between maternal and trophoblasl 
cells of complete moles, the cytogenetic heterogeneity as detected in the proliferating 
cytotrophoblasts, confirmed the relatively large hyperdiploid fraction observed by cyto-
metric analyses. 
Gastric tumor:, 
DNA probes for chromosomes 1, 7, 17, X and Y were used for a cytogenetic study of 
ten histologically moderately or poorly differentiated gastric adenocarcinomas (Van Dekken 
et al, 1990). The chromosome aneuploidy as detected by ISH was shown to run parallel 
with the DNA-ploidy as detected by flow cytometry. Moreover, the ISH technique detected 
in a high percentage of cells the loss of the (small) Y chromosome, which could not be 
seen in the flow cytometric DNA histograms. This significant clonal absent of the Y 
chromosome possibly represents a chromosomal marker in this type of tumor. 
Future Prospects 
The ISH procedure gives rapid and statistically more reliable results about genomic 
alterations as compaied to cytogenetic procedures. When compared to data obtained with 
(flow) cytometric procedures ISH gives more precise information about numerical and 
structural aberrations of the genome Because single cell suspensions of solid tumors often 
contain variable mixtures of non-malignant cells, such as stromal or inflammatory cells, 
ISH analysis of such tumor cell suspensions are often difficult to interpret and the real 
tumor cell fraction may be missed or grossly underestimated. Recently, Beck et al (1991) 
have described the application of keratin antibodies in the use of flow cytometry to sort the 
epithelial tumor cells, and to separate them from keratin negative stromal and inflammatory 
cells. In a multi-parameter flow cytometric analysis the tumor cells were sorted onto glass 
slides. After ISH analyses tumor cell populations of for example malignant body cavity 
fluids are enhanced and more convincingly shown to have aberrant numerical spot numbers 
for individual chromosomes. Therefore, a combination of immunocytochemistry and flow 
cytometry, followed by non-isotopie ISH methods, allows the detection of chromosome 
abnormalities in specific cell populations. 
Immunohistochemistry for antigen detection is used successfully in the examination of 
histological and cytological preparations for many clinical and research purposes. While the 
ISH for the detection of nucleic acids is also being increasingly used, there are certain 
situations in which combined use of the two techniques on the same preparation can be 
advantageous. The simultaneous detection of proteins and (viral) DNA by immuno-
histochemistry and ISH, respectively (Mullink et al, 1989; Porter et al, 1990) permits the 
combined demonstiation of antigen and nucleic acid on cytology preparations (Figure IP), 
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but also on routinely processed tissue sections It is to be expected that the techniques for 
such combinations of immunohistochemistry and ISH will be optimized and find in-
creasingly important applications in diagnostic and experimental procedure. 
This review demonstrates that numerical chromosome aberrations can be detected in 
pathologic specimens using centromeric probes, detected with different markers Numerical 
as well as structural aberrations can be detected by the combined use of a centromeric and a 
telomeric probe (Van Dekken et al, 1989) In future, the application of chromosome 
specific probe libraries for interphase cytogenetics offers the opportunity to study structural 
chromosome aberrations in more detail, especially for solid tumors where the existing 
karyotyping procedures are not helpful Furthermore, the identification of marker chromo-
somes and analyses of complex karyotypes may be aided by using the combination of these 
types of DNA probes 
30 
References 
Anastasi J, Le Beau MM, Vardivar JW, Weslbrook CA (1990) Detection of numerical chromosomal 
abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific 
probe Am J Pathol 136 131-139 
Angerer RC, Cox KH, Angerer LM (1985) In situ hybridization to cellular RNAs Gen Eng 7 
43-65 
Arnoldus EPJ, Noordermeer IA, Peters ACB, et al (1991) Interphase cytogenetics on brain tumors 
Genes, Chromosomes & Cancer 3 101-107 
Arnoldus EPJ, Wieganl J, Noordermeer IA, et al (1990) Detection of the Philadelphia chromosome in 
interphase nuclei Cytogenet Cell Genet 54 108-111 
Beck JLM, Hopman AHN, Vooijs GP, Ramaekers FCS (1991) Chromosome detection by in situ 
hybridization in cancer cell population which were flow cytometncally sorted after ïmmuno-
labeling Cytometry, submitted 
Brigati DJ, Myerson D, Leary JJ, et al (1982) Detection of viral genomes in cultured cells and 
paraffin embedded tissues sections using biotin-labelled hybridization probes Virology 126 32-50 
Bums J, Graham AK, Franks C, Fleming KA, Evans MF, McGee JO'D (1987) Detection of low 
copy human papilloma virus DNA and mRNA in routine paraffin sections of cervix by non-iso-
topic in situ hybridization J Clin Pathol 410 858 864 
Burns J, Redfern DRM, Esin MM, McGee JO'D (1986) Human and viral gene detection in routine 
paraffin embedded tissue by in situ hybridization with biotinylated probes viral localization ш 
herpes encephalitis J Clin Pathol 39 1066-1073 
Buroker N, Bestwick R, Haight G, Magenis RE, Lut M (1987) A hypervariable repeated sequence on 
human chromosome lp36 Human Genet 77 175 181 
Coghlan JP, Aldred P, Haralambndis J, Niall HD, Penschow JD, Tregear GW (1985) Hybridization 
histochemistry Analyl Biochem 149 1 28 
Cooke HJ, Hindley J (1979) Cloning of human satellite III DNA different components are on 
different chromosomes Nucleic Acid Res 6 3177 3197 
Cooke HJ, Schmidtke J, Gosden JR (1982) Characterization of a human Y chromosome repealed 
sequence and related sequences in higher primates Chromosoma 87 491-502 
Cremer T, Landegent J, Bruckner A, et al (1986) Detection of chromosome aberrations in the human 
interphase nucleus by visualization of specific target DNAs with radioactive in situ hybridization 
techniques diagnosis of trisomy 18 with probe LI 84 Human Genet 74 346-352 
Cremer T, Lichter Ρ, Borden J, Ward DC, Manuelidis L (1988) Detection of chromosome aberrations 
in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library 
probes Human Genet 80 235 246 
Cremer T, Tessin D, Hopman AHN, Manuelidis L (1988) Rapid interphase and metaphase assessment 
of specific chromosomal changes in neuroectodermal tumor cells by in situ hybridization with 
chemically modified DNA probes Exp Cell Res 176 199-206 
Denijn M, De Weger RA, Berends MJH, et al (1990) Detection of calcitonin-encoding mRNA by 
radioactive in situ hybridization Improved colorimetrie detection and cellular localization of 
mRNA in thyroid sections J Hislochem Cytochem 38 351-358 
31 
Devilee Ρ, Cremer Τ, Slagboom Ρ, et al (1986) Two subsets of human alphoid repetitive DNA show 
distinct preferential localization in the pencentromenc regions of chromosomes 13, 18 and 21 
Cytogenet Cell Genet 41 193-202 
Devilee P, Kievits T, Waye JS, Pearson PL, Willard HF (1988) Chromosome-specific alpha satellite 
DNA isolation and mapping of a polymorphic alphoid repeat from human chromosome 10 
Genomics 3 1-7 
Devilee P, Thierry RF, Kievits T, et al (1988) Detection of chromosome aneuploidy in interphase 
nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes 
Cancer Res 48 5825-5830 
Donlon T, Wyman AR, Mulholland J, et al (1986) Alpha satellite-like sequences at the centromere of 
chromosome 8 Am J Hum Genet 39 A196 
Fuscoe JC, Collins CC, Pinkel D, Gray JW (1989) Efficient method for selecting unique-sequences 
cloned from DNA libraries and its application to fluorescent staining of human chromosome 21 
using in situ hybridization Genomics 5 101-109 
Giwercman A, Hopman AHN, Ramaekers FCS, Skakkebaek NE (1990) Detection of malignant germ 
cells in seminal fluid by means of in situ hybridization Am J Pathol 136 497-504 
Harper ME, Ullrich A, Saunders GF (1981) Localization of human insulin gene to the distal end of 
the short arm of chromosome 11 Chromosoma 83 431-439 
Hemngton CS, Burns J, Graham AK, Evans M, McGee JO'D (1989) Interphase cytogenetics using 
biotin and digoxigenin labelled probes I relative sensitivity of both reporter molecules for HPV 16 
detection in CaSki cells J Clin Pathol 42 592-600 
Higgins MJ, Wang H, Shtromas I, et al (1985) Organization of a repetitive human 1 8 kb Kpnl 
sequence localized in the heterochromatin of chromosome 15 Chromosoma 93 77-86 
Hopman AHN, Hooren van E, Kaa van de CA, Vooijs GP, Ramaekers FCS (1991) Detection of 
numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely 
processed bladder cancers Modern Pathol in press 
Hopman AHN, Moesker O, Smeets WGB, Pauwels RPE, Vooijs GP, Ramaekers FCS (1991) 
Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybri­
dization Cancer Res 51 644-651 
Hopman AHN, Poddighe PJ, Smeets WGB, et al (1989) Detection of numerical chromosome 
aberrations in bladder cancer by in situ hybridization Am J Pathol 135 1105-1117 
Hopman AHN, Raap AK, Landegenl JE, Wiegant J, Boerman RH and Van der Ploeg M (1988) 
Non-radioactive in situ hybridization In Van Leeuwen FW, Buijs RM, Pool CW and Pach O, 
Eds Molecular neuroanatomy Amsterdam Elsevier pp 43-68 
Hopman AHN, Ramaekers FCS, Raap AK, et al (1988) In situ hybridization as a tool to study 
numerical chromosome aberrations in solid bladder tumors Histochemistry 89 307-316 
Hopman AHN, Wiegant J, Raap AK, Landegent JE, Van der Ploeg M, Van Duijn Ρ (1986) Bi-color 
detection of two target DNAs by поп-radioactive in situ hybridization Histochemistry 85 1-4 
Jabs EW, Wolf SF, Migeon BR (1984) Characterization of a cloned DNA sequence that is present at 
centromeres of all human autosomes and the X chromosome and shows polymorphic variation 
Proc Natl Acad Sci USA 81 4884-4888 
Jelinek WR, Schmid CW (1982) Repetitive sequences in eukaryolic DNA and their expression Ann 
Rev Biochem 51 813 844 
32 
John H, Birnstiel M, Jones К (1969) RNA DNA hybrids al the cytological level Nature 223 
582-587 
Kaa van de CA, Nelson KAM, Ramaekers FCS, Vooijs GP, Hopman AHN (1992) Interphase 
cytogenetics in paraffin sections of routinely processed hydalidiform moles and hydropic abortions 
J Pathol in press 
Kibbelaar RE, Kamp van H, Dreef EI, et al (1991) Detection of trisomy 8 in hematological disorders 
by in situ hybridization Cancer Genet Cytogenet in press 
Landegent JE, Jansen in de Wal Ν, Dirks RW, Baas F, Van der Ploeg M (1987) Use of whole 
cosmid cloned genomic sequences for chromosomal localization by non-radioactive in situ 
hybridization Human Genet 77 366 370 
Landegent JE, Jansen in de Wal Ν, Ploem JS, Van der Ploeg M (1985) Sensitive detection of 
hybridocytochemical results by means of reflection-contrast microscopy J Histochem Cylochem 
33 1241-1246 
Lichter Ρ, Chang Tang C-J, Call K, et al (1990) High resolution mapping of human chromosome 11 
by in situ hybridization with cosmid probes Science 247 64-69 
Looijenga LHJ, Smit VTHBM, Wessels JW, et al (1990) Localization and polymorphism of a 
chromosome 12 specific alpha satellite DNA sequence Cytogenet Cell Genet 54 216-218 
McGee JO'D, Burns J and Fleming KA (1987) New molecular techniques in pathological diagnosis 
visualisation of genes and mRNA in human tissue In Bleehen NM, Ed Investigational techniques 
in oncology London Springer-Verlag, pp 21-34 
Moyzis RK, Albright KL, Bartholdi MF, et al (1987) Human chromosome-specific repetitive DNA 
sequences Novel markers for genetic analysis Chromosoma 95 375-382 
Mullink H, Walboomers JMM, Tadema TM, Jansen DJ, Meijer CJLM (1989) Combined ìmmuno-
and non-radioactive hybndocytochemistry on cells and tissue sections Influence of fixation, 
enzyme pre-treatment, and choice of chromogen on detection of antigen and DNA sequences J 
Histochem Cytochem 37 603-609 
Nederlof PM, Robinson D, Abuknesha R, et al (1989) Three-color-fluorescence in situ hybridization 
tor the simultaneous detection of multiple nucleic acid sequences Cytometry 10 20-28 
Nederlof PM, Van der Flier S, Raap AK, et al (1989) Detection of chromosome aberrations in 
interphase tumor nuclei by non radioactive in situ hybridization Cancer Genet Cytogenet 42 
87-98 
Nederlof PM, Van der Flier S, Wiegant J, et al (1990) Multiple-fluorescence in situ hybridization 
Cytometry 11 126-131 
Pardue ML, Gall JG (1969) Molecular hybridization of radioactive DNA to the DNA of cytological 
preparations Proc Natl Acad Sci USA 64 600 604 
Pinkel D, Landegent J, Collins C, et al (1988) Fluorescence in situ hybridization with human 
chromosome-specific libraries Detection of trisomy 21 and translocations ot chromosome 4 Proc 
Natl Acad Sci USA 85 9138 9142 
Poddighe PJ, Moesker O, Smeets D, Awwad BH, Ramaekers FCS, Hopman AHN (1991) Interphase 
cytogenetics ot hematological cancer Comparison ot classical karyotyping and in situ hybridi-
zation using a panel of eleven chromosome specific DNA probes Cancer Res 51 1959-1967 
33 
Porter HJ, Heryel A, Quantrill AM, Fleming KA (1990) Combined non-isotopie in situ hybridization 
and immunohistochemistry on routine paraffin wax embedded tissue identification of cell type 
infected by human parvovirus and demonstration of cytomegalovirus DNA and antigen in renal 
infection J Clin Pathol 43 129-132 
Raap AK, Arnoldus EPJ, Nederlof PM, Smit VTHBM, Comehsse CJ and Van der Ploeg M (1990) 
Detection of numerical and structural chromosome aberrations in interphase nuclei by fluorescence 
in situ hybridization In Elder HY, Ed Transactions of the Royal Microscopic Society London 
MICRO 90, pp 661-667 
Raap AK, Hopman AHN and Van der Ploeg M (1989) Hapten labeling of nucleic acid probes for 
DNA in situ hybridization In Bullock GR, Petrusz P, eds Techniques in immunocytochemistry 
Cambridge Cambridge University Press, pp 165-186 
Sandberg AA, Turc-Carel C, Gemmili RM (1988) Chromosomes in solid tumors and beyond Cancer 
Res 48 1049-1059 
Tkachuk DC, Westbrook CA, Andreeff M, el al (1990) Detection of bcr-abl fusion in chronic 
myelogeneous leukemia by in situ hybridization Science 250 559 562 
Van Dekken H, Bauman JGJ (1989) A new application of in situ hybridization detection of numerical 
and structural chromosome aberrations with a combination centromenc-telomenc DNA probe 
Cytogenet Cell Genet 78 251 259 
Van Dekken H, Hagenbeek A, Bauman JGJ (1989) Detection of host cells following sex-mismatched 
bone marrow transplantation by fluorescent in situ hybridization with a Y-chromosome specific 
probe Leukemia 3 724 728 
Van Dekken H, Pizzolo JG, Kelsen DP, Melamed MR (1990) Targeted cytogenetic analysis of gastric 
tumors by in situ hybridization with a set of chromosome-specific DNA probes Cancer 66 
491 497 
Van Dekken H, Pizzolo JG, Reuter VE, Melamed MR (1990) Cytogenetic analysis of human solid 
tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes Cytogenet 
Cell Genet 54 103-107 
Walt H, Emmerich P, Cremer T, Hofmann M С, Bannwarl F (1989) Supernumerary chromosome 1 
in interphase nuclei ot atypical germ cells in paraffin embedded human seminiferous tubules Lab 
Invest 61 527-531 
Waye JS, Creeper LA, Willard HF (1987) Organization and evolution of alpha satellite DNA from 
human chromosome 11 Chromosoma 95 182 188 
Waye JS, England SB, Willard HF (1987) Genomic organization of alpha satellite DNA on human 
chromosome 7 Evidence for two distinct alphoid domains on a single chromosome Mol Cell 
Biol 7 349-456 
Waye JS Willard HF (1989) Chromosome specificity of satellite DNAs short- and long-range 
organization of a diverged dimenc subset ot human alpha satellite from chromosome 3 Chromo­
soma 97 475-480 
Waye JS, Willard HF (1986) Molecular analysis of a deletion polymorphism in alpha satellite of 
human chromosome 17 Evidence for homologous unequal crossing-over and subsequent fixation 
Nucleic Acid Res 14 6915 6927 
Willard HF, Smith KD, Sutherland J (1983) Isolation and characterization of a major tandem repeat 
family from the human X chromosome Nucleic Acids Res 11 2017 2033 
34 
Chapter two 
Interphase Cytogenetics of Hematological Cancer: Comparison of 
Classical Karyotyping and In Situ Hybridization using a Panel of Eleven 
Chromosome Specific DNA Probes 
Pino J. Poddighe, Olof Moesker, Dominique Smeets, Baha H. Awwad, Frans C S . 
Ramaekers, and Anton H.N. Hopman 
Cancer Research (¡991) 51: ¡959-1967 
35 
Abstract 
Numerica! chromosome aberrations were detected in hematological cancers by non-
radioactive in situ hybridization (ISH) procedures, using centromere specific probes for 
chromosomes 1, 7, 8, 9, 10, 11, 16, 17, 18, X, and Y. All 15 cases could be evaluated by 
ISH for these eleven probes. Our experiments show that in seven of these randomly 
selected leukemia bone marrow cell suspensions numerical aberrations for one or two 
chromosomes could be detected by this method. The results of ISH on interphase nuclei and 
in some cases on metaphase preparations were compared with karyotyping data. Seven 
cases of chromosomal aberrations observed with ISH (three for monosomy and four for 
trisomy) were confirmed by this classical cytogenetic technique, whereas in five instances 
an aberration was found only with ISH (twice for monosomy, twice for trisomy and one 
disomy for the Y-probe). One case of a trisomy for chromosome 1 observed by ISH on 
interphase nuclei could be explained by a marker chromosome, a finding that was further 
substantiated by ISH on metaphase spreads. In this case double-target ISH on interphase 
cells with the probes for chromosomes 1 and 16 strongly suggested a translocation between 
these chromosomes. Also, in one case a marker chromosome could be characterized as a 
translocation between chromosomes 7 and 17. In this latter case the cytogenetic exami-
nations revealed only monosomy for chromosomes 7 and 17 in addition to non-charac-
terized marker chromosomes. 
Our results indicate that the nonradioactive ISH procedure in combination with 
chromosome specific repetitive centromeric probes is a powerful tool for studying both 
numerical and structural chromosomal aberrations in interphase nuclei of leukemias. It may 
therefore become a valuable and routine diagnostic tool in addition to the existing karyo-
typing procedures. 
Introduction 
Cytogenetic analysis, using karyotyping on basis of chromosome banding techniques, 
plays an important role in the detection of chromosomal abnormalities in human solid 
tumors (Teyssier, 1989). In some cases these aberrations can be correlated with diagnosis 
and/or prognosis of the malignant disease and may thus dictate therapeutic modalities. 
However, the interpretation of the chromosome banding patterns is often difficult due to the 
small number of recognizable metaphases, minimal chromosome spreading, poor banding 
quality, and condensed or fuzzy appearance of the chromosomes. A further limitation of 
this technique is that it requires dividing cells, and as a result the majority of the tumor 
cells are excluded from such analyses (Sandberg et al, 1988). Furthermore, in order to 
obtain analyzable metaphase chromosomes, culturing of tumor cells may be needed. This 
can introduce an additional unwanted parameter, i.e., the selection of a certain highly 
proliferative subpopulation of tumor cells. 
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Karyotyping of bone marrow cells from patients with hematological cancers has 
revealed many specific chromosomal abnormalities, which provide diagnostic as well as 
prognostic information (Croce, 1986; Fleischman et al, 1989; Rowley, 1990). A classical 
example of such a marker in chronic myeloid leukemia (CML) is a translocation, resulting 
in the Philadelphia chromosome (Rowley, 1973). However, in cases of terminally differen-
tiated (tumor) cells, such as segmented neutrophils, or cells that have a low proliferative 
capacity, such as cells from patients with chronic lymphatic leukemia, karyotyping is often 
difficult or sometimes even impossible. 
The cytogenetic analysis by 1SH of non-mitotic cells was introduced by Cremer et al 
(1986) and is generally referred to as "interphase cytogenetics". The use of chromosome 
specific DNA probes in combination with the ISH technique enables the detection of 
numerical and structural chromosome aberrations in both metaphase spreads and interphase 
nuclei. As described previously by our group and others (Cremer et al, 1988; Devilee et al, 
1988; Hopman et al, 1988, 1989; Van Dekken et al, 1990), this approach is of great 
importance in studies of solid tumors, where direct chromosome analysis is frequently 
hampered by the small number of recognizable metaphases or disturbed by the fact that the 
tested metaphases are not representative of the tumor because of in vitro selection. 
Until now, only a few ISH studies have been performed in cases of leukemia and even 
fewer studies have correlated ISH results with classical karyotyping data (Nederlof et al, 
1989; Van Dekken et al, 1989; Anastasi et al, 1990; Kibbelaar et al, 1991). In the 
underlying study we have analyzed bone marrow specimens from 15 randomly selected 
leukemia patients with the ISH procedure, using 11 DNA probes recognizing highly 
repetitive sequences in the (peri-)centromeric region of specific chromosomes. These results 
were correlated with cytogenetic analyses of G-banded metaphase chromosomes. 
Materials and methods 
Sample Preparation 
Bone marrow aspirations of three cases of CML, eight cases of acute leukemia 
(AML/AUL/ALL)(Bennett et al, 1985) and four cases of myeloid dysplastic syndromes 
(MDS/CMMol)(Bennett et al, 1982) were randomly selected for our study. Cell prepa-
rations for ISH were made with freshly obtained bone marrow or peripheral blood. The 
samples were layered onto Ficoll Hypaque (Pharmacia/LKB, Sweden; specific density, 
1077 g/ml) and centrifuged at 1200 rpm for 30 min. The low density cells were recovered, 
washed in PBS, fixed in 70% ethanol (-20°C), and stored at -30°C. 
Metaphase spreads were obtained from bone marrow cells that had been cultured in 
RPMI-1640 for 1 or 24 h. Colcemid was present during the last hour of the culture. Before 
fixation in methanohglacial acetic acid (3:1), the cells were exposed to a hypotonic solution 
(0.075 M KCl) for 15 min. Slides were made according to routine cytogenetic procedures. 
Karyotyping was performed using the GTG technique. 
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Tumor Cell Processing for In Sir и Hybridization 
For ISH, 5 μ\ of a cell suspension were dropped onto poly-L-lysine (Sigma Chemical 
Co , St Louis, MO, M
r
 150,000 300,000) coated slides, air dried and heated at 80°C for 1 
h To obtain an optimal recovery of cells and proper removal of cellular protein for 
improvement of DNA probe and antibody penetration, a proteolytic digestion step was 
applied as described before (Hopman et al, 1989) The digestion was performed with pepsin 
(Sigma) at a concentration of 100 /¿g/ml in 0 01 M HCl for 20 min at 37°C. After 
subsequent dip washes in H20 and PBS, the nuclei were post-fixed in 4% formaldehyde in 
PBS for 20 min at 4°C Then the slides were subsequently washed in PBS and H20, 
respectively, and equilibrated in 60% formamide-2xSSC (0 3 M NaCI, and 30 mM Na-
Citrate), pH 7 0, for 10 min at room temperature 
DNA Probes 
For the detection of the target sequences on chromosomes 1, 7, 8, 9, 10, 11, 16, 17, 
18, X, and Y, the plasmid probes (as summarized in Table 1) were used The probes were 
labeled by nick translation with biotin-11-dUTP (Sigma)(Bngati et al, 1982), or modified 
with digoxygenin (Boehnnger, Mannheim, Germany) according to the instructions of the 
supplier Several ot these probes are commercially available from ONCOR (Gaithersburg, 
MD) 
Table 1 Chromosome specific centramene probes used m this study 
Insert Sequence 
Chromosome Name Vector (kilobases) type Reference 
1 
7 
8 
9 
10 
11 
16 
17 
18 
X 
Y 
pUCl 77 
p7t 1 
D8Z2 
pHUR98 
plO 1 
pLCllA 
pHUR195 
pl7H8 
LI 84 
pBAMX5 
DYZ3 
pUC12 
pUC9 
pBS 
pBR322 
pUC9 
pSP65 
pBR322 
pSP65 
pAT153 
pBR322 
pSP65 
1 77 
0 68 
2 55 
0 16 
0 95 
0 85 
1 20 
2 70 
0 68 
2 00 
2 45 
sat III 
alphoid 
alphoid 
sat III 
alphoid 
alphoid 
sat II 
alphoid 
alphoid 
alphoid 
sat HI 
Cooke et al, 1979 
Waye et al, 1987 
Donion et al, 1986 
Moyzis et al, 1987 
Devileeetal, 1988 
Waye et al, 1987 
Moyzis et al, 1987 
Waye et al, 1986 
Devilee et al, 1986 
Willard et al, 1983 
Cooke et al, 1982 
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Table 2. Hybridization data of normal bone marrow and peripheral blood samples from 
male controls (n=6). Of each sample 200 nuclei were counted. Given are the mean 
percentages of the number of ISH signals per nucleus ± SD. 
Probe for 
chromosome 
1 
7 
8 
9 
10 
11 
16 
17 
18 
X 
Y 
0 
0 5 ± 0 3 
0 
0 
0 
0 5 ± 0 6 
0 
0 5 ± 0 3 
0.5 ± 0.3 
0.5 ± 0.3 
0.5 ± 0.5 
1 1 ± 0.8 
Number of ISH 
1 
6 7 ± 2 8 
5 5 ± 15 
4 5 ± 1 5 
6 2 + 2.0 
7 1 + 2.0 
5 0 + 1 1 
10.1 ± 1 1 
5.3 ± 2 1 
8 1 ± 2 7 
98.6 ± 0.5 
98 6 ± 1.8 
signals per nucleus 
2 
92.8 ± 2.7 
94.0 ± 1.7 
95.0 ± 1 2 
93 3 ± 1.6 
92.3 ± 2.1 
94.5 ± 1.2 
89.3 ± 0.8 
94.0 ± 2 6 
92.9 ± 2.5 
1.0 ± 0.6 
0 
3 
0.5 ± 0.8 
0.5 ± 0 8 
0.5 ± 0.5 
0.5 ± 0.5 
0.3 ± 0.5 
0.5 + 0.8 
0.3 ± 0.5 
0.5 ± 0.6 
0.7 ± 0.8 
0 
0 
In Situ Hybridization 
The DNA probes were hybridized to the (tumor-) cell preparations (in single- and 
double-target ISH) as described before (Hopman et al, 1989, 1991) in 60% formamide, 
2xSSC, and 10% dextran sulfate at a probe concentration of 1 ng/μΙ hybridization mixture. 
Under these stringency conditions, hybridization to minor binding sites was avoided Of the 
hybridization mixture, 8 μ\ were applied to the slides under a covershp (18 χ 18 mm) 
Denaturation of probe and target DNA was carried out by heating the slides in a moist 
chamber to 70°C for 2 5 mm Hybridization was then performed overnight at 37°C. The 
covershps were removed by immersing the slides in 60% formamide-2xSSC, pH 7.0. Next, 
the slides were washed three times for 5 min in the same buffer at 42°C and subsequently 
three times for 5 min in 2xSSC, pH 7 0 at 42°C 
Detection of hybrids was accomplished with fluorescent reporter molecules as described 
previously (Hopman et al. 1991) The single-target ISH reactions were performed using 
biotinylated probes and immunocytochemically detected in 4xSSC-0.05% Tween 20-0 5% 
Boehnnger milk, using FITC conjugated avidin (Vector Laboratories, Burlingame, CA) and 
if necessary immunologically amplified using biotin-labeled goat anti-avidm (Vector) 
followed by a second layer of FITC conjugated avidin (Pinkel et al, 1986) Double-target 
ISH using biotin-labeled and digoxygenin-labeled probes, which were hybridized simul-
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taneously, were immunocytochemically detected using monoclonal anti-digoxin (Sigma) in 
PBS-0.05% Tween 20-0.5% Boehringer milk, followed by an incubation of FITC conju­
gated rabbit anti-mouse antibody (Dakopatts, Glostrup, Denmark) in the same buffer. After 
a brief wash in 4xSSC-0.05% Tween 20, the biotinylated probes were immunocyto­
chemically detected using Texas Red conjugated avidin (Vector), and if necessary amplified 
with biotin-labeled goat anti-avidin and a second layer of Texas Red conjugated avidin. All 
the immunocytochemical steps were performed for 30 min at 37°C. 
Figure 1. In situ hybridization results on interphase nuclei from normal lymphocytes with the probe for 
chromosome 1 (B) and to nuclei of bone marrow from case 3 with the probe for chromosome 10 (D). 
(A and C, DNA counterstaining with DA PI). In A and В more than 98% of the interphase nuclei 
exhibit two spots. In С and D, 31 % of the nuclei show three spots, indicated as a trisomy. 
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Evaluation oflSH results 
The ISH procedure was optimized with respect to sensitivity and specificity for the 
chromosome specific centromenc probes used in this study Evaluation and counting of 
fluorescent ISH signals were done by two trained observers according to criteria described 
before (Devilee et al, 1988, Hopman et al, 1988, 1989, Nederlof et al, 1989) Evaluation 
of the preparations was performed by counting 200 nuclei/ slide The analyses of the ISH 
preparations and karyotyping were done without previous knowledge of the results obtained 
by the complementary technique 
Using this ISH procedure, at least 98% of the interphase nuclei of the human lympho­
cytes, the bone marrow cells and the leukemic cells showed one, two or three ISH signals 
in all preparations After the proteolytic digestion step with pepsin, which allowed a good 
penetration of the DNA probes and reporter molecules, the cells retained a good morpho­
logy, while discrete ISH signals with a high fluorescence intensity were obtained By 
counting the number of hybridization spots in 200 nuclei of individual control specimens 
from normal human lymphocytes and bone marrow of healthy donors, the percentages of 
cells containing the euploid number of spots for each of the eleven probes varied between 
approximately 90% and 98% (Table 2, Figure 1A and B) Intra- and interobserver studies 
revealed limited variability (< 2%) in the percentages of detected spotnumbers (see also 
Hopman et al, 1988, 1989) The percentage of cells with one ISH signal can be explained 
partly by close juxtaposition or overlapping of two ISH signals For the specimens used in 
our study we therefore decided upon a monosomy or trisomy for a certain chromosome 
only when the percentage of cells with one or three ISH signals, respectively, was greater 
than the mean ± 3xSD (standard deviation) of the controls The detection of three ISH 
signals in control cells was the case in less than 1 % of the cells for all the probes A 
diagnosis of trisomy in leukemic specimens could theoretically be made if more than 2% of 
the nuclei showed three distinct hybridization signals Paired or split spots, as described 
previously (Hopman et al, 1989, Nederlof et al, 1989, Van Dekken et al, 1989), were 
normally counted as one ISH signal Finally, to avoid misinterpretations with regard to 
monosomy or trisomy, we performed double target hybridization experiments with the 
DNA probe showing the presumed aberration, in combination with a DNA probe, that 
revealed the euploid number of signals in more than 90% of the nuclei 
Results 
The clinical data cytogenetic analyses on GTG-banded metaphase spreads and ISH 
results of the 15 patients are summanzed in Table 3 
Twelve of 15 patients, which can be subdivided in three different groups, ι e , those 
with chronic leukemia (patients 1 to 3) acute leukemia (patients 4 to 11) and myelo-
dysplastic syndrome (patients 12 to 15), showed structural and/or numerical chromosome 
aberrations on basis ot karyotyping assays For one patient with an AML (case 5), no 
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metaphases were found for karyotyping, although a monosomy 16 was observed by ISH. 
Therefore, a comparison of numerical chromosome aberrations detected by cytogenetic 
analyses of bone marrow cells with the results obtained by in situ hybridization to inter­
phase nuclei, was possible for 14 patients screened with the 11 probes (154 of 165 probe 
hybridizations) In 144 of these 154 probe hybridizations a good correlation between results 
of both methods is found In 7 of the 144 probe hybridizations numerical chromosome 
aberrations were observed with both procedures, ι e , three instances of monosomy and 
four instances of trisomy In 10 of the 154 probe hybridizations there was no correlation 
between the karyotyping and ISH In 5 of these 10 tests an aberration was found only with 
ISH (two instances of trisomy, two instances of monosomy, and one instance of disomy for 
the Y-probe) On the other hand in the classical karyotyping procedure 5 numerical 
aberrations were observed (one trisomy, three monosomy, one nullisomy), which were not 
detected by ISH of interphase nuclei 
Those cases in which either the conventional cytogenetic analysis or the ISH procedure 
revealed aberrations for the chromosomes, detectable by the probes used in this study, will 
be discussed in detail 
Table 3 Clinical darà, cytogenetic analyses and ISH results on interphase nuclei of bone 
marrow from patients with leukemia 
Age 
(yr) Diagnosis Karyotype 
Numerical and structural chromosome 
aberrations detected by ISH using 
probes for chromosomes 1, 7, β, 9, 
10, 11, 16, 17, 18, X, and T. 
9 
10 
12 
13 
U 
15 
51 
50 
40 
39 CML 46,XY,t(9,22)(q34,q11),l(17q), 
i(9q),+8, 9, 16, 16, 17,+mar1 
46 XY,t(9,22)/44,Y,t(9,22), X 
46,XX,t(9,22)/47,XX,t(9,22),+Ph' 
46,XY 
no metaphases found 
46,XY 
46,XY,10p+,11p ,many additional 
non clonal aberrations 
46,XY/46,XY,t(9,22)/ 
46,XY,t(9,22), 7,+der(7)t(7p,->) 
46 XX,t(9,22)(q34,q11) 
46,XY,t(9,22)/ 
46,XY,t(9,22),dup(7q)/ 
47,XY,t(9,22),9p+,+5,+B, 6, 7,+marl 
AML Мб 46,XY/44,XY 1, 5, 7, 17,-Hirarl, 
<RAEB t *ΠΒΓ2, »2хтагЗ 
62 CMoL 46, XX 
70 CMoL t 46,Xt/45,XY, 16/46,XY,+11, 16 
47 DA 46,XY/47,XY,+B 
58 RAEB.t 46,XY/44,XY,del(3q),+8, 5, 6 
CML 
CML 
AML.M1 M2 
43 AML Mo 
43 AML-M4 
41 AML M5 
44 AUL 
44 AUL 
42 ALL 
61 
trisomy 1(65%), trisomy 8(87%), 
t(1,16)C60%) 
none 
trisomy 10(31%), monosomy 16(16%) 
none 
monosomy 16(18%) 
none 
none 
none 
none 
monosomy 7(65%), trisomy 8(67%) 
monosomy 1(71%), t(7,17)(65%) 
none 
trisomy 11(72%); monosomy 16(97%) 
none 
monosomy 17(96%), disomy Y(20%), 
trisomy 8(94%) 
In all three cells with 44 chromosomes one X chromosome was missing next to other different 
aberrations in the different individual cells 
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case 1 
ISH on interphase nuclei with the panel of probes revealed significant aberrations for 
chromosome 1 (65% three spots)(Figure 2, C, G, and H) and chromosome 8 (87% three 
spots) Trisomy 8 could be confirmed by karyotyping 
Hybridization on metaphase spreads with the probe for chromosome 1 (Figure 2A) 
showed a similar number and distribution of ISH spots, as shown in Figure ЗА The 
karyotype observed in the bone marrow cells of this patient was extremely complex (Table 
3) The alterations of chromosome 9, 16 and 17, detected by karyotyping, were not seen by 
our ISH assays However, the appearance of an i(9q) and i(17q) can explain the differences 
between karyotyping and ISH on chromosomes 9 and 17. Apparently these isochromosomes 
still contain the alphoid centromenc regions which are recognized by the probes used 
The extra ISH spot with the probe for chromosome 1 as well as the normal number of spots 
with the probe for chromosome 16 could be explained after double-target ISH experiments, 
in which we combined the DNA probes for the chromosomes 1 and 16 The results showed 
a colocalization of ISH signals for chromosomes 1 and 16 in approximately 60% of the 
interphase nuclei (see Figure 2, С Ν) suggesting a translocation between (parts of) 
chromosomes 1 and 16 Reexamination ot metaphases hybridized with the probe for 
chromosome 1 showed a marker chromosome (marl) with two or perhaps even three 
centromenc regions as detected by DAPI counierstaining (Figure 4A) This marker could, 
however, not be characterized as being derived from chromosome 1 and/or chromosome 16 
by karyotyping 
case 2 
Cytogenetic analysis of bone marrow trom this patient with CML showed 2 cell 
populations, although only 8 mitoses were available for examination In 5 of the analyzed 
metaphases 46 chromosomes weie counted, whereas in the other 3 metaphases only 44 
chromosomes were counted In these three cells an X-chiomosome was missing next to 
other aberrations in the different individual cells Virtually all the nuclei contained one 
tluorescent ISH spot after incubation with the X-probe The fact that karyotyping showed 
no marker chromosomes in the latter cell populations suggested that for this case a 
discrepancy in results of the two cytogenetic procedures exists Double-target ISH on 
interphase cells with the probes for the chromosomes X and Y showed that virtually all 
cells had one fluorescent signal per nucleus for each of these centromenc probes in both 
interphase nuclei as well as metaphase spreads The absence of the X chromosome was 
probably a preparation artifact, since in these metaphase spreads also another chromosome 
was missing (see Table 3) 
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case 3 
The nuclei of this patient with CML showed a significantly different distribution for 
chromosome 10 in ISH (31% three spots, 65% two spots and 4% one spot) as compared to 
karyotyping results. Furthermore, with the probe for chromosome 16 we detected a 
statistically significant percentage (16%) of cells with one fluorescent ISH spot. No 
numerical and/or structural chromosome aberrations for one of these two chromosomes was 
detected by cytogenetical analysis (Figures 1, С and D). The ISH results could not be 
examined on metaphase spreads because no samples where available. 
case 7 
Cytogenetic analysis of bone marrow cells from this patient with AML showed a normal 
number of chromosomes, but with many structural aberrations, including 10p+ and lip-. 
ISH with the probes for chromosomes 10 and 11 showed that almost all cells contained two 
ISH fluorescent signals per nucleus (respectively, 96% and 93%). 
case 8 
ISH on interphase nuclei from this patient with AUL with the panel of probes revealed 
no aberrant distribution of spot numbers as compared to the control cells. The cytogenetic 
data showed a monosomy of chromosome 7, in combination with an additional marker 
chromosome, which contained parts of the lacking chromosome 7. 
case 10 
Hybridization to interphase nuclei from this patient with ALL, using the panel of 
probes, showed a significant number of cells that contain one ISH fluorescent signal (65%) 
with the probe for chromosome 7, and three ISH signals (67%) with the probe for 
chromosome 8. The cytogenetic analysis also observed a significant high number of 
metaphases with only one chromosome 7 and three chromosomes 8 (73%). As a result, in 
this case a good correlation between the two analytical procedures could be demonstrated. 
Figure 2. Results of single- (A,B) and double-target (C-Q) in situ hybridization on interphase nuclei 
and metaphase spreads of specimens from case 1 (A, C-N) and case 11 (B, O-R) Blue (J,N,R) or red 
(A,B) counterstaimng of DNA was done with DAPI or propidium iodide, respectively. 
In A, three hybridization signals are demonstrated on a metaphase spread of a malignant cell from 
case 1 after incubation with the probe for chromosome 1. In B, one hybridisation signal with probe 
pUCI 77 is seen on a metaphase spread of case II, indicating a monosomy for chromosome 1 
In C-N, a double-target hybridization was performed with the probe for chromosome 1 (green spots) 
and the probe for chromosome 16 (red \pots) Colocalization of red and green spots, resulting in 
yellow/white signals in E, F, I, J, M and N, suggest a translocation between a (part of) chromosome 1 
and chromosome 16 (see arrow). In O-R, double-target hybridization was performed with the probe for 
chromosome 7 (green spots) and the probe for chromosome 17 (red spots) Again, colocalization of the 
red and green spots (resulting in the yellow signal in Q) indicates the translocation between chromo­
somes 7 and 17 The arrows ¡η Ε, Ι, M and Q indicate a colocalization of red and green spots. 
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Figure 3. Evaluation of in situ hybridization reaction* with the probe for chromosome I in case 1 (A) 
and ca.se 11 (B). A comparison of the spot number distribution between interphase nuclei and 
metaphase spreads is shown Ли· closed bars represent the percentages of interphase nuclei with the 
indicated spot number; the hatched bars represent the percentages of metaphase spreads with indicated 
spot number. In (A) 400 nuclei and 26 metaphase spreads .and in (B) 400 nuclei and 15 metaphase 
spreads are evaluated 
case 11 
ISH on interphase nuclei with the panel of probes revealed that about 70% of the bone 
marrow nuclei from this patient with AML showed one fluorescent ISH signal with the 
probe for chromosome 1 (not shown). The same result was observed by ISH on metaphase 
spreads (Figure 2B). The distribution of spots in interphase nuclei and metaphase spreads 
are shown in Figure 3B. The cytogenetic analysis from bone marrow of this patient 
demonstrated two cell lines: one with a normal karyotype (46,XY, in two metaphases) and 
one with a complex karyotype (in 34 metaphases). A monosomy for chromosomes 1, 5, 7, 
17, 20, and 21, and several marker chromosomes marl, mar2 and 2xmar3 were found. 
Marl was cytogenetically characterized with a part of chromosome 1, mar2 was a 
translocation between a chromosome 17 and 7p. and mar3 was a translocation product of 
chromosome 20p and 21. 
The single-target ISH results obtained with probes for chromosomes 7 and 17 showed 
two spots per nucleus in, respectively, 96% and 91% of the cells. Double-target ISH with 
the centromeric probes for chromosomes 7 and 17, however, demonstrates the translocation 
between chromosomes 7 and 17 in approximately 65% (Figure 2, O-R), as also charac­
terized by the cytogeneticist (Figure 4B). Double-target ISH on metaphase spreads could 
not be performed because of lack of samples. 
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case 13 
ISH on bone marrow cells from this patient with MDS (CMol.t) revealed significant 
aberrations for chromosome 11 (3% four spots; 72% three spots; 23% two spots; 2% one 
spot) and chromosome 16 (97% one spot; 3% two spots) (Figure 5, Α-D). Both types of 
aberrations were confirmed by karyotyping. From the 19 analyzed metaphases, one had a 
normal chromosome number, 9 showed only a monosomy for chromosome 16, and 9 
spreads revealed a monosomy for chromosome 16 and a trisomy for chromosome 11 (i.e., 
93% monosomy 16; 47% trisomy 11). The lower number of cells with trisomy 11 found 
with the karyotyping could indicate that these cells show a lower proliferative capacity to 
the other cell population(s). In this case the interphase cytogenetic analysis gives a better 
estimation of the real number of cells than the conventional karyotyping procedure. 
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Figure 4. Représentative partial karyotypes from case 1 (A) and case И (В). Cytogenetic inves­
tigations were carried out from bone marrow as described in section Materials and Methods. 
In case 1 (A) a very complex karyotype was found (Table 3) with one marker chromosome (marl), 
showing two centromeric regions in the DAP1 counterstain (*). Double-target ISH proved that 
chromosomes 1 and 16 were involved (see Figures 2c-n). In case 11 (B) one chromosome 1 was absent 
in 34 out of 36 metaphases, while several marker chromosomes were present as a result of alterations, 
for chromosomes 1, 7, 17, 20 and 21. The arrows indicate several marker chromosomes that were also 
identified by ISH. 
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Figure S. Results of single- (B,D) and double-target (F,G) in situ hybridization on bone marrow 
specimens from case 13 (Α-D) and case 15 (Ε-G). In А, С and E, the DNA was counterstained with 
DAP1. In A and B, a significant number of nuclei showed trisomy for the chromosome 11 probe, while 
in С and D a significant number of interphase nuclei showed monosomy for chromosome 16. Both 
aberrations were also characterized by karyotyping (see Table 3). The arrow indicates a cell with two 
spots per nucleus. In Ε-G a double-target in situ hybridization procedure was performed with the 
chromosome 1 probe (F, two spots per nucleus) and the chromosome 17 probe (G, 95% of the nuclei 
show one spot), suggesting monosomy for chromosome 17. 
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case 14 
ISH on interphase nuclei from this patient with MDS (refracting anemia) using the panel 
of probes revealed no aberrant distribution of spot numbers as compared to the control 
cells The cytogenetic analysis, however, showed two cell lines one with a normal 
karyotype (46,XY), and one with a trisomy 8 (in 4 of 38 metaphases) The discrepancy 
between the two cytogenetic analyses is most probably due to the fact that the sample used 
for karyotyping was analyzed 10 years before the ISH data were obtained To be able to 
perform these ISH reactions for our study, a new sample had to be used, which could not 
be karyotyped 
cene 15 
Cytogenetic analysis of bone marrow cells from this patient with MDS (refracting 
anemia with excess of blast in transformation) showed two cell lines, one with a normal 
karyotype (46,XY, in five of the analyzed metaphases) and one with many chromosomal 
aberrations (44,XY, del(3q),+ 8,-5,-6, in five analyzed metaphases) ISH on interphase 
nuclei revealed a trisomy with the probe for chromosome 8 in 93% of the nuclei, and a 
monosomy for chromosome 17 in 95% of the tumor cells (Figure 5, Ε-G) The trisomy 8 
could be confirmed by karyotyping, but the monosomy 17 was in contrast to the cytogenetic 
analysis, where two normal chromosomes 17 were observed Also, with the probe for 
chromosome Y there is a significant number of cells with two spots per nucleus, suggesting 
a disomy (in 20% of the tumor cells) Double-target ISH experiments on interphase nuclei 
with the X and Y probe supported these results (not shown) 
Discussion 
Several studies have demonstrated that DNA probes, recognizing specific repetitive 
sequences in the (pen-)centromeric region of a particular chromosome, can be used to 
detect and quantify their respective chromosomes or chromosome areas in the interphase 
nucleus (Cremer el al, 1988, Devilee et al, 1988, Hopman et al, 1988, 1989, Van Dekken 
et al, 1989, 1990, Nederlof et al, 1989, Anastasi et al, 1990, Kibbelaar et al, 1991) 
Recently, some studies were published, comparing the interphase cytogenetic procedure 
using nonradioactive ISH with conventional cytogenetic analyses of cell lines derived from 
solid tumors, in neoplastic cells from bone marrow and peripheral blood (Nederlof et al, 
1989, Van Dekken et al, 1989, Anastasi et al, 1990, Kibbelaar et al, 1991) However, only 
a few DNA probes were used, furthermore, the number of specimens from patients with 
leukemia was rathei small (Anastasi et al, 1990, Kibbelaar et al, 1991) In the present study 
we analyzed a group of 15 randomly selected patients suffering from leukemia with the ISH 
procedure, using 11 DNA probes, specific for repetitive target sequences on human 
chromosomes 1. 7, 8, 9, 10, 11, 16, 17. 18. X. and Y (see Table 1) and compared these 
results to data obtained through conventional karyotyping methods 
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Using the ISH procedure as described in Materials and Methods', at least 98% of the 
interphase nuclei ot a human lymphocyte preparation, bone marrow cells and the leukemic 
cells showed one, two, or three ISH signals in all preparations After the proteolytic 
digestion step with pepsin, which guarantees a good penetration of the DNA probes and 
reporter molecules, the cells retained a good morphology, while discrete ISH signals with a 
high fluorescence intensity were obtained With ISH we detected 13 numerical chromosome 
aberrations in 165 analyses Seven were in good correlation with the classical karyotyping 
procedure (cases 1, 10, 11, 13, and 15) However, the trisomy for chromosome 10 (case 3, 
Figure 1, С and D) and monosomy for chromosome 16 (cases 3 and 5), and the monosomy 
for chromosome 17 and disomy for chromosome Y (case 15, male) could not be confirmed 
by the cytogenetic analysis, although the double-target ISH results further supported these 
aberrations (Figure 5, E G) This can be explained by the fact that the difficulties of the 
classical karyotyping techniques are often a consequence of the lack of mitoses and/or poor 
banding quality as a result of condensed or fuzzy appearance of the chromosomes (Sand-
berg et al, 1988, Teyssier, 1989) On the other hand, in addition to the 7 correlated 
aberrations, 14 abnormalities for the 11 examined chromosomes were found only with the 
classical karyotyping Some of these where structural aberrations, as in case 1 [i(9q) and 
i(17q), tOóq.lóp)1], case 7 [10p + , l ip 1, case 8 (-7, +der(7)t(7p,'>)] and case 10 [9p+] 
The nature of the probes used for ISH in this study was such that they did not allow 
detection of these aberrations Trisomy 8 as detected by karyotyping in case 14 and the 
discrepancy with the ISH results is due to the fact that the sample used for karyotyping was 
analyzed 10 years before the ISH data were obtained The new sample which had been used 
for our ISH studies could not be karyotyped The nullisomy for chromosome X as detected 
by the cytogenetics in 3 of 8 analyzed metaphases in case 2 (male) was not in accord with 
the results obtained by single- and double-target ISH experiments, where one spot per 
nucleus for the X centramene region was detected (94%) This finding can probably be 
explained by a preparation artifact, since other different chromosomes also were missing in 
these three individual cells This result illustrates an advantage of the ISH procedure, in 
which more cells can be analyzed, as compared to karyotyping 
Although centramene DNA probes are already able to detect numerical chromosome 
aberrations, our results suggest that ISH with centramene probes is also capable of 
detecting structural aberrations The translocation in case 11 between chromosomes 7 and 
17 as observed by karyotyping (Figure 4B), could also be demonstrated by ISH in 
interphase nuclei (Figure 2, O-R) The trisomy for chromosome 1 in case 1 (Figure 2A) 
could not be demonstrated with the classical karyotyping Double-target ISH experiments 
on interphase nuclei suggested that there might be a translocation between a chromosome 
16 and a chromosome 1 (Figure 2, С Ν) Reexamination of the GTG-banded metaphase 
spreads of this case revealed a marker chromosome which contained two or three centro-
mene regions, probably derived from chromosome 1 and both chromosomes 16 (Figure 
4A) Detection of chromosomal abnormalities in leukemia, using cytogenetic analyses on 
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the basis of chromosome banding techniques, plays an important role in determining 
diagnosis, prognosis, and treatment protocols of some specific types of cancer such as CML 
and AML 
The DNA probes, specific for the (pen-)centromeric targets of chromosomes, enable the 
detection of part of a chromosome, only the copy number of the target sequence is 
obtained The development of chromosome specific library DNA probes (Cremer et al, 
1988, Pinkel et al, 1988, Lichter et al, 1990) offers the opportunity to study structural 
aberrations in more detail Also the identification of marker chromosomes and analyses of 
complex karyotypes may in the future be solved by using the nonradioactive ISH with 
centromeric probes, single copy sequences, and total chromosomal libraries 
It can be concluded that detection of numerical and structural chromosome aberrations 
as detected by ISH on interphase nuclei will in the future become an important additional 
technique to support and complement the classical karyotyping technique 
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Abstract 
We describe a novel approach to determine the presence of chromosomal aberrations in 
progenitor cells by in situ hybridization (ISH) on agar cultures Bone marrow cells of 3 
patients suffering from acute myeloid leukemia (AML) were selected to develop the 
method In all 3 cases, numerical aberrations for chromosome 1 and/or 8 were detected by 
karyotyping and ISH using chromosome-specific centromenc-associated DNA probes. 
These aberrations were used as markers in this study After in vitro culture of the bone 
marrow samples in agar, the cells were pretreated in order to perform ISH This approach 
retains the cytological architecture of the agar assay, allowing discrimination between 
chromosomal aberrations detected in the clonogenic and non-clonogenic cells in culture. 
With this new technique, the presence of the cytogenetic aberration in clonogenic cells can 
be shown at the interphase level 
Introduction 
Hematopoietic neoplasms are assumed to be clonal diseases originating from a single 
cell (Messner et al, 1986, Fialkow et al, 1989); therefore, monoclonality can be used to 
further characterize these neoplasms In the majority of myeloproliferative disorders, 
progenitors can be cultured in vitro Information about the lineage involvement of these 
neoplasms may increase understanding of their pathogenesis and response to treatment 
Because the origin of clonogenic cells may be difficult to determine by morphology alone 
(Raskind el al, 1987), additional techniques have been developed to demonstrate the 
monoclonal origin ot progenitors The X-chromosome-linked enzyme glucose-6-phosphate 
dehydrogenase (G6PD), or restuction fragment length polymorphisms (RFLP) of other X-
chromosome-hnked enzymes, can be used as a genetic marker in heterozygous women 
(Fialkow et al, 1989) Kaiyotyping and surface marker expression analysis can also be used 
(Dubé et al, 1981, Raskind et al, 1987) 
Except for the latter technique, all methods analyze colonies that are individually 
harvested Apart from being time-consuming, harvesting may lead to sampling error 
because non-clonogenic cells may be removed in place of clonogenic cells due to colony 
overlap Since kaiyotyping analyzes dividing cells, cell populations with a selective growth 
advantage will be favored (Dubé et al, 1981) Furthermore, within a colony, sufficient 
proliferative cells must be available Only relatively large colonies (> 100 cells) could be 
analyzed, although with technical improvements smaller colonies (± 50 cells) are being 
investigated now (Dube et al, 1981) 
Non-radioactive in situ hybridization (ISH) of chromosome-specific, centromenc-
associated DNA probes to interphase cells has become available, determining the copy 
number of a target chromosome by counting the number of hybridization signals (Hopman 
el al. 1989, 1991, 1992, Poddighe el al, 1992) Although this interphase analysis provides 
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only limited information about the karyotype, it enables rapid screening of large numbers of 
cells. 
Until now, few ISH studies have been published in which bone marrow and peripheral 
blood interphase nuclei from patients suffering from leukemia were analyzed at the total 
cell level (Nederlof et al, 1989; Anastasi et al, 1990; Poddighe et al, 1991; Jenkins et al, 
1992; Price et al, 1992). Although the detection of structural aberrations is limited using 
centromeric DNA probes, double-target fluorescent ISH experiments on interphase nuclei 
have shown that the detection of structural chromosome aberrations is feasible (Lichter et 
al, 1988; Poddighe et al, 1991). A two-color ISH approach can be used to demonstrate the 
bcr-abl fusion, which is responsible for the appearance of the Philadelphia chromosome, in 
interphase cells of chronic myeloid leukemia (CML) patients (Arnoldus et al, 1990; 
Tkachuk et al, 1990). Also, marker chromosomes can be characterized by using these 
procedures. 
In the present study, the application of interphase cytogenetics at the progenitor cell 
level is described. For this approach we developed a method to perform ISH on cells 
cultured in agar. Since the cytological architecture of the agar assay remains intact, 
discrimination between chromosomal aberrations detected in both the clonogenic and non-
clonogenic cells can be detected. 
Materials and Methods 
Sample selection and preparation 
Three karyotyped AML bone marrow samples with numerical chromosome aberrations 
were selected: monosomy for chromosome 1, trisomy for chromosome 8, and a polyploid 
karyotype. As a control, the samples were hybridized with a chromosome-specific probe for 
which no chromosomal aberration was detected. In addition, normal bone marrow cells of a 
healthy donor served as a control. 
Preparations for ISH were made with freshly obtained bone marrow cells. The samples 
were layered onto Ficoll-Hypaque (specific density 1085 g/ml)(Pharmacia/LKB, Uppsala, 
Sweden) and centnfuged at 1200 rpm for 20 minutes. 
Part of the collected low-density cells were washed in phosphate buffered saline (PBS), 
fixed in 70% ethanol (-20°C) and stored at -30°C. Shortly before ISH, 5 μ\ of a cell 
suspension were dropped onto slides coated with poly-L-lysine (molecular weight 150 to 
300 kd)(Sigma, St.Louis, MO), air-dried and heated at 80°C for 1 hour. 
The remaining low-density cells were cultured in Iscove's medium (Flow Laboratories, 
Irvine, Scotland), supplemented with 20% fetal calf serum (FCS), 50 IU/ml penicillin, 50 
/¿g/ml streptomycin (both Flow Laboratories), and 0.3% bacto-agar (Difco, Detroit, MI). 
The cells were stimulated with the combination of IL-3 (40 ng/ml; Sandoz BV, Uden, The 
Netherlands), granulocyte-macrophage colony-stimulating factor (GM-CSF) (20 ng/ml, 
Sandoz BV) and granulocyte colony-stimulating factor (G-CSF) (5 ng/ml, Behring, 
57 
Marburg, Germany). Duplicates were cultured in 35x10 mm culture dishes (Costar, 
Cambridge, MA) at 37CC in a fully humidified atmosphere containing 5% C0 2 (Van Der 
Lely et al, 1991). The cells (2 χ 10s) were plated in a minimum volume of 0.85 ml 
Iscove's medium per dish in order to make them more accessible to the probes After 7 
days, the total number of clusters (5 to 40 cells) and the total colony number (>40 cells) 
was counted The agar cultures were lifted out of the culture dishes and, after division into 
quarters, spun down on poly-L-lysine-coated slides (Sigma) by cytocentrifugation. 
Subsequently, the samples were fixed in 70% ethanol, air-dried and stored at 4°C until ISH 
was performed 
Tumor Cell Processing for In Situ Hybridization 
A proteolytic digestion step with pepsin at a concentration of 100 jig/ml in 0.01 M HCl 
for 20 minutes at 37°C was performed to obtain an optimal recovery of cells and proper 
removal of cellular protein for improvement of DNA probe and antibody penetration 
(Poddighe et al, 1991, Hopman et al, 1992) Thereafter, the nuclei were postfixed in 4% 
formaldehyde in PBS for 20 minutes at 4°C Subsequently, the slides were washed in PBS 
and H 2 0 and equilibrated in 2xSSC (0 3 M NaCI, and 30 Mm Na-Citrate), pH 7.0, for 5 
minutes at room temperature 
DNA Probes 
The plasmid probes pUCl 77 (Cooke et al, 1979) and D8Z2 (Oncor, Gaithersburg, 
MD)(Donlon et al, 1986) were used for the detection of target sequences on chromosomes 
1 and 8, respectively The probes were labeled by nick-translation with biotin-11-dUTP 
(Sigma), according to the supplier's instructions 
In Situ Hybridization 
The DNA probes were hybridized to the (tumor-)cell preparations as described before 
(Poddighe et al, 1991) in 60% formamide, 2xSSC and 10% dextran sulfate at a probe 
concentration of 1 ng/μΐ hybridization mixture Tern microliters of the hybridization 
mixture were applied to the slides under a coverslip (18x18 mm). Denaturation of probe 
and target DNA was performed simultaneously by heating the slides to 70°C in a moist 
chamber for 2 5 minutes Hybridization was then performed for 2 to 16 hours at 37°C. The 
coverslips were removed by immersing the slides in 60% formamide, 2xSSC, pH 7.0. 
Thereafter, the slides were washed 3 times tor 5 minutes in the same buffer at 42°C and 
subsequently 3 times for 5 mm in 2xSSC, pH 7 0 at 42°C 
Immunocytochemibtry 
Detection of hybridized cells was accomplished using mouse anti-biotin (Dakopatts, 
Glostrup, Denmark) in PBS and 0 05% Tween 20 with 0 5% blocking milk (Boehnnger, 
Mannheim, Germany), followed by an incubation with biotin-labeled horse anti-mouse 
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(Vector, Burl ι rigame, CA) Next, a final incubation with the ABC complex (avidin-biotin-
labeled peroxidase compIex)(Vectastain Elite ABC Kit) was performed according to the 
supplier's instructions All immunocytochemical steps were performed for 30 minutes at 
37°C Finally, the DNA probe was visualized with 0 5 mg/ml 3,3-diaminobenzidin 
tetrahydrochlonde (DAB)(Sigma), 0 65% imidazole (Merck, Darmstadt, Germany) and 
0 015% H 2 0 2 (Merck), pH 7 8, in PBS for 5 minutes Slides were rinsed in distilled water 
and the signal was amplified with CuS04 (0 5% in 0 9% NaCI) for 5 minutes at room 
temperature, washed with distilled water, counterstained with hematoxylin and mounted in 
Permount (Fisher Scientific, Fair Lawn, NJ) 
Evaluation oflSH results 
Using the described ISH procedure, at least 90% of the interphase nuclei showed one, 
two or three distinct ISH signals in all preparations Evaluation of the preparations and 
counting of ISH signals were done by two trained observers according to criteria as 
described before (Poddighe et al, 1991, Hopman et al, 1992) Minor hybridization signals, 
which can be recognized by a lower intensity and spot area, and overlapping nuclei were 
not counted (Hopman et al, 1988) In the control cells, one ISH signal for a targeted 
chromosome was found in 5 to 10% of the cells, depending on the efficiency of the ISH 
procedure, or the colocalization of two ISH signals The detection of three loi* sipnals 
occured in less than 1% of the normal cells 
Of the cells from suspension preparations, 200 nuclei per slide were counted. The agar 
preparations were evaluated by counting 200 single cells in agar (representing non-
clonogenic cells), and approximately 50 aggregates (both colonies and clusters) Since the 
aggregates represent clonogenic cells, all the cells in an aggregate should be the same, and 
the distribution of ISH signals would be an indication for the clonality of the aggregates 
Therefore, a cell count of the distribution of ISH signals in an aggregate was not necessary 
Moreover, the same criteria for evaluation as described previously (Hopman et al, 1988; 
Poddighe et al, 1991) could be applied In an aggregate, about 90% showed ISH signals 
When more than 90% of the cells within an aggregate contained one ISH signal, it was 
classified monosomy Consequently, if it contained two or three ISH signals, it was 
classified as disomy and trisomy, respectively 
Results 
Development of the technique 
The success rale of the ISH procedure using chromosome-specific DNA probes in inter­
phase nuclei is mainly dictated by the accessibility of the target DNA Therefore, the effect 
of different conditions, such as the fixative, pretreatment with agarase and proteolytic 
digestion were studied 
To avoid detachment of the agar preparations from the glass slides during pretreatment 
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and ISH denaturation, the slides were coated with poly-L-lysine. Fixation with 70% ethanol 
was sufficient to avoid loss of material from the slides and to preserve morphology during 
the permeabilization steps. 
To improve the accessibility of the target DNAs and to achieve good penetration of 
DNA probes and immunological reagents through the agar, a proteolytic digestion with 
pepsin or agarase was performed. Pretreatment with pepsin, which removes a large part of 
the cytoplasmic and nuclear proteins, was shown to be more effective than agarase in 
improving sensitivity and reproducibility. The most crucial parameter for the success rate of 
ISH, however, was a reduction of the agar layer thickness. We observed that a reduced 
volume of agar medium at a technical minimum of 0.85 ml instead of the standard 2.0 ml 
per dish resulted in about 90% analyzable nuclei. 
Table 1. Results from karyotyping and in situ hybridization procedures in single-cell 
suspension preparations and in the semisolid assay of bone marrow cells of a healthy donor 
and acute myeloid leukemia patients. 
case 
no 
1 
2 
3 
4 
diagnosis 
normal 
bone marrow 
AML 
AML 
AML 
probe 1er 
karyotype chromosome 
4G XY 
46 XY / 
44.XY,-1.-5. 
-7,-17 + m a r l . 
-f mar2 + 2xmar3 
46.XY / 
44.XY. 5, 6, 
+ 8, + marl 
polyploid 
92-96 chromosomes 
XX In = 6) 
#1 
#8 
*1 
#8 
#1 
»β 
«1 
cell 
ISH 
Ü 
1 
0 
0 
0 
0 
0 
0 
suspension 
sigr 
1 
5 
4 
71 
9 
6 
1 
5 
lals/nuc'eus 
2 
93 
95 
28 
91 
94 
5 
33 
3 
1 
1 
1 
0 
0 
94 
18 
4 
0 
0 
0 
0 
0 
0 
44 
semi solid 
aggregates' 
disomy (n = 50)b 
disomy (n = 50) 
monosomy (n = 35) 
disomy ln = 23) 
disomy In = 50) 
trisomy In = 64) 
disomy (n = 38) 
assay 
singl 
ISH : 
0 
2 
3 
0 
0 
0 
11 
0 
e cell 
Bigna 
1 
4 
3 
88 
8 
6 
4 
2 
Is in agar 
Is/nucleus 
2 
94 
92 
12 
90 
93 
12 
32 
3 
0 
2 
0 
2 
1 
73 
16 
4 
0 
0 
0 
0 
0 
0 
50 
' for evaluation see Materials and Methods 
ь
 number of aggregates (colonies > 5 0 cells, clusters 20-50 cells) analyzed 
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For the immunological detection assay, fluorochromes or peroxidase-conjugated markers 
could be applied to detect the biotin-labeled probes The evaluation of ISH results by 
bnghtfield microscopy was preferred because of the permanency of the staining. Further-
more, fluorescent techniques are hampered by autofluorescence from the remaining agar. 
Figure 1. Application of the in ntu hybridization procedure to in vitro cultured progenitor cells from 
patients with AML (A) Almost all clonogemc cells of case 2 demonstrate one ISH signal per cell for 
chromosome I, as detected by ISH on single cells and b) karyotyping (B) Part of an aggregate from 
normal bone marrow (case I) showing two ISH signals per nucleus (C) Three ISH signals per cell for 
the chromosome S centromeric-associated DNA probe were detected in case 3, in which a trisomy 8 
was karyotyped (D) The cytological architecture of the agar assay remains intact (E, F and G) Case 
4 was karyotyped as polyploid The aggregates (E) demomtrated two ISH signals per nucleus, whereas 
single cells in the agar could be recognized showing three (G) or four (F) ISH stgnah with the 
chromosome I probe 
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Experimental results 
The ISH results of the bone marrow samples with the probes for chromosome 1 and 8 
are summarized in Table 1 
Normal bone marrow cells from case 1 showed two ISH signals for both centromenc-
associated probes (93% for chromosome 1 and 95% for chromosome 8) in the cells from 
the suspension preparation We also detected a low frequency of cells with one ISH signal 
for these two probes (5% and 4%) All the aggregates screened (n=50) in the semisolid 
assay contained a majority of cells with two ISH signals (Figure IB) Within aggregates, 
about 10% of the nuclei showed one signal as a result of overlap of ISH signals No 
differences in this respect were seen between chromosome 1 and chromosome 8. 
ISH on the interphase nuclei of the cells from the case 2 suspension preparation with a 
monosomy for chromosome 1, according to its karyotype, showed one ISH signal per 
nucleus in 71% and two ISH signals in 28% Analysis of the semisolid assay showed that 
the majority of cells (about 80%) in the aggregates (n = 35) contained one ISH signal per 
nucleus for chromosome 1 (Figure 1A) A low percentage of cells (< 10%) was found with 
two ISH signals The single cells in agar, however, showed 12% of the nuclei with two 
ISH signals and 88% with one ISH signal Karyotyping revealed no chromosomal aber­
ration for chromosome 8 Hybridization of the cells from the suspension preparation and 
the semisolid assay with a chromosome 8 specific probe showed frequency distributions 
similar to the hybridization results for normal bone marrow cells 
The nuclei of case 3 with a trisomy for chromosome 8 (46,XY/ 44,XY,-5,-6, + 8, 
+marl) showed three ISH signals in 94% of the nuclei in the cell suspension pre-paration. 
The majority of the nuclei in the aggregates (n=64) contained three ISH signals (Figure 
1С), while the nuclei of the single cells in the agar demonstrated three ISH signals in 73% 
and two ISH signals in 12% Furthermore, in this case 11% of the single cells in the agar 
showed no signal at all Even after repeated hybridizations, a low frequency of nonreacting 
cells was observed The results of hybridization with the chromosome 1-specific probe were 
comparable to those ot normal bone marrow cells 
ISH on the interphase cells of case 4 with a polyploid karyotype (female, 92-96 
chromosomes) showed for chromosome 1 two (33%), three (18%) and four (44%) ISH 
signals in the single cell suspension preparation The single cells in agar also demonstrated 
the same distribution of ISH signal counts (see Table 1), showing three and four ISH 
signals (Figures 1, F and G) The main population of cells within aggregates showed two 
ISH signals (Figure IE) Within aggregates, however, a low percentage of cells with three 
or four ISH signals was observed (<20%) 
Discussion 
The approach described in this study demonstrates the application of the ISH technique 
for the determining chromosomal aberrations in hematopoietic progenitor cells cultured in a 
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semisolid assay 
The distribution of the ISH signals in the interphase cells of the cell suspension 
preparations was shown to be similai to those of the single cells in agar in all four cases 
This means that these cells are representative of the total cell population In cases 2 and 4, 
a mixed cell population, according to the number of ISH signals for the probe for chromo-
some 1, was observed The cells in the aggregates in each of these cases, however, 
revealed one type of ISH signal In case 2, a monosomy and in case 4, a disomy could be 
detected, suggesting monoclonality of the progenitors 
All the analyzed aggregates of cases 2 and 3 contained the clonal marker (monosomy 1 
and trisomy 8, respectively) and no disomic aggregates were assessed Therefore, they all 
confirmed the leukemic origin In case 4, which had a polyploid karyotype, the aggregates 
were diploid The aggregates demonstrated a mixed population, however, predominantly 
diploid cells with a few polyploid cells A possible explanation is that the large colonies 
overlapped the aneuploid cells in this case This may be the result of the high plating 
concentration (8xl05 cells per dish) that was required to obtain the colonies 
The major advantage of the ISH approach over karyotyping is that not only metaphase 
spreads, but also interphase cells can be examined for chromosomal aberrations Therefore, 
at least 90% of the cells can be analyzed Another advantage of the ISH approach is that 
the cytological architecture of the agar assay remains intact (Figure ID) This makes it pos-
sible to analyze small clusters containing about 5 to 40 cells, by previous techniques (Dubé 
et al, 1981), only large colonies could be analyzed Furthermore, the aggregates and single 
cells in agar can be analyzed individually This makes it possible to discriminate between 
the clonogenic and non-clonogenic cells in a mixed population The main advantage of ISH 
over the G6PD technique is that heterozygous females are not the only patients who can be 
monitored for the detection of progenitor cells 
ISH, using a specific chromosomal aberration as a marker, can now be applied in 
addition to cytogenetic analyses to determine the leukemic origin of in vitro cultured cells 
Furthermore the ISH technique enables the origin of blood and bone marrow progenitor 
cells in patients with myeloproliferative disorders to be determined at different stages of the 
patients' disease Bone marrow can be maintained in culture for at least 10 days to serve as 
an autograft in patients with intensive chemo radiotherapy It is assumed that normal stem 
cells survive this period better than leukemic stem cells (Coulombel et al, 1985) The ISH 
technique facilitates the detection of numerical chromosome aberrations in progenitor cells 
to monitor the in vitro culture system 
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Abstract 
Interphase cytogenetics was applied to investigate bone marrow (BM) cells, peripheral 
blood (PB) cells, and in vitro cultured progenitor cells of five patients with acute myeloid 
leukemia (AML) and myelodysplasia Recently, a new technique was developed to perform 
in situ hybridization (ISH) on agar cultures Two patients with respectively trisomy 8 and 
polyploidy as ISH marker were studied both at presentation and during remission. At 
presentation, the in vitro growth pattern of one leukemia consisted of small clusters, while 
the other demonstrated a hypoplastic growth pattern In both cases, the ISH marker was not 
present in aggregates Therefore, despite the abnormal growth patterns, the cultured 
progenitors could have been residual normal cells Alternatively, they could have originated 
from a preleukemic clone with a normal karyotype In both cases, a low percentage 
(maximally 6%) of abnormal BM and/or PB cells was detected with ISH during remission. 
Consequently, the remissions in these patients could have been partially or completely 
clonal 
One patient with trisomy 10 as ISH marker was analyzed during myelodysplastic phase 
and after progression to AML On both occassions, abnormally appearing clusters were 
cultured However, only part of the clusters carried trisomy 10 The presence of a subclone 
characterized by trisomy 10 and an abnormally growing (pre)leukemic clone without 
trisomy 10 may explain this observation 
Monosomy 1 and 17 were respectively used as ISH markers in two other AML patients. 
In one case, typed as M6, the percentage of BM cells with monosomy 1 was much higher 
(71%) than the amount of blasts (28%) This indicated that at least part of the normoblasts 
belonged to the abnormal clone, suggesting a multipotent stem cell origin In vitro, both 
leukemias exhibited a leukemic growth pattern of small clusters ISH confirmed the 
leukemic origin of these progenitors Long-term liquid cultures of these leukemias were 
performed for 10-20 days In both cases, no residual normal clonogenic cells could be 
delected Therefore, the selective growth advantage of normal progenitor cells in long-term 
marrow cultures cannot be demonstrated in all patients with leukemia 
This paper illustrates the usefulness of the ISH technique to study the diverse biology of 
AML during preleukemic phase, active disease, remission, and under in vitro culture 
conditions 
Introduction 
Acute myeloid leukemia (AML) is considered to be the result of a clonal expansion of 
one single cell (Fialkow et al, 1981, Raskind et al, 1987) The origin of the leukemic clone 
may be either a totipotential hematopoietic stem cell (HSC) or a cell restricted to the 
granulocyte monocyte pathway (Fialkow et al, 1981, 1989, Messner étal, 1986, Raskind et 
al, 1987) AML is characterized by an accumulation of immature blasts that fail to 
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differentiate to functional granulocytes or monocytes Normal hematopoiesis is suppressed 
either by displacement of the stem cells by leukemic cells, by production of inhibitory 
factors, or directly cellular inhibition (Griffin et al, 1986, Messner et al, 1986) In 
myelodysplastic syndrome (MDS), the abnormal preleukemic clone is assumed to arise at 
stem cell level (Jacobs, 1990) MDS is characterized by dysmyelopoiesis and cytopenia in 
one to three cell lines (Raymakers et al, 1991) In time, the disease may progress to overt 
acute leukemia (Jacobs, 1990) Observations suggest that (pre)leukemic clones may be 
organized in a fashion similar to normal hematopoiesis, with a hierarchy of progenitor cells 
(CFU-L) generating large numbers of non-proliferating leukemic cells (Messner et al, 
1986) The CFU-Ls, the putative leukemic stem cells, are held responsible for the 
maintenance of leukemia (Laitha, 1981) This property makes the leukemic progenitors an 
interesting population for further characterization In the majority of AML/MDS cases, 
progenitor cells can be cultured in vitro (Griffin et al, 1981, Laitha, 1981, Van Der Lely et 
al, 1991, Raymakers et al, 1991) The origin of these clonogenic cells may be difficult to 
assess, since colonies derived from (pre)leukemic progenitors are not always morpho-
logicall) distinguishable from those derived from normal progenitors (Fialkow et al, 1987) 
Several techniques are developed to determine the clonal origin of hematopoietic cells 
For example, in heterozygous females, the X chromosome linked enzyme gIucose-6-
phosphate dehydrogenase (G6PD) or restriction fragment length polymorphisms (RFLP) of 
other X-chromosomal enzymes can be used as a genetic marker (Fialkow et al, 1981, Pui et 
al, 1989, Raskind et al, 1987) Karyotyping and surface marker expression analysis offer 
another approach (Dubé et al, 1981, Raskind et al, 1987, Gerhartz et al, 1990) Progenitors 
of AML patients have been examined with these techniques both at presentation and clinical 
remission Mostly, at presentation the myeloid colonies derive from the malignant clone 
Occasionally, the myeloid colonies originate fiom normal stem cells (Fialkow et al, 1987) 
During remission, in some patients lestoration of nonclonal hematopoiesis and repopulation 
of the marrow by normal stem cells has been observed These normal stem cells must have 
been present during the initial phase of the leukemia, but the suppression of their prolifera-
tion or differentiation along the granulocytic pathway in vivo prevented detection (Fialkow 
et al 1981) Clonal remissions have been observed the abnormal clone persists throughout 
complete clinical remission (Gerhartz et al, 1990, Fialkow et al 1989, 1991) 
The results obtained with long-term bone marrow culture (LTBMC) of BM cells from 
AML patients additionally support the presence ol residual normal stem cells in leukemic 
patients during active disease In most cases, the leukemic colonies and clusters are no 
longer detectable after one to four weeks of culture, whereas normal progenitors reached 
near normal numbers (Coulombel et al, 1985, Chang et al, 1986, 1989, Singer et al, 1988) 
The few reports about progenitors in MDS suggest the existence of a transformed stem cell 
either with or without an abnormal karyotype (Raskind et al, 1984, Jacobs, 1990) 
Recently, we described a method to determine chromosomal aberrations by 1SH in 
myeloid progenitor cells cultured in agar (Poddighe et al, 1993) The major advantage of 
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this technique is that numerical and structural chromosomal aberrations can be detected in 
interphase nuclei (Poddighe et a!, 1991, 1992). Furthermore, the cytological architecture 
remains intact, allowing individual analysis of colonies and single cells in culture. 
The present study describes the application of this ISH technique to determine the clonal 
origin of blood and bone marrow cells and myeloid progenitors in five patients with AML 
and MDS at different stages of their disease. 
Patients and Methods 
Patient selection 
Patients with de-novo AML or AML after a myelodysplastic phase characterized by a 
numerical chromosomal aberration were selected for this study. AML and MDS were 
diagnosed according to the French-American-British (FAB) classification (Bennett et al, 
1982, 1985) 
Case 1 
In February 1988, a 52-year-old man was diagnosed to have an AML, type M4. The 
relevant clinical and hematological data are shown in Table 1. The patient received 
combination induction chemotherapy He achieved complete remission (CR). Subsequently, 
he was treated with 2 intensive consolidation courses He relapsed in May 1992 and died of 
infectious complications during remission induction therapy. 
Case 2 
After a history of inflammatory bowel disease for 10 years, a 34-year-old woman 
suffered from a severe exacerbation of ulcerative colitis in March 1987. She was treated 
with prednison and sulfasalazine In the following weeks (April) she developed a leuco-
cytosis with a pronounced shift to the left. The percentage of blasts in the bone marrow 
was 36% (see Table 1) One week later, a second bone marrow aspiration was performed, 
revealing only 2% blasts. The white blood cell count (WBC) had normalized as well, 
although myelopoiesis was still shifted to the left Despite specific therapy, the colitis 
deteriorated and a subtotal colectomy was performed. The condition of the patient improved 
and her blood counts normalized completely The reversible blood and bone marrow 
abnormalities were diagnosed retrospectively as a leukemoid reaction In September 1987, 
the patient presented with an increased bleeding tendency and she was found to have an 
AML, type M4 She received combination induction chemotherapy and achieved CR. In 
December 1988, just prior to a second consolidation course, she was still in CR and an 
autologous bone marrow transplant (ABMT) was planned. In February 1989, bone marrow 
was aspirated from the posterior iliac crests and cryopreserved in liquid nitrogen. Unfortu-
nately, she relapsed one month later and died before ABMT could be performed. 
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Table 1. Clinical data 
Case Disease 
No Date Status 
Age WBC Hb Platelets Blood BM FAB 
(yr) Sex (109/1) (mmol/1) (109/1) % Blasts % Blasts Type 
1 2/88 presen­
tation 
52 M 10.5 6 4 26 85 M4 
5/91 CR 8 6 7 5 173 
11/91 CR 5 4 6 9 155 NA 
4/87 colitis/ 34 
"leukemoid 
reaction" 
F 43 6 7 7 236 36 M 4 ' 
4/87 colitis/ 
(1 week "leukemoid 
later) reaction" 
4 6 7 1 266 
9/87 presen­
tation 
46 9 7 4 23 42 80 M4 
12/87 CR 
2/88 cryopre-
servation 
3 12/91 MDS 54 M 
5/92 presen­
tation 
7 5 
6.7 
7 3 
24.7 
7.1 
7 8 
7 1 
5 7 
274 
140 
30 
12 
0 
0 
2 
3 
2 
6 
33 
RAEB 
M2 
4 5/89 presen- 60 M 21 6 5 7 
tation 
16 27 28 
Мб 
5 2/89 presen- 58 M 8 6 5 6 
tation 
29 73 75 M2 
Abbreviations. M, male; F, temale; WBC, white blood сеііь; Hb, hemoglobin; BM, bone marrow; 
FAB, French-American-British classification; NA, not available. 
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Case 3 
In November 1990, this 54-year-old man was diagnosed to have a MDS, type refracting 
anemia In October 1991, his disease had progressed to refracting anemia with excess of 
blasts (RAEB), and in May 1992 to AML, type M2 The patient was treated with poly-
chemotherapy and died of bleeding during aplasia The clinical and hematological data of 
this patient are presented in Table 1 
Case 4 
In May 1989, a 60-year-old man developed an AML, type M6, three months after he 
was diagnosed to have a MDS, type RAEB Clinical and hematological data are shown in 
Table 1 The patient received polychemotherapy, but failed to achieve CR and died. 
Case 5 
In February 1989, a 58-year-old man was diagnosed to have AML, type M2. Five 
months earlier, he had presented with a MDS, type RAEB-t (RAEB in trans-formation). 
The clinical and hematological data concerning this patient are depicted in Table 1. For 
remission induction, he was treated with combination chemotherapy. Due to cardiac and 
infectious complications, the patient died during aplasia 
Collecting of Cells, Cryo-Preservation, and Thawing 
Bone marrow cells were collected in sterile buffered acid-citrate dextrose, pH=7.0. 
Peripheral blood cells were collected in preservative-free heparin After centrifugation on a 
Ficoll (1085 g/ml) density gradient, part of the collected cells were cryopreserved and 
another part prepared for ISH. Vials containing 5 to 20 χ IO6 cells in Iscove's medium 
(Flow Laboratories. Irvine, Scotland), supplemented with 10% fetal calf serum (FCS, heat 
inactivated, HyClone, Logan, Utah), 50 IU/ml penicillin, 50 /xg/ml streptomycin (both 
Flow Laboratories) and 10% dimethylsulfoxide were frozen in liquid nitrogen using a 
temperature-controlled freezer (Kryo 10, Planer Biomed, Sunbury, Middlesex, UK). Just 
prior to the experiments, cells were thawed in a 37°C waterbath, resulting in a recovery of 
>90% Freezing and thawing procedures have been described in detail elsewhere (Van de 
Ouweland et al, 1982) For ISH, cells were fixed in 70% ethanol (-20°C), and stored at -
30' С 
Human Recombinant Growth Factors 
Human recombinant interleukin 3 (1L-3) and human recombinant granulocyte-monocyte 
colony-stimulating factor (GM-CSF) were kindly donated by Sandoz BV (Uden, The 
Netherlands) Human recombinant granulocyte colony-stimulating factor (G-CSF) was a 
kind gift from Behring (Marburg, Germany) Final concentrations of 40 ng/ml, 20 ng/ml, 
and 5 ng/ml, respectively, were used and resulted in plateau stimulation 
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Clonogenic Assay (CFU С) 
Cells were cultured in Iscove's medium, supplemented with 20% FCS, 50 lU/ml 
penicillin, 50 /ig/ml streptomycin, and 0 3% bacto-agar (Difco, Detroit, Michigan) The 
cells were stimulated with the combination of IL-3, GM-CSF, and G-CSF. Duplicates were 
cultured in 35- χ 10-mm culture dishes (Costar, Cambridge, Massachusetts) at 37_C in a 
fully humidified atmosphere containing 5% C0 2 In order to make the cells better accessi­
ble for the DNA probes, a reduced volume of 0 85 ml per dish was plated (Poddighe et al, 
1993) After 7 days, the total number of clusters (5-40 cells) and colonies (>40 cells) was 
counted The in vitro growth pattern was defined normal when the number of colonies 
exceeded 20 per 2 χ 10 NC and the cluster to colony ratio did not exceed five When less 
colonies were cultured, but with a normal cluster to-colony ratio (less than five), the 
growth pattern was considered hypoplastic All other growth patterns were regarded 
leukemic Mostly, a pattern of small (maximum size, 20 cells) or large (maximum size, 40 
cells) cluster formation was observed After counting, the agar cultures were dried by 
cytocentnfugation and processed for 1SH or stained with hematoxylin solution (Merck, 
Darmstadt, Germany) to evaluate morphology (see below) 
Liquid Culture 
Cells were suspended in Iscove's medium supplemented with 20% FCS, 50 IU/ml 
penicillin, 50 μg/ml streptomycin and a combination of IL 3, GM-CSF, and G-CSF The 
liquid cultures were maintained in an incubator (37°C, 5% C0 2 and fully humidified 
atmosphere) for a period up to 20 days At regular intervals, part of the cells were 
collected, washed, and used for clonogenic assay and ISH 
Drying Agar Cultures by Cytocentnfugation 
Conventionally processed agar cultures have a relatively thick agar layer which prevents 
sufficient penetration and subsequent hybridization of DNA probes Therefore, a method 
based on a technique described by Barnes (1989) was used The cultures were shaken into 
glucose-phosphate buffer and cut into quarters Each quarter was lifted onto a 76- χ 26-mm 
poly-L lysine (Sigma Chemical Co St Louis Missouri, MW 150 000-300 000) coated 
glass slide and covered with a cellulose acetate strip (Sepraphore, Gelman Sciences, Ann 
Arbor, Michigan) Next, a piece of filter paper (Schleicher & Schuell, Dassel, Germany) 
was overlaid, followed by a filter card (Shandon, Pittsburgh, Pennsylvania) During 30 to 
60 minutes the cultures were allowed to dry partially Thereafter, the slides were centri-
fuged in a cytospin centrifuge (Shandon) at 1,500 rpm for 10 minutes Subsequently, the 
filters were removed A thin agar layer, containing the cells, remained on the glass slide 
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Table 2. Bone Marrow and Blood, cases Nos. 1. 2. and 3 
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Karyotyping 
Metaphase spreads were obtained from BM or PB cells after cultunng in RPMI 1640 
(Flow Laboratories) for 1 or 24 hrs Colcemid was present during the last hour of the 
culture Before fixation in methanol glacial acetic acid (3 1), the cells were exposed to a 
hypotonic solution (0 075 M KCl) for 15 minutes Slides were prepared according to 
routine cytogenetic procedures Karyotyping was performed using the GTG technique. 
In Situ Hybridization 
For the detection of the target sequences on chromosomes 1, 8, 10, and 17, the plasmid 
DNA probes pUCl 77 (Cooke et al, 1979), D8Z2 (Donlon et al, 1986), plO 1 (Devilee et 
al, 1988), and pl7H8 (Waye et al, 1986) were used, respectively ISH was performed on 
single cells and dried agar cultures, fixed in 70% ethanol as described elsewhere (Poddighe 
et al, 1993) Five μΙ of a cell suspension were dropped onto a poly-L lysine coated glass-
slide, air dried, and heated at 80°C for 1 hour For a good penetration of the DNA probes 
and antibodies, a proteolytic digestion step with pepsin (P7000 Sigma) was performed at a 
concentration of 100 μg/ml in 0 01 M HCl for 20 mm at 37°C After several dip washes in 
H 2 0 and phosphate-buffered saline (PBS), the nuclei were postfixed in 4% formaldehyde in 
PBS for 20 min at 4°C Of the hybridization mixture (60% formamide-2xSSC-10% dextran 
sulphate, pH 7 0, probe concentration 1 ng/μΙ), 10 μ\ were applied under a coverslip. 
Denaturation of target DNA and probe was carried out simultaneously at 70°C for 2 5 min 
in a moist chamber Hybridization was performed for 2 to 16 hours at 37°C After three 
stringent washes in 60% formamide-2xSSC, pH 7 0, at 42°C, and subsequent washes in 
2xSSC, pH 7 0 at 42"C for five minutes each, the hybridized probes were detected by 
horseradish peroxidase (HRP) conjugated avidin (Dakopatts, Glostrup, Denmark) Finally, 
the DNA probe was visualized with 0 5 mg/ml 3,3-diaminobenzidin tetrahydrochlonde 
(DAB, Sigma), 0 65% imidazole (Merck), 0 015% H 2 0 2 (Merck), at pH 7 8 in PBS As 
a control, the samples were hybridized with a chromosome-specific DNA probe for which 
no chromosomal aberration was detected In these controls, the cells from suspension 
preparations demonstrated one ISH signal for a target chromosome in 5 to 10% of the cells, 
and three ISH signals in less than 1% of the cells Of these suspension preparations, 200 
nuclei per slide were counted 
The agar preparations were evaluated by counting 100 single cells in agar, and 
approximately 50 aggregates In these controls, at least 90% of the cells contained ISH 
signals The percentages of cells containing the euploid number of ISH signals for the 
control DNA probe-targets varied between 85-90% A detailed description of the evaluation 
of the ISH results has been presented elsewhere (Poddighe et al, 1991, 1993) 
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Results 
Case I 
Presentation 
At presentation, 12 of the 13 analyzed BM cell metaphases showed trisomy 8 (see Table 
2). With ISH, trisomy 8 was found in 71% of the BM cells. A leukemic growth pattern 
was observed when BM cells were cultured in agar. The clusters consisted of 5 to 25 
immature myeloid cells. After hybridization with the probe for chromosome 8, disomy was 
found in all analyzed clusters, whereas 14% of the single cells in the semi-solid culture had 
trisomy 8. 
Complete remission 
In May 1991, karyotyping revealed only normal BM cells, whereas no metaphases could 
be detected in the PB. However, by ISH, 6% of the BM cells showed trisomy 8. Both BM 
and PB exhibited a normal in vitro growth pattern. The colonies appeared morphologically 
normal and were diploid when analyzed with the probe for chromosome 8. However, part 
of the single cells in the semi-solid cultures contained three ISH signals. In the BM culture 
respectively 19% and 4% of the single cells had trisomy and tetrasomy for chromosome 8, 
whereas the single cells of the PB cultures showed trisomy and tetrasomy for chromosome 
8 in 12% and 2%, respectively. 
In November 1991, the patient was still in clinical CR although his Hb had decreased to 
6.9 mmol/l. Only PB was analyzed. No metaphases were obtained. ISH was not performed 
by lack of a sample. A normal growth pattern of the cells was observed, demonstrating a 
disomy 8 by ISH in all aggregates, while part of the single cells in culture had trisomy 8 
(7%). 
Case 2 
At leukemic presentation, all investigated BM metaphases appeared to be polyploid, 
containing about 96 chromosomes (see Table 2). For ISH analysis, we applied a centromere 
associated DNA probe for chromosome 1. 
Colitis I "leukemoid reaction " 
During "leukemoid reaction", on two occasions a normal karyotype was found in a 
limited number of BM metaphases (see Table 2). In contrast, ISH revealed that 4% of the 
BM cells contained three or four ISH signals with the chromosome 1 probe. The number of 
colonies in the semi-solid culture was depressed on one occasion and normal one week 
later. Morphology and size of the colonies appeared normal. All analyzed colonies were 
disomic, whereas 8% of the single cells in agar contained three or four ISH signals. 
Presentation 
During overt leukemia, when all analyzed BM metaphases were polyploid, tri- or 
tetrasomy 1 was found by ISH in 62% of the BM cells. Only very few colonies and 
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Clusters could be cultured in agar. They appeared to have normal morphology and size and 
were disomic for chromosome 1 after ISH. Sixty-six percent of the single cells in those 
cultures were tri- or tetrasomic. 
Complete Remission 
During CR in December 1987, only BM cells with a normal karyotype were found. 
Normal numbers of colonies and clusters could be cultured in vitro. Since no material was 
cryopreserved, ISH could not be performed. In February 1988, when bone marrow was 
aspirated for cryopreservation and the patient was still in CR, both normal and polyploid 
cells were detected by chromosomal analysis. ISH revealed tri- or tetrasomy 1 in 5% of the 
BM cells. Normal colony numbers were observed. Their morphology and size appeared 
also normal. All analyzed colonies were disomic, whereas 2% of the single cells in the 
semi-solid culture showed tri- or tetrasomy. 
Case 3 
MDS 
Karyotyping of the BM revealed that eight of 32 analyzed metaphases had trisomy 10 
(see Table 2). With ISH 26% of the BM cells had trisomy 10. In the PB cells, on which no 
karyotyping was performed, 14% showed trisomy 10 by ISH. Both BM and PB cells 
showed a leukemic growth pattern characterized by clusters consisting of 10 to 35 immature 
Ш 
ЩШ 
w* 
> 
в 
Figure 1. Examples of ISH result to in vitro cultured progenitor cells from patients with AML. (A) 
representi a small cluster of clonogemc cells of case 5 (after 20 days of liquid culture), demonstrating 
one ISH signal per cell for chromosome 17 (B Represents a small cluster of clonogemc cells of case 3 
at presentation, demonstrating three ISH signals per cell for chromosome 10. 
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cells. Although morphologically not distinguishable, both clusters with and without trisomy 
10 were observed by ISH in the BM and PB cell cultures. The single cells in the BM and 
PB cultures demonstrated a trisomy for chromosome 10 by ISH in 35% and 37%, respec-
tively. 
Presentation 
At leukemic presentation, no BM metaphases were detected. By ISH, 16% of the BM 
cells showed a trisomy 10. The clusters appeared morphologically identical to the clusters 
cultured during MDS phase. Trisomy 10 was found in seven of 30 clusters (Figure 1A), 
whereas 8% of the single cells in culture showed trisomy 10. 
In the following two cases, BM was cultured in liquid in the presence of IL-3, GM-CSF, 
and G-CSF for up to 20 days to investigate whether residual normal progenitors had a 
growth advantage compared to the leukemic clone. 
Case 4 
Presentation 
At leukemic presentation, karyotyping of BM cells revealed multiple abnormalities in 
almost all metaphases (see Table 3). The probe for chromosome 1 was selected as a marker 
for ISH. Monosomy 1 was found in 71% of the BM cells. In vitro, a leukemic growth 
pattern was observed. The small clusters (5 to 20 cells) appeared immature. All analyzed 
clusters and 88% of the single cells showed monosomy 1. 
Liquid culture 
Liquid culture for 10 days did not significantly influence the number of abnormal cells 
and clusters. Ninety-one percent of the cells in suspension demonstrated monosomy 1. 
Again, only immature appearing small clusters could be cultured, which were all monoso-
mic for chromosome 1. The single cells in the semi-solid assay showed in 91% monosomy 
1. 
Case 5 
Presentation 
During active disease, one of 10 BM metaphases was normal. The other nine meta-
phases showed multiple chromosomal aberrations (Table 3). In this case, monosomy 17 was 
chosen as ISH marker. Monosomy 17 was detected by ISH in 96% of the BM cells. In the 
clonogenic assay, a leukemic growth pattern was observed. The clusters consisted of five to 
25 immature cells and showed all a monosomy for chromosome 17. Moreover, in 82% of 
the single cells in the semi-solid assay a monosomy 17 was detected. 
Liquid culture 
The high plating efficiency allowed in liquid culturing of the leukemic cells up to 20 
days. Liquid culture cells and agar cultures (both single cells and clusters) were analyzed at 
regular intervals. During the whole period, the proportion of abnormal cells remained 
79 
essentially the same (95% to 99%) At any time, only aggregates with monosomy 17 were 
detected by ISH, as is demonstrated in Figure 1A 
Discussion 
Five patients with de novo AML or AML after myelodysplastic phase and abnormal 
clones characterized by numerical chromosomal abnormalities were subject of this study In 
all cases, the chromosomal aberrations found with cytogenetics could also be detected by 
ISH However, the incidence of abnormal cells was not always the same for both methods 
Conventional cytogenetic analyses examines fewer cells than ISH and may result in a less 
accurate estimation of the real number of abnormal cells Furthermore, it can be performed 
solely to dividing cells, which can lead to a selective growth advantage for the abnormal 
subpopulation (Dube et al, 1981) Non dividing interphase lymphocytes are included in the 
ISH analysis and cannot be analyzed by karyotyping The lymphoid lineage is usually not a 
part of the abnormal clone and thus may account for the lower incidence of abnormal cells 
found with ISH (Raskind et al, 1987) 
A leukemic growth pattern was observed in case no 1 at presentation, but the ISH 
marker for the abnormal cells (trisomy 8) was not detected in the cells of the clusters 
These clusters could be normal progenitor cells which exhibited an abnormal growth pattern 
probably due to influences of the leukemic clone In the majority of reported cases, myeloid 
progenitors are part of the leukemic clone al presentation However, in a few patients 
normal CFU-GM has been detected (Fialkow et al, 1987) If the clusters in case no 1 did 
originate from normal cells, then the in vitro growth pattern and morphology by itself are 
not sufficient to determine the origin of progenitor cells The inaccuracy of morphology has 
been described before by Singer et al (1988), where LTBMC of leukemic BM resulted in 
morphologically normal colonies which nevertheless belonged to the leukemic clone An 
alternative explanation tor our results could be that these progenitor cells represent a part of 
the leukemic clone without trisomy 8 This concept can be confirmed by a multistep 
leukemogenesis with a preleukemic stage an early step causes clonal proliferation, and a 
later step results in a chromosomal abnormality in descendants of these progenitors (Pui et 
al, 1989, Fialkow et al 1991) 
During CR, abnormal cells were detected by ISH in both BM and PB cells of case no 
1 A growth advantage for the clonogenic cells with a normal karyotype and the lower 
number of analyzed cells may explain why karyotyping detected only normal BM cells The 
absence of metaphases in the PB demonstrated one of the limitations of cytogenetic 
analysis In vitro normal appearing, disomic colonies could be cultured, but part of the 
single cells were abnormal, containing three or four ISH signals The number of ISH 
signals is constant during the whole cell cycle, and in normal diploid cells the number of 
cells with four ISH signals is maximally 1% (Poddighe et al, 1991) Therefore, the detected 
tetrasomy 8 should be considered significant, suggesting an additional chromosomal 
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aberration Since the differential counts of both BM and PB did not contain blasts, and 
blood consisted only of segmented neutrophils (81%), monocytes (11%), and lymphocytes 
(8%), apparently differentiated cells must have had trisomy 8. This suggests that morpho-
logically normal differentiated blood cells developed from the abnormal leukemic clone. 
Similar observations have been made in G6PD and RFLP studies (Fialkow et al, 1987). At 
least two and possibly three populations were present in this patient during remission. One 
population of trisomy 8 cells capable of maturation and another colony-forming population 
without trisomy 8. This latter population could either have originated from residual normal 
stem cells, a preleukemic clone, or a combination of both Conse-quently, the remission 
might have been partially or completely clonal. 
In case no 2, 4% abnormal BM cells, containing three and four ISH signals, were 
observed at the time of "leukemoid reaction". This suggests that the leukemic clone was 
already present at that time The diagnosis leukemoid reaction has to be considered 
incorrect. The activation of the BM as a physiological response to the colitis apparently 
lifted the number of abnormal cells above the detection level of ISH By cytogenetic 
analysis at presentation, only cells with an abnormal karyotype were found, whereas ISH 
revealed 62% polyploid cells The same explanations as given in case no 1 can be applied 
to this observation One month before relapse, at the time of cryopreservation, abnormal 
cells were detected with both ISH and cytogenetic analysis, indicating the presence of the 
leukemic clone. In contrast to the colitis period, a higher number of metaphases could be 
karyotyped This probably explains why in this occasion cytogenetic analysis revealed 
abnormal cells as well 
Since in case no 2 the ISH marker was not detected in the cells of colonies and clusters 
cultured at the different stages of the disease, these cells may have originated from residual 
normal progenitors. The depressed colony number observed during leukemoid reaction and 
full-blown situation could indicate that in vivo the number of normal clonogenic cells was 
reduced It also may have been the result of inhibition by the leukemic cells or the 
concomitant prednison/sulfasalazine medication As in case no. 1, it can not be excluded 
that these progenitors originated from a preleukemic, abnormal clone without polyploidy. 
As a result, the remission in this patient may be partially or completely clonal. 
In case no. 3 the progression from MDS to AML could be observed. During MDS, the 
percentage of BM cells with trisomy 10 found by karyotyping and ISH were the same, 
probably since a considerable number of cells could be analyzed by both techniques. The 
abnormal but similar appearing clusters could be distinguished in two subpopulations, 
consisting of progenitors with and without trisomy 10 However, no increase in either BM 
cells or progenitor cells with trisomy 10 was observed when the patient developed AML. 
Only the plating efficiency of cultured progenitors increased This observation matches the 
theory that MDS arises from a transformed progenitor cell and progresses from a preleuke-
mic state to overt leukemia by successive genetic changes (Raskind et al, 1984; Jacobs, 
1990) In that case, all cultured clusters belong to a (pre)leukemic clone with abnormal 
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growth characteristics, but only part of this clone obtains a chromo-somal aberration 
(trisomy 10) 
In case no 4, the percentage of abnormal BM cells as detected by ISH was much 
higher than the percentage of BM blasts, but still lower than the karyotyped incidence Due 
to overlap of ISH signals, an overestimation of monosomy of maximally 10% can occur 
(Poddighe et al, 1991) This can never explain completely the observed difference between 
the number of cells with one ISH signal for chromosome 1 and the percentage of blasts. In 
this BM, 28% blasts and 50% normoblasts were present Considering the high percentage 
of monosomy 1 (71%), this implicates that at least part of the normoblasts belonged to the 
abnormal clone This suggests that the origin of this clone was a multipotent progenitor 
cell The 60-year-old patient developed AML after a period of MDS, which is assumed to 
originate at stem cell level (Griffin et al, 1981) Furthermore, it has been reported that 
especially in elderly patients leukemias may arise from stem cells with multipotent 
differentiative expression (Fialkow et al, 1987) 
The cultured clusters from case nos 4 and 5 contained the same ISH marker as found 
in the total blast population This was in concordance with the observed leukemic growth 
pattern and undifferentiated appearance of the clusters, and confirmed the leukemic origin 
of these myeloid progenitors Although in both cases part of the BM cell metaphase spreads 
and interphase nuclei appeared normal, no residual normal clonogenic cells could be 
detected after long-term culture in liquid In the majority of reported cases, long-term 
marrow cultures provide a selective growth advantage for normal progenitor cells But in 
some AML cases, like in cases nos 4 and 5, persistence of the leukemia has been observed 
(Coulombel et al, 1985, Chang et al, 1986, 1989, Singer et al, 1988) 
Forty to 70% of the AMLs and 25 to 50% of the MDSs have numerical chromosomal 
abnormalities (Yums, 1984, Jacobs et al, 1986), indicating that a substantial number of 
patients with AML and MDS can be analyzed by ISH using centromere associated DNA 
probes Moreover, probes against fusion genes, like the bcr-abl gene, have become 
available (Tkachuk et al, 1990) This may further increase the number of patients which 
can be studied by ISH techniques By performing ISH on agar cultures, the cytological 
architecture remains aio intact This enables individual analysis of aggregates and single 
cells in the culture Sample errors are avoided since removal of colonies is not necessary 
In contrast to the conventional cytogenetic techniques, not only large colonies but also small 
clusters can be analyzed Furthermore, it is less time consuming to investigate large 
numbers of aggregates Therefore, ISH may help to clarify the complex biology of MDS 
and AML both during full blown situation and clinical remission In addition, it can be 
applied to monitor in vitro culture systems and in vitro purging of autologous bone marrow 
grafts 
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Abstract 
The nuclear DNA content of 53 transitional cell carcinomas (TCCs) of the urinary 
bladder, as determined by flow cytometry (FCM), was compared with chromosome ploidy 
as detected by nonradioactive in situ hybridization (1SH) For this purpose, probes for 
repetitive DNA targets in the (pen)centromenc region of chromosomes 1 and 18 were 
used. Hybridization results with both probes of 35 TCCs, which had a DNA index of 
approximately 1 0 as concluded from FCM, showed evident chromosome 1 aberrations in 
approximately 25% of the tumors, and in a few cases an aberration for chromosome 18 was 
detected Comparison of the ISH spot numbers for both chromosomes showed in most cases 
a higher number for chromosome 1 than for chromosome 18. ISH on 18 cases of TCCs, 
which showed a single peak in FCM with a DNA index of 1 2 to 3.2, exhibited a 
profound heterogeneity In these TCCs the ratio between chromosomes 1 and 18 varied 
over a wide range, resulting in cases showing more hybridization signals for chromosome 1 
than for chromosome 18 or the opposite Furthermore, using ISH minor cell populations 
showing polyploidization and giant cells containing numerous ISH signals could occasio-
nally be detected Results showed that interphase cytogenetics by ISH enable a fast 
screening of numerical chromosome aberrations and detection of different cell populations 
within one tumor, which was apparently homogeneous according to FCM. 
Introduction 
Because the DNA index is a prognostic parameter, flow cytometry (FCM) has become a 
method for rapid and objective screening of malignant tumors (Barlogie et al, 1983; 
Tribukait et al. 1986, Merkel et al, 1987, Smeets et al, 1987) However, by FCM the total 
DNA content of a cell nucleus is estimated and no information about the specific chromo-
some aberrations is obtained Chromosomal analysis is described as a more objective 
criterion of the malignant potential of, for example, bladder cancer (Sandberg, 1977; 
Summers et al, 1981, Wijkstrom et al, 1984; Kovacs, 1985; Atkin et al, 1985, 1986; 
Tribukait et al, 1986, Babu et al, 1987, Smeets et al, 1987, Vanni et al, 1988), although it 
should be mentioned that cytogenetic studies of transitional cell carcinomas (TCCs) showed 
a positive correlation between the modal chromosome number and the DNA index as 
measured by FCM (Tribukait et al, 1986; Smeets et al, 1987). 
Chromosome analysis of solid tumors is possible with or without previous culturing of 
the tumor cells Culturing may result in a selective growth of cells and changes in 
chromosomal material Direct analysis is frequently hampered by the small number of 
recognizable metaphases and cannot be performed routinely 
Recently it was demonstrated that in situ hybridization (ISH) using chromosome-specific 
probes allows the detection of chromosome aberrations at the cellular level (Cremer et al, 
1986, 1988a, 1988b, Hopman et al, 1986a, 1988, Devilee et al, 1988; Nederlof et al, 
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1989) Because such ISH analyses can be performed on nonmitotic cells, it is generally 
referred to as interphase cytogenetics (Cremer et al, 1986) and has become a powerful 
tool in the study of numerical and structural chromosome aberrations in tumor cells 
(Cremer et al, 1988a, 1988b, Hopman et al, 1988, Nederlof et al, 1989) In this study ISH 
DNA probes recognizing highly repetitive sequences in the centromeric region of chromo­
somes were applied to a series of TCCs, which had been analyzed previously by FCM We 
applied a probe specific for chromosome 1 (Cooke et al, 1979) because for this chromo­
some nonrandom numerical aberrations were described in several tumor types (Atkin, 
1985) Furthermore, a probe for chromosome 18 (Devilee et al, 1986) was used, because 
this chromosome is not specifically or nonrandomly affected in bladder cancer (Teyssier, 
1989) 
Materials and Methods 
Patient Material 
Sixty TCC specimens were analyzed, of which ten were collected after chemotherapy or 
radiotherapy Tissues were obtained after transurethral resection One part of each tumor 
was used for histopathologic diagnosis, whereas the other part was used for FCM and ISH 
studies The tumois were collected in 10 ml RPMI 1640 (Flow Laboratories, Ltd, Irvine, 
CA) medium containing 17% fetal calf serum (Flow Laboratories), 50 μ% gentamycin, 50 
μg penicillin, and 50 /¿g streptomycin/ml Single-cell suspensions of fresh tissues were 
prepared as previously described (Smeets et al, 1987) in brief, the tissues were mechani-
cally disaggregated by scraping and cutting in a Petri dish and filtered through a 100 μνη 
nylon filter (Ortho Diagnostic Systems, Beerse, Belgium) The filtered cell suspensions 
were fixed in 70% ethanol (-20 °C) and stored at 30 °C The cell suspensions can be stored 
for more than 3 years without noticeable differences in the ISH results 
Flow Cytometry 
DNA analysis was performed using a Cytofluorograph 50H (Ortho Instruments, 
Westwood, MA) The pellet obtained after centrifugation of the ethanol-fixed cells was 
suspended in propidium iodide (PI, final concentration 20 mg/l in 150 mM sodium 
phosphate buffer, pH 7 4) The fluorochrome PI was excited at 488 nm with an argon laser 
(Spectra Physics, Mountain View, CA), and PI fluorescence was measured using a 630 nm 
pass filter The DNA content is expressed as the DNA index The TCCs were qualified 2C, 
3C, 4C, and >4C, 2C DNA index = 0 9 to 1 1, 3C DNA index = 1 2 to 1 7, 4C DNA 
index = 1 8 to 2 2, >4C DNA index = > 2 2 Chicken red blood cells were used as an 
internal standard whereas human lymphocytes were used as the external standard 
Tumor Cell Processing for In Situ Hybridization 
The suspensions that were not immediately used had been stored from a few months to 
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several years Cells fixed in ethanol were postfixed in methanol/acetic acid (3/1; four 
times. 5 minutes at O'C), and spotted onto poly-L-lysine-coated slides Optionally, the 
cytoplasm was partly removed by a 70% acetic acid wash (Hopman et al, 1988), for 
improvement of DNA probe and antibody penetration A second procedure that was applied 
and that gave an optimal recovery of cells and proper removal of cellular protein was 
proteolytic digestion of the cells before 1SH For this purpose, 5 μΐ of a suspension was 
dropped onto the slides, air-dried, and then digested with pepsin (Burns et al, 1986) from 
porcine stomach mucose (2500 to 3500 units per mg protein, Sigma Chemical Co , St. 
Louis, MO) at a concentration ot 40 to 200 μg/ml in 0 01 M HCl for 10 min at 37°C. 
After subsequent dip washes in H20 and phosphate-buffered saline (PBS) and fixation in 
4% paraformaldehyde in PBS toi 5 minutes at 0°C, the slides were dehydrated, air dried, 
and heated at 80 "C tor 30 minutes 
Metaphase spreads of human lymphocytes, ethanol fixed T24 Bubenfk et al, 1973) and 
Molt-4 (Minowada et al, 1972) cells were used as controls for the detection of disomy, 
trisomy, and tetrasomy for the chromosome 1 and chromosome 18 probe 
DNA Probes and Nonradioacti\e Labeling 
The DNA probe for chromosome 1 (pUC 1 77, indicated as probe lc) has been 
described by Cooke and Hindley (1979) and recognizes a tandem repeat of 1 77 kb in the 
(pen)centromenc region <lq 12) The probe for chiomosome 18 (LI 84, probe 18c) has 
been described by Devilee et al (1986) and recognizes a tandem repeat in the centromenc 
region of chromosome 18 Biotinylalion of the probes (Langer et al, 1982) was performed 
using Bio-ll-dUlP (hnzo. New Yoik, NY) in a nick translation reaction as described by 
Brigati et al (1982) Mercuration ot the probes was performed by using the mercury(II) 
acetate method described by Hopman et al (1986b, 1988) 
In general, when double target ISH was performed the chromosome 1 probe was 
biotinylated, whereas the chromosome 18 probe was mercurated 
Figure 1. In snu hybridization on the bliiddn rumor cell line T24 nun probe lc (b) and probe 18c (d) 
(а,с DNA counterstmning Kith DAP1) 
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In Siru Hybrtdizarion (ISH) 
The probes were hybridized (in single- and double-target ISH) in 60% formamide, 2 χ 
SSC of pH 5 0 (0 3 M NaCI, 30 mM Na-citrate), 1 mM KCN and 1 μg/^ l^ salmon sperm 
DNA as carrier DNA. at a probe concentration of 2 to 6 ng/μΙ hybridization mixture. 
Under these stringency conditions, hybridization to minor binding sites was avoided. Of the 
hybridization mixture, 5 μ\ was added to the slides and sealed with rubber cement under a 
coverslip (18x18 mm) Denaturation was performed at 70 to 80°C on a heating plate during 
2 5 minutes Hybridization was performed overnight at 37°C. Posthybridization washings 
and fluorescent detection of hybrids were performed as previously described (Hopman et al 
1986c, 1988) Evaluation and counting of fluorescent ISH signals were done according to 
criteria as described before (Hopman et al, 1988) Microphotographs were taken with a 
Leitz Dialux 20 EB microscope (Leitz Wetzlar, Germany), equiped for FITC, TRITC, and 
DAPI fluorescence using Tmax Kodak 400 ASA film (Kodak, Rochester, NY) Exposure 
times were approximately 2 minutes for FITC fluorescence, approximately 40 seconds for 
TRITC fluorescence, and 1 second for DAPI fluorescence Evaluation of the preparations 
was performed by counting approximately 200 nuclei per slide With respect to the 
interpretation and statistical analysis of the ISH preparations, it must be stated that in all 
samples nuclei not reacting with the DNA probes were seen These negative nuclei were 
not counted and therefore did not contribute to the data mentioned in the text and figures. 
When the cell population with negative nuclei exceeded 15%, the procedure was regarded 
as suboptimal and, theiefore, the data from seven of 60 cases could not be used. 
Results 
Technical aspects 
The ISH procedure was tested on human lymphocytes, the bladder carcinoma cell line 
T24, and the leukemic tumor cell line Molt-4, which showed a maximum of two, three, 
and four ISH signals per nucleus, respectively These cells were used to develop proper cell 
preparation techniques and to optimize the specificity and sensitivity of the ISH procedure. 
In Figure la through d, examples of ISH on T24 with probes lc and 18c are shown, 
indicating that both probes detect the three DNA targets per nucleus When the ISH 
procedure was performed as described in Materials and Methods, at least 80% of the 
interphase nuclei of the lymphocytes, the T24 cells, and the Molt-4 cells reacted as 
expected In the remaining 20% of the cells, mainly lower copy numbers for both chromo­
somes were found This percentage varied between the two different procedures used The 
least reproducible results were obtained when the methanol/acetic acid postfixation step was 
used The reproducibility was highest when a proteolytic digestion step was included in the 
procedure to remove cytoplasmic and nuclear proteins For this purpose, an optimal pepsin 
concentration had to be established to obtain a maximal penetration of DNA probes and 
antibodies and, thus, a maximal ratio between the nuclei showing the real copy number and 
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nuclei with lower copy numbers For a statistical analysis of human lymphocytes and T24 
cells hybridized with several DNA probes, see Hopman et al (1988, 1989) The optimali-
zation of the proteolytic digestion step for MoIt-4 cells has also been described before 
(Hopman et al, 1989) The cells from the solid TCCs were isolated by mechanical 
disaggregation technique and fixed in 70% ethanol As a result of this technique, some 
cytoplasm was left around the nucleus This remainder can give rise to a high 
autofluorescent background, which is higher when the storage time is increased A low 
fluorescent ISH reaction was noticed in these cases, and this was most pronounced in those 
cells having the nucleus partly covered by cytoplasm To remove the cytoplasm and part of 
the nuclear proteins two procedures were followed 
1 Postfixation of the samples with a methanol/acetic acid mixture and preparation of 
the microscopic slides by dropping the cell suspension onto glass slides, which was 
sometimes followed by dipping in acetic acid 
2 Dropping of the cell suspension onto glass slides and proteolytic digestion with 
pepsin Coating of the slides with poly L-lysine, fixation with paraformaldehyde and 
heating as described in Materials and Methods were found to be essential for retention of 
the cells on the glass slides, as well as for optimal preservation of nuclear 
morphology and DNA staining 
The latter approach was the most reproducible one with respect to removal of protein 
and, thus, for penetration of the probe or for exposing the DNA target for reaction 
Furthermore, in general it gave the best morphology and the most discrete ISH signals, 
with a high fluorescence intensity Cells fixed with methanol/acetic acid were often flat 
compared to the pepsin-treated cells Microscopic examination of pepsin-treated cells was, 
however, difficult, and counting of ISH signals needed focusing at different levels of the 
nucleus With respect to the pepsin treatment of the cells, it can be stated that cells with a 
higher DNA content and larger nuclei generally needed lower enzyme concentrations to 
obtain optimal hybridization signals than cells with smaller nuclei For practical reasons we 
normally used the highest concentration of pepsin (50 to 200 /ig/ml) still having an 
acceptable nuclear morphology With respect to the appearance of the ISH signal, we noted 
split-spots and blurred spots next to the more discrete signals Examples of such a deviating 
spot morphology are shown in Figure 2b, Figure 3b, f, and m, and Figure 4d We earlier 
listed the criteria for the evaluation of such signals (Hopman et al, 1988) To analyze the 
variations that have been introduced into the final result by different observers and between 
different experiments, we performed comparative studies with three observers that analyzed 
two different ISH incubations of 21 TCCs Figures 5A and В show examples of a diploid 
and an aneuploid TCC analyzed by the three observers The results obtained by two 
observers in two independently repeated experiments on the same 21 TCCs are compared in 
Figure 5C This plot illustrates the limited variability in the detection of aneuploid cells that 
occurs among different experiments, even when only 200 (randomly chosen) nuclei per 
tumor are examined 
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Figure 2. Single- and double-targe! ISH on a 2C diploid bladder tumor, α-d: Single-target ISH on 
isolated bladder tumor cells with probe Ic (bj and probe 18c (d). Asterisk in b indicates a split or 
paired spot for probe Ic. e-g: Double-target ISli of the same tumor showing DNA staining with DAPI 
(t), TRITC-fluorcsccnce signals of probe Ic (J), and FITC-fluorescence signah of probe 18c (g). 
Overlap of the TRITC-fluorescence signals in the UTC channel is indicated by the arrows in g(a, С 
and e, DNA counterstaining with DAPI. 
In Situ Hybridization on Cell Suspensions of TCCs 
2 С TCCs (35 Cases) 
These tumors had a single peak in FCM and a DNA index of 0.9 to 1.1. The expected 
number of ISH signals for both probes in the cells with a normal DNA content (DNA index 
= 1.0) was two. as is the case with normal human lymphocytes. Our ISH results in these 
91 
Figure 3. Single- and double-target ISH on 2C bladder tumors showing numerical chromosome 
aberrations, α-d: Single-target ISH on a bladder tumor (DNA index, 1.0) with probe 1c (b) and probe 
18c (d). e-g: Double-target ISH on the same tumor showing DNA staining with DAP! (e), probe Ic 
ISH signals φ, and probe 18c hybridization (g). Overlap of the TRITC-fluorescence signals in the 
FITC channel is indicated by the arrows in g. h and i: Cell nucleus showing five ISH signals for probe 
1c next to a cell nucleus with three ISH signals within the same tumor cell suspension for probe le. j 
and k: Giant cell within this suspension showing multiple \pots for probe 1c. I and m: Example of a 
1С bladder tunwr with a tetrusomy Jor probe Ic. Asterisk in b indicates blurred spots and asterisks in f 
and m indicate examples of split spots, (a, c, e, h, j , and I, DNA counlerslaining with DAP1. 
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Figure 4. Single- and double-target ISH on 3C and 4C tumors, a-c: Double-target ISH on an 
aneuploid tumor (DNA index, 1.5) with probe ¡c (b) and probe ¡8c (c). d-i: Single-target ISH on 4C 
bladder tumors with probe 1c (d, e, and g) and probe 18c (i). j-l: Double-target ISH on the same 
tumor shown in f lo i with probe ¡с (к) and probe 18c (I). Overlap of the TRITC fluorescence signaL· 
in the FITC chamiel is indicated by the arrows in с and I. Asterisk in d indicates a large ISH spot as 
compared to the other two hybridization signals in the same nucleus, (a, f, h, and j , DNA counter-
staining with DAPI). 
TCCs using probe lc showed that all tumors contain cell populations with two copies for 
chromosome 1. However, in nine of these 35 cases, evident additional cell populations (i.e. 
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comprising more than 35% of the total cell population) were detected showing three or four 
ISH signals for probe lc Examples of those cell populations with a disomy, trisomy, and 
tetrasomy for chromosome 1 are shown in Figures 2 and 3 The 35 analyzable diploid 
tumors showed different patterns Twenty TCCs showed a major cell fraction (approxi­
mately 80% of the cells) with two ISH signals for chromosome 1, and minor cell popula­
tions with one (an average of 8% of the cells, range, 2% to 24%), three and four ISH 
signals (an average of 8% of the cells, range, 2% to 12%) Fifteen TCCs showed two 
major cell populations, one showing two ISH signals for chromosome 1 (approximately 
60% of the cells) and another showing three ISH signals (an average of 28% of the cells; 
range, 11% to 83%) and a minor population with four ISH signals In four of these tumors 
the population of cells with four ISH signals exceeded 10% By FCM none of these 
aneuploid cell populations could be detected in different types of TCCs 
Evaluation of ISH signals using probe 18c was possible in 19 of 35 cases of the TCCs 
analyzed with probe lc Comparison with the ISH data for probe 18c showed that in two of 
the cases with a monosomy for chromosome 1 a monosomy for chromosome 18 was also 
detected, whereas in one of these cases the copy number for 18c was higher In the tumors 
with a disomy for chromosome 1, the copy number for probe 18c corresponded to that of 
probe lc (compare Figure 2b to 2d) By means of the double target ISH procedure we also 
demonstrated that most of these cells contained two copies of both chromosome targets 
(Figure 2e-g) Hybridization of probe 18c on tumors with three and four copies for 
chromosome 1 showed in most cases a higher copy number for probe lc than for probe 
18c Figure 3d illustrates an example of disomy for 18c, whereas the same fraction of cells 
within this TCC showed a trisomy for probe lc (Figure 3b) Figure 6a to с depicts the 
FCM analysis and the frequency distribution of ISH signals for probe lc and 18c, in both 
the single- and double-target ISH method, for this tumor The latter procedure proves that 
in one and the same cell different copy numbers for probe lc and 18c can be detected This 
is illustrated in Figures 2g and 3f where an example of this double-target ISH method 
clearly shows different ploidies Within the same tumor cells with five and six ISH signals 
were also seen (Figure 3i), and in the double-target ISH we even found one cluster of cells 
containing six copies for probe lc and four copies for probe 18c (Figure 3f, g- the cell in 
the upper right corner) In four TCCs, a fraction of cells was found with four ISH signals 
for probe lc (Figure 3m) In these tumors, however, larger fractions with a trisomy for 
chromosome 1 were also detected In a number of the tumors with a DNA index of 1 0, 
cells with a very high copy number for probe lc were found (Figure 3k) 
3C, 4C, >4C TCCs (18 Cases) 
These tumors had a DNA index between 1 2 and 3 2 as measured by FCM. ISH of 
probe lc on these TCCs showed an extensive heterogeneity in the number of hybridization 
signals, on the one hand between TCCs with a similar DNA index, and on the other hand, 
within one tumor In eight tumors with a DNA index between 1 2 and 1 7, the copy 
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number for chromosome 1 ranged between three (Figure 4b) and five, but most of these 
TCCs contained cell populations (accounting for more than 10% of the total cell population) 
with both three and four ISH signals per cell (Figure 6d-f) Two of eight TCCs had a 
major fraction showing chromosome 1 trisomy, whereas one tumor showed mainly 
tetrasomy for probe lc. 
In the eight TCCs with a DNA index between 1.8 and 2 2, most tumors contained 
fractions with trisomy, tetrasomy, and pentasomy for chromosome 1. Four of these cases 
had a major fraction with tetrasomy (Figure 5B). However, within these TCCs cell 
populations with ISH signals for chromosome 1 ranging from one to six were observed. In 
one case a monosomy was frequently detected next to the disomic fraction (Figure 4e). In 
some cells of this case one large ISH signal next to some smaller ISH signals was also 
observed (Figure 4d). 
ISH spots per nucleus 
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Figure 5. A and В [nterobserver variability for the evaluation of in situ hybridization reactions in a 
diploid (A) and tetraploid (B) transitional cell carcinoma Three different observers analyzed at least 
200 nuclei m two experiments The results found by the three individual observers are presented as 
closed, open and hatched bars С Comparison of the results of two different ISH experiments of 21 
tumors analyzed by two independent observers plotted in a scatter diagram. The closed circles indicate 
the percentage of aneuploid cells m 18 diploid TCCs, as detected by observer 1 m experiment 1 (on 
the X-axis) and by observer 2 in experiment 2 (on the Y-axis) Similarly, the open circles represent 
these values for three aneuploid TCCs, indicating a statistically highly significant correlation 
(correlation coefficient Pearson's r=0 98 with a Ρ < 0 0001) between both experiments 
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Figure 6. Typical examples of flow cytometric analyses of a 2C (a-c), 3C (d-f), and two 4C (g-l) TCCs 
and ISH analyse* of chromosome I and chromosome 18 a, d, g, and j DNA histogram of TCC cell 
suspensions stained with propidium iodide and analyzed by flow cytometry b, e, h, and k Frequency 
distribution of the number of ISH signals per nucleus (S/N) after the single-target procedure with probe 
le (closed bars) and probe 18c (open bars) Usually, 100 to 200 nuclei were analyzed c, f, I, and I 
Percentage of cells with the indicated number of ISH signaL· per nucleus after a double-target ISH 
with probe 1c (vertical rows) and probe 18c (horizontal rows) Asterisk in с indicates that six spots for 
probe Ic and four spots for probe 18c were found in a cluster of cells 
Figures 4g and к depict results obtained with the tetraploid TCC also shown in Figure 6g to 
ι, which contained four, five, and six ISH signals, respectively, for chromosome 1. The 
ISH results with probe lc of the TCC evaluated in Figure 6j to 1 (DNA index, 2.1) are 
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depicted in Figure 7b and f It can be seen that most of these tumor cells show two strong 
hybridization signals for probe lc, whereas in this case several minor, less intense ISH 
signals were also detected It could not be concluded whether these signals represented a 
specific hybridization with chromosome 1 or minor binding sites on other chromosomes 
The two tumors with the highest DNA index (2 6 and 3 2) also showed high copy numbers 
for chromosomes 1 and 18 Figure 7i shows an example of the case with a DNA index of 
3 2, illustrating cells with eight and nine ISH signals for probe lc 
The profound heterogeneity observed for chromosome 1 became even more pronounced 
after application of probe 18c in the double-target ISH Evaluation with probe 18c was 
possible in 12 of the 18 cases analyzed with probe lc In five cases studied with probe 18c 
a heterogeneity similar to that observed with probe lc was seen, whereas in four cases the 
number of ISH signals counted for probe lc was greater than for probe 18c (Figure 6b, d, 
e, f, h, and ι) Examples of such preparations are shown in Figure 7f to i, in which the 
chromosome 1 number varied between 4 and 6 whereas the copy number for chromosome 
18 varied between 3 and 5 Figuie 7h to к shows the hybndization results with probe 18c 
on the TCC with a DNA index of 3 2 and also reveals that in this case the copy number for 
chromosome 18 is smaller than for chromosome 1 Analyses showed ratios of 8 to 9 and 5 
to 6 for probes lc and 18c respectively Examples of cases with higher spot numbers for 
probe 18c than for probe lc are given in Figure 4b and с and Figure 7a to g This latter 
case is evaluated in Figure 6k, which shows that the spot numbers for probe lc varied 
between 2 and 3 whereas the spot numbers for probe 18c varied between 2 and 4 
Discussion 
Earlier studies showed that probes to repetitive DNA sequences located predominantly 
in the (pen)centromenc region of one particular chromosome will, under proper hybridi­
zation conditions, exclusively reveal their targets as distinct spots in the interphase nucleus 
(Cremer et al, 1986, Devilee et al, 1988, Hopman et al, 1988, Nederlof et al, 1989) In this 
study we showed that nonradioactive ISH in combination with two of these repetitive DNA 
probes (for chromosomes 1 and 18) can detect numerical chromosome aberrations in cases 
of solid bladder tumors, ι e , transitional cell carcinomas (TCCs) This approach provided a 
simple means for the rapid detection and statistical analysis of numerical chromosome aber­
rations in interphase tumor cells and allowed us to evaluate and detect individual tumor 
cells and tumor cell populations within TCCs 
A number of technical items needed for the technique need discussion Single cell 
suspensions prepared by a mechanical disaggregation method from fresh tumor material 
followed by fixation in ethanol were stored for up to several years and still could be used 
for ISH Treatment of the cells by postfixation in methanol/acetic acid or by pepsin 
digestion enables the evaluation of approximately 90% and 70% of the tumors with probes 
lc and 18c, respectively Evaluation of the ISH signals by counting the number of hybridi-
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Figlile 7. Single- and double-target ISH on a 4C and a >4C bliulder tumor α-d Single-target ISH on 
4C tumor with probe le lb) and pi ohe I8c (cl) e-g Double-target ISH on the same tumor with probe 
le φ and piobe ¡Se tg) 0\eilap of the TRI ГС fluorescence ugnali in the FITC channel u indicated 
In the arww\ in g h-k Sinvle-targa ISH on a >4C tumor (DNA index, 3 2) with probe le (i) and 
probe Ibi (k) AstirisLs in b andJ piobabh indicate minor hybridization ugnals (a, e, e, h, and j , 
DNA touniirstaming with DAPI) 
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zation spots is, however, sometimes difficult because of the way the hybridization signals 
are manifested Paired (or split) spots and a blurred appearance of the spots have been 
described previously (Devilee et al, 1988, Hopman et al, 1988, Cremer et al, 1988). Part 
of these patterns may be artifacts resulting from the methanol/acetic acid fixation, the 
fragile structure of the nucleus of some large tumor cells, or both, which may lead to a 
disaggregation of the heterochromatin. Mild pepsin digestion or heat denaturation resulted 
in more distinct signals similar to those seen in ISH studies on paraffin sections (Hopman et 
al, 1989) We also noticed that in most TCCs a population of cells showed no spots at all 
or cells showing only one ISH spot for chromosome 1 and 18. It can furthermore be 
expected that inefficient protein removal may block penetration of probe and antibodies, 
that paired localization of target DNAs may occur, and that DNA may be lost as a result of 
overdigestion and the denaturation Therefore, these analyses may underestimate the 
numerical chromosome aberrations or number of targets Thus it is easier to detect cell 
populations with an increased numbers of the tested chromosomes than cell populations with 
chromosome losses On the contrary, clumping of cells during the isolation procedure or 
the presence of split-spots may result in the counting of apparently higher copy numbers 
The validity of the ISH method for detecting of numerical chromosome aberrations has 
been tested in cell lines with known chromosome number In these preparations the 
published karyotyping îesults for chromosomes 1 and 18 correspond with the number of 
detected ISH signals for probes lc and 18c (Cremer et al, 1986, 1988b). In general, ISH 
on cell lines resulted in one major peak representing the cells with the real copy number for 
the individual chromosomes In all cases minor fractions of cells with a lower spot number 
were counted. Similarly, in diploid TCCs with mainly two ISH signals for chromosome 1 a 
relative small fraction (<10%) of nuclei with none or one ISH signal for individual 
chromosomes was always detected next to the major fraction with two ISH signals. 
However, in several of these malignancies a fi action with higher spot numbers (three and 
four) was also found From comparisons of the results in the cell lines and normal 
lymphocytes with the TCCs we are convinced that even these minor fractions in these 
TCCs with higher spot numbers represent aneuploid cells (see also Figure 5C). Preliminary 
results of karyotyping and ISH on paraffin sections of the same tumors as described above 
support this assumption (Hopman et al, to be published). 
Thus far no comparative data are available that draw parallels between classic karyo-
typing and interphase cytogenetics on the same solid tumors In five cases karyotyping data 
could be obtained concerning chromosomes 1 and 18 In one case the aberration detected 
by karyotyping was a + lp- This aberration was detected by the ISH as an extra spot with 
probe lc (Figure 3b and 0 In another case an isochromosome Iq and two normal copies of 
chromosome 1 were seen by the cytogenetics ISH occasionally showed one large spot, in 
some cases consisting of two signals, and two smaller spots (Figure 4d), confirming the 
cytogenetic data A trisomy tor chromosome 18 was detected by ISH in a TCC with a 
DNA index of 1 0, in which karyotyping showed a dicentric chromosome 18, thus 
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explaining the extra spot with probe 18c Although these data already demonstrate the 
validity of the ISH-method, proper evaluation and comparison of these two methods must 
be performed on a larger scale in the future 
TCCs with a DNA index of 0 9 to 1 1, as measured by FCM, all contained a popula-
tion of cells with two ISH signals for probes lc and 18c, most probably representing or 
containing the normal epithelial and stromal cells next to diploid tumor cells In these 
tumors a monosomy, trisomy, or tetrasomy for probe lc could frequently be detected, thus 
demonstrating the profound ploidy aberrations in tumors with an apparently normal DNA 
content In approximately 25% of these TCCs evident chromosome aberrations were 
detected The number of 2C tumors with a numerical chromosome 18 aberration was much 
lower than for chromosome 1 By means of the double-target ISH-method, we nicely 
demonstrated these numerical differences of chromosomes 1 and 18 in one and the same 
cell From the foregoing it may be obvious that apparently homogeneous tumor cell 
populations within one TCC, as concluded from DNA FCM, may show a heterogeneous 
composition when analyzed by ISH (Figure 5C) Furthermore, cells with a tetrasomy for lc 
were seen in these 2C tumors by ISH That these cells are no normal G2M cells, as 
measured by FCM, can be detected because the number of the ISH signals for the DNA 
targets were not doubled during proliferation due to their (pen)centromenc localization 
Finally, cells with a very high spot number for probe lc were occasionally found These 
cells, which probably represent the giant cells as described for TCCs, are most probably 
formed by polyploidization (Fossa et al, 1976) These cells are normally not detected by 
FCM because of their low frequency, or cannot be distinguished from cell clusters by this 
method 
In most aneuploid and tetraploid tumors a cell population was also present that showed 
two ISH signals for probes lc and 18c, most probably representing the normal epithelial 
and stromal cells However, in all these TCCs a cell population with an ISH spot number 
deviating from two was detected for probes lc and 18c In most tumors this cell population 
exceeded 30% of the total cell number Comparison of the FCM data with the chromosome 
copy number detected by ISH showed that single, sharp DNA peaks in FCM contained 
several populations with different chromosome numbers In FCM, furthermore, prolifera-
ting cells in the G,M phase, which have twice the DNA content of the G0G, cells, cannot be 
discriminated from the tetrasomic tumor cells ISH can distinguish between these popula-
tions, because mitotic cells show the same spot numbers as nonmitotic cells, at least with 
probes used in this study 
In the TCCs with a DNA index greater than 1 2, a large heterogeneity was detected for 
both probes lc and 18c This means that within a certain TCC two or more evident cell 
populations weie detected that had different spot numbers for probe lc and probe 18c. 
Also, when comparing diffeient TCCs with a similar DNA index, profound differences in 
copy numbers for both probes were observed Tumors with higher copy numbers for 
chromosome I than for 18 were detected and, on the other hand, tumors with higher copy 
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numbers for chromosome 18 than for chromosome 1 were seen This was best demonstra-
ted in the double-target ISH It should be stated, however, that the number of probe 18c 
spots normally correlated better with the DNA index as estimated by FCM than did the 
probe lc spot numbers This was perhaps to be expected on the basis of karyotyping 
results, because chromosome 1 aberrations contrary to chromosome 18 aberrations were 
reported by several authors in various types of human malignancies This chromosome has 
frequently been reported to undergo structural along with numerical changes (Sandberg, 
1977, Atkin et al, 1985, 1986, Smeets et al, 1987, Devilee et al, 1988, Teyssier, 1989) 
Breakpoints within this chromosome are mostly situated in or near the centromere hetero-
chromatin region and duplications of a part of the long arm are common (Atkin, 1986) 
The latter aberrations could result in a doubling of the target for probe lc (located on the 
lq arm) and thus give an extra ISH signal An example of a structural aberration that we 
observed by our ISH approach is shown in Figure 4d and dealt with an isochromosome lq 
In general, chromosome 1 aberrations have been described as late events Our results with 
the diploid TCCs indicate that such aberrations may also occur in an early stage of 
malignant transformation Future studies comparing conventional karyotyping data with ISH 
data on an extended series of TCCs, as well as in other malignancies, should reveal the 
usefulness of interphase cytogenetics Furthermore, clinical follow-up data must be 
correlated with the ISH data, to investigate the prognostic value of this technique 
101 
References 
Atkin NB Chromosome 1 aberrations in cancer (1986) Cancer Genet Cytogenet 21 279-285 
Atkin NB, Baker MC (1985) Cytogenetic study of ten carcinomas of the bladder Involvement of 
chromosomes 1 and 11 Cancer Genet Cytogenet 15 253-268 
Babu VR, Lulz MD, Miles BJ, Farah RN, Weiss L, Van Dijk DL (1987) Tumor behaviour in 
transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology 
Cancer Res 47 6800 6805 
Barlogie B, Raber M, Schuman J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff 
M, Freireich EJ (1983) Flow cytometry in clinical cancer research Cancer Res 43 3982-3997 
Brigati DJ, Myerson D, Leary JJ, Spalholz B, Travis S, Fong CKY, Hsiung GD, Ward DC (1982) 
Detection of viral genomes in cultured cells and paraffin-embedded tissues sections using 
biotin labeled hybridization probes Virology 126 32 50 
Bubenik J, Baresova V, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell 
line of urinary bladder carcinoma (T24) containing tumour specific antigen Int J Cancer 11 
765-733 
Burns J, Redfern DRM, Esin MM, McGee JO'D (1986) Human and viral gene detection in routine 
paraffin embedded tissue by in situ hybridization with biotinylated probes viral localisation in 
herpes encephalitus J Clin Pathol 39 1066 1073 
Cooke HJ, Hindley J (1979) Cloning ot human satellite III DNA different components are on 
different chromo-somes Nucleic Acid Res 6 3177 3197 
Cremer T, Landegent J, Biuckner A, Schuil HP, Schardin M, Hager HD, Devilee Ρ, Pearson Ρ, Van 
der Ploeg M (1986) Detection ot chromosome aberrations in the human interphase nucleus by 
visualization ot specific target DNAs with radioactive and non radioactive in situ hybridization 
techniques diagnosis ot trisomy 18 with probe LI 84 Hum Genet 74 346-352 
Cremer T, Lichter Ρ, Borden J, Ward DC, Manuehdis L (1988a) Detection of chromosome aberra­
tions in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific 
library probes Hum Genet 80 235 246 
Cremer Τ lessin D, Hopman AHN, Manuehdis L (1988b) Rapid interphase and metaphase 
assessment ot specific chromosomal changes in neuroectodermal tumor cells by in situ hybridi­
zation with chemically modified DNA probes Exp Cell Res 176 199-206 
Devilee P, Cremer T, Slagboom Ρ, Bakker E, Scholl HP, Hager HD, Stevenson AFG, Cornelisse CJ, 
Pearson PL (1986) Two subsets ot human alphoid repetitive DNA show distinct preferential 
localization in the pencentromeric heterochromatin ot chromosome 13, 21, 18 Cytogenet Cell 
Genet 41 193-201 
Devilee P, Thierry RF, Kievits T, Kolluri R, Hopman AHN, Willard HF, Pearson PL, Cornelisse CJ 
(1988) Detection of chromosome aneuploidy in interphase nuclei from human primary breast 
tumors using chromosome specific repetitive DNA probes Cancer Res 1988 48 5825-5830 
Fossa SD, Kaalhus О (1976) Nuclear size and chromatin in transitional cell carcinoma of the human 
unnary bladder Beitr Path Bd 157 109 125 
Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Devilee Ρ, Van der Ploeg M, Vooijs GP 
(1988) In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder 
tumors Histochemistry 89 307 316 
102 
Hopman AHN, Ramaekers FCS, VOOIJS GP (1989) Interphase cytogenetics on solid tumors In In situ 
hybridization principles and practice Eds Polak JM, McGee JO'D, Oxford University Press, in 
press 
Hopman AHN, Wiegant J, Raap AK, Landegenl JE, Van der Ploeg M, Van Duijn Ρ (1986c) Bi-color 
detection ot two target DN As by non radioactive in situ hybridization Histochemistry 85 1-4 
Hopman AHN, Wiegant J, Tesser Gl, Van Duijn Ρ (1986b) A non-radioactive in situ hybridization 
method based on mercurated nucleic acid probes and sulthydryl-hapten ligands Nucleic Acids Res 
14 6471 6488 
Hopman AHN, Wiegant J, Van Duijn Ρ (1986a) Mercurated nucleic acid probes, a new principle for 
non-radio-active in situ hybridization Exp Cell Res 169 357-368 
Kovacs G (1985) Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer J Cancer 
Res Clin Oncol 110 24*9 251 
Langer PR, Waldrop AA, Ward DC (1982) Enzymatic synthesis ot biotin labeled polynucleotides 
novel nucleic acid affinity probes Proc Natl Acad Sci USA 78 6633-6637 
Merkel DE, Dressler LG, McGuire WL (1987) Flow cytometry, cellular DNA content, and prognosis 
in human malignancy J Clin Oncology 5 1690-1703 
Minowada T, Ohnuma T, Moore G (1972) Rosette-forming human lymphoid cell lines I Establish­
ment and evidence for origin of thymus-denved lymphocytes J Natl Cancer Inst 49 891 
Nederlof PM, Van der Flier S, Raap AK, Tanke HJ, Van der Ploeg M, Kornips F, Geraedts JPM 
(1989) Detection of chromosome aberrations in interphase tumor nuclei by non radioactive in situ 
hybridization Cancer Genet Cytogenet , m press 
Sandberg AA (1977) Chromosome markers and progression in bladder cancer Cancer Res 37 
222 229 
Smeets W, Pauwels R, Laarakkers L, Dehruyne F, Geraedts J (1987) Chromosomal analysis of 
bladder cancer III Nonrandom alterations Cancer Genet Cytogen 29 29-42 
Smeets AWGB, Pauwels RPE, Beck HLM, Feitz WFJ, Geraedts JPM, Debruyne FMJ, Laarakkers L, 
Vooijs GP, Ramaekers FCS (1987) Comparison of tissue disaggregation techniques of transitional 
cell bladder carcinomas tor flow cytometry and chromosomal analysis Cytometry 8 14-19 
Smeets AWGB, Pauwels RPE, Beck HLM, Geraedts JPM Debruyne FMJ, Laarakkers L, Feitz WFJ, 
Vooijs GP, Ramaekers FCS (1987) Tissue specific maikeis in flow cytometry of urological 
cancers III Comparimi chromosomal and flow cytometric analysis of bladder tumors Int J 
Cancer 39 304-310 
Summers JL, Falor WH, Ward R (1981) A 10 year analysis of chromosomes in non-invasive 
papillary carcinoma of the bladder J Urol 125 177-178 
Teyssier JR (1989) The chromosomal analysis ot human solid tumors A triple challenge Cancer 
Genet Cytogenet 37 103-125 
Tnbukait B, Granberg-Ohman I, Wijkstrom H (1986) Flow cytometric DNA and cytogenetic studies 
in human tumors A comparison and discussion of the differences in modal values obtained by two 
methods Cytometry 7 194-199 
Vanni R, Scarpa RM, Nieddu M, Usai E (1988) Cytogenetic investigation on 30 bladder carcinomas 
Cancer Genet Cytogenet 30 35-42 
103 
Wijkstrom H, Granberg-Ohman I, Tribukait В (1984): Chromosomal and DNA paneras in transitional 
cell bladder carcinoma A comparative cytogenetic and flow-cytotluorometric DNA study. Cancer 
53 1718-1723. 
104 
Chapter six 
Structural Chromosome 1 Aberrations in Transitional Cell Carcinoma 
of the Bladder: 
Interphase Cytogenetics Combining a Centromeric, 
Telomeric, and Library DNA Probe. 
Pino J. Poddighe, Frans C S . Ramaekers, Α. Wim G.B. Smeets, 
G. Peter Vooijs, and Anton H.N. Hopman 
Cancer Research (1992) 52: 4929-4934 
105 
Abstract 
Fluorescence in situ hybridization (FISH) was used to study numerical and structural 
chromosome 1 aberrations in interphase nuclei of transitional cell carcinomas (TCCs) of the 
urinary bladder One of the characteristic numerical aberrations, as detected previous-ly in 
low-grade noninvasive TCCs, included trisomy for chromosome 1 (AHN Hopman et al, 
Cancer Res 51 644, 1991) We examined in more detail 22 cases with a centromeric 
(lql2) and a telomeric associated (lp36) DNA probe, and with a library DNA probe from 
sorted human chromosome 1 in single- and double-target FISH procedures All flow 
cytometrically determined DNA diploid TCCs (13 cases), which showed three spots for 
lql2 (6 cases), had two spots for lp36 Since the library DNA probe showed three separate 
domains in the nuclei of these cases, the additional copy for lq 12 could be explained as an 
extra chromosome lp-, containing the 1 q 12 target 
In the flow cytometrically DNA tetraploid/aneuploid tumors, the results were more 
complex In 6 of 9 cases, we observed an overrepresentation of lql2 as compared to lp36, 
also suggesting the presence of extra copies of lp- chromosomes 
The results of the present study demonstrate the utility of the FISH method to assess 
structural chromosome aberrations in interphase nuclei of solid tumors 
Introduction 
The malignant potential of transitional cell carcinoma (TCC) of the bladder can be 
assessed on basis of its extent of invasion (stage) and histological appearance (grade) 
(Cummings, 1980) Fuithermore, quantitative DNA analysis by FCM has provided comple-
mentary prognostic information However, the detection of specific chromosome aberra-
tions and minor genomic changes is limited by means of FCM (Smeets et al, 1987a; Koss 
et al, 1989) Although genetic aberrations can be detected more precisely by karyotyping, 
for solid tumors it is hampered by difficulties such as a low mitotic index, poor banding 
quality, and a condensed or fuzzy appearance of the chromosomes Furthermore, the 
number of cells that can be analysed is extremely limited (Atkin et al, 1985b, Smeets et al, 
1987b, Sandberg et al, 1988, Teyssier, 1989) 
FISH using repetitive DNA probes that hybridize to the centromeric associated region 
of a specific chromosome is a powerful technique to study numerical, and in a limited 
number of cases, structural chromosome aberrations within the interphase nuclei of tumor 
cells (Cremer et al, 1988a, Hopman et al, 1988a, Nederlof el al. 1989, Raap et al, 1990, 
Perez Losada et al, 1991) It has been shown that this method of interphase cytogenetics 
enables routine screening of a large number of tumor cells (Hopman et al, 1989, 1991; 
Poddighe et al, 1991) and allows the detection of minor cell populations or imbalance in 
chromosome copy number within one tumor (Hopman et al, 1988b, Devilee et al, 1988, 
Van Dekken et al, 1990, Poddighe et al, 1992) The application of chromosome in situ 
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suppression-hybridization using library DNA probes can specifically stain individual human 
chromosomes to identify chromosomal aberrations. This approach has been used for the 
rapid detection of numerical aberrations, such as trisomy for chromosome 21 (Lichter et al, 
1988b; Pinkel et al, 1988, Fuscoe et al, 1989), and analysis of chromo-some changes in 
metaphase and interphase cells (Cremer et al, 1988b, Lichter et al, 1988a; Jauch et al, 
1990) 
Numerical and structural aberrations involving several chromosomes, such as chromo­
somes 1, 7, 9, 11, and 17, have been detected for bladder cancer using metaphase and 
interphase cytogenetics (Atkin et al, 1985b, Hopman et al, 1989, 1991; Waldman et al, 
1991). In particular, allelic loss on 9q, lip, and 17p has been found recently in high-stage, 
high-grade TCCs using restriction fragment length polymorphism analysis (Tsai et al, 1990; 
Olumni et al, 1990). 
In the present study, we have focussed on chromosome 1, since aberrations in chromo­
some 1 copy number have been previously detected in TCCs of the bladder by FISH with 
centromenc associated probes (Hopman et al, 1989, 1991) In general, numerical and 
structural chromosome 1 aberrations have been found in many solid tumors (Atkin, 1985a; 
Croce, 1986, Sandberg et al, 1988, Teyssier, 1989) Therefore, we combined two probes 
that recognize repetitive sequences in the centromenc (lq 12) and the telomenc (lp36) 
region and a library DNA probe from sorted human chromosome 1 to study structural 
chromosome 1 aberrations and the imbalance in FISH copy number for lql2 and lp36 in 
interphase nuclei of TCCs 
Materials and Methods 
Tumor Samples 
For FISH analysis, seven cases with a disomy for lq 12 and six cases with a trisomy for 
1 q 12 were selected from a series of 28 FCM-determined diploid TCCs (Hopman et al, 
1991) Nine TCCs were DNA tetraploid/aneuploid. The TCC specimens were obtained 
immediately after transurethral resection FCM quantitation of DNA content was performed 
as described previously (Smeets et al, 1987a) The DNA content is expressed as the DNA 
index (DI) The TCCs weie qualified as DNA (near-)diploid (DI = 0.9-1 1) and DNA 
tetraploid/aneuploid (DI > 1 2-3 2) 
Tumor Cell Piocessmg 
Preparation of slides from the TCC cell suspensions, fixed in 70% ethanol, and steps 
necessary to remove cellular proteins for an improvement of DNA probe and antibody 
penetration were performed as described before (Hopman et al, 1989b, 1992; Poddighe et 
al, 1991). Briefly, 5 μ\ of a TCC cell suspension were dropped onto glass slides coated 
with poly L-lysine (Sigma Chemical Co , St Louis, MO; M
r
 150,000-300,000), air dried, 
and heated at 80°C for 1 h Thereafter, a proteolytic digestion was performed with pepsin 
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(Ρ 7000, Sigma) at an optimized concentration of 100 /ig/ml in 0 01 N HCl for 20 min at 
37°C After dipwashes in H 2 0 and PBS, the nuclei were postfixed in 4% formaldehyde in 
PBS for 20 mm at 4°C Then, the slides were subsequently washed in PBS and H 2 0 and, 
finally, dehydrated in an ethanol series of 70, 90 and 100% 
DNA Probes and Nonradioactive Labeling 
For the detection of the target sequences on chromosome 1, we used the repetitive DNA 
probe pUCl 77 (Cooke et al, 1979) for the detection of the pencentromeric region lql2, 
the repetitive DNA probe lp79 (Buroker et al, 1987) for the telomeric region lp36, and a 
library DNA probe from sorted human chromosome 1 The probes were labeled by nick-
iranslation with biotin 11-dUTP (Sigma) (Pinket et al, 1986) or digoxygenin-11-dUTP 
(Boehnnger, Mannheim, Germany) according to the instructions of the supplier 
FISH 
The single-target FISH with the repetitive DNA probes for lql2 and lp36 was 
performed as described previously (Hopman el al, 1989, 1992, Poddighe et al, 1991) in 
60% formamide 2xSSC, pH 7 0-10% dexlran sulfate-1 Mg/jul salmon sperm DNA as carrier 
DNA, at a probe concentration of 0 4 and 1 0 ng/μΐ hybridization mixture, respectively 
Hybridization mixture (10 μ\) was applied to the slides under a coverslip (18 χ 18 mm) and 
sealed with photo-paper glue Denaturation of probe and target DNA was carried out 
simultaneously by heating the slides in a moist chamber at 70°C for 2 5 min 
For the chromosome in situ suppression hybridization procedure, the library DNA probe 
from sorted human chromosome 1 was hybridized to the cells at a concentration of 12,5 
ng/μ] hybridization mixture containing 50% formamide-2x SSC, pH 7 0-10% dextran 
sulfate 1 μg/μl salmon sperm DNA as carrier Furthermore, for the suppression of 
hybridization signals from repeated sequences, such as Alu and Kpnl elements, human coti 
DNA at a concentration of 600 ng/μΐ was used in a reannealing procedure The probe 
mixture was heated at 95°C for 5 mm to denaturate the DNA and then incubated at 37°C 
for 20 min to promote partial reannealing The preparations on the glass slides were 
separately denaturated in 70% formamide-2x SSC, pH 7 0 at 70°C for 2 5 min and then 
dehydrated in a series of ethanol (70, 90 and 100%) at -20°C For the hybridization, 10 μ\ 
of the preannealed probe mixture were applied to the prewarmed slides (37°C) under a 
coverslip and sealed with photo-paper glue 
In the double-target FISH procedure with the repetitive probes for the lql2 and lp36 
target, the hybridizations were performed in 60% formamide hybridization mixture When 
the library DNA probe was involved, in combination with the probe for either lql2 or 
lp36, the reaction was performed in 50% formamide hybridization mixture In these 
experiments, the denaturated repetitive probe was added to the preannealed library probe 
mixture just before applying to the slides 
All hybridization steps were performed overnight at 37°C 
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Table 1 Summary of remits of interphase cytogenetics in 22 TCCs 
in situ hybridization copy number 
DNA Chromosomal 
Case index lql2 targetb lp36 targetb Domains" 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 0 
1 3 
1 6 
1 6 
1 7 
1 7 
1 8 
1 8 
2 0 
3 2 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
trisomy 
trisomy 
trisomy 
trisomy 
trisomy 
trisomy 
trisomy 
tetrasomy 
trisomy 
pentasomy 
tetrasomy 
tetrasomy 
letiasomy 
tetrasomy 
hexasomy 
pentasomy 
disomy 
monosomy 
nonasomy 
octasomy 
septasomy 
disomy 
,90%)c 
[87%) 
[93%) 
[95%) 
[96%) 
[91%) 
(85%) 
(74%) 
(71%) 
(76%) 
(70%) 
(62%) 
(63%) 
(79%) 
(38%) 
(41%) 
(35%) 
(37%) 
(81%) 
(81%) 
(73%) 
(50%) 
(24%) 
(51%) 
(41%) 
(20%) 
(36%) 
(17%) 
(12%) 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
disomy 
trisomy 
trisomy 
trisomy 
tetrasomy 
tetrasomy 
tetrasomy 
trisomy 
pentasomy 
tetrasomy 
(95%) 
(98%) 
(97%) 
(97%) 
(92%) 
(92%) 
(91%) 
(95%) 
(87%) 
(94%) 
(91%) 
(93%) 
(70%) 
(70%) 
(81%) 
(68%) 
(85%) 
(71%) 
(66%) 
(59%) 
(30%) 
(74%) 
(70%) 
two 
two 
two 
two 
two 
two 
two 
three 
three 
three 
three 
three 
three 
three 
three 
n d d 
four 
four 
four 
n d 
five 
n d 
' The maximum number ot FISH domains is mentioned In all diploid cases, one and two domains 
were observad Also, in the letiaploid/dneuploid cases the number of domains varied from one to the 
maximum number 
ь
 In all cases, Ihe major population is mentioned It more than one subpopulation was present, with 
<15% in discrepancy, then both subpopulations are mentioned 
' Percentage of cells 
Λ
 η d , not determined 
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Immunocytochemical Detection 
After FISH, the slides were washed three times for 5 mm under stringent conditions 
(60% formamide-2xSSS, pH 7 0 for the repetitive DNA probes, and 50% formamide-
2xSSC, pH 7 0 when the library DNA probe was involved) at 42°C and, subsequently, 
three times for 5 min in 2xSSC, pH 7 0 at 42°C 
Detection of hybrids was accomplished with fluorescent reporter molecules as described 
previously (Hopman et al, 1991, 1992) The single-target FISH reactions were performed 
using biotinylated probes, detected with FITC-conjugated avidin (Vector Laboratories, 
Burhngame, CA), and, if necessary, amplified using biotin-labeled goat anti-avidin (Vector) 
followed by a second layer of FITC-conjugated avidin (Pinkel et al, 1986) After double-
target FISH, the digoxygenin-labeled probe was detected using monoclonal anti-digoxin 
(Sigma), followed by incubation with FITC-conjugated rabbit anti-mouse antibody 
(Dakopatts, Glostrup, Denmark) The biotinylated probe was detected using Texas Red-
conjugated avidin (Vector), and, if necessary, the FISH signals were amplified as described 
above All the immunocytochemical steps were performed for 30 min at 37°C 
Results 
Evaluation and Interpretation of In Situ Hybridization Signals 
The validity and specificity of the detection of the FISH signals were determined on 
metaphase spreads and interphase nuclei of lymphocytes from normal healthy donors The 
evaluation of the single-target FISH results with the centramene associated probe for lql2 
and telomeric associated probe for lp36 was done according to criteria as described 
previously (Nederlot et al, 1989, Poddighe et al, 1991, Hopman et al, 1991) For these 
probes, the number of signals per nucleus was determined by counting 200 nuclei per slide 
We performed double-target FISH reactions to confirm the results with the probes for lql2 
and for lp36 and to avoid misinterpretations with regard to the imbalance of FISH spot 
numbers for these regions in the TCCs Evaluation of these results was done by counting 
100 nuclei/slide 
In contrast to the repetitive DNA probes, interpretation of the FISH results in interphase 
nuclei with the chromosome 1 library probe was more difficult The domains in these 
preparations are not always clearly separated, because of the 3-dimensional structure of the 
nuclei, the close juxtaposition of two individual domains in some cells, or the inability to 
resolve domains that actually occupy different areas within the nucleus According to 
results observed by others (Lichter et al, 1988a, Cremer et al, 1988b), the number of 
interphase nuclei with (artificially) one single domain was 10-20%, whereas in the 
metaphase spreads of the control human lymphocytes both chromosomes were decorated. 
Also, about 5-10% of the nuclei showed no signals Therefore, the evaluation of these 
domains in the interphase nuclei of the TCCs was mostly done qualitatively Furthermore, 
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double-target FISH reactions of the library DNA probe in combination with the probe for 
either lql2 or lp36 were performed to investigate whether small or substantial portions of 
chromosome 1 were duplicated in these tumor cells 
DNA Diploid TCCs (n = 13) 
Hybridization results of the three probes in the FCM-established DNA diploid TCCs in 
single target FISH are summarized in Table 1 Using the centromenc associated probe, we 
detected three copies for the lql2 target in six of 13 cases The percentage of trisomy 
detected by FISH in the individual cases ranged from 62-76% of the cells For the 
telomenc associated probe, in all cases, two copies for the lp36 target were detected (range 
70-98% of the cells) Hybridization with the library DNA probe in the diploid interphase 
nuclei resulted in the detection of three domains in all cases in which three FISH signals for 
the centromenc probe were detected To prove imbalance between the centromere and 
telomere targets, double-target FISH was performed In Figure 1, A and B, we illustrate 
the trisomy for lql2 and disomy for lp36 in a double-target procedure In Figure 1, С and 
D, the imbalance between the chromosomal domains and telomere sequences is illustrated 
Figure ID shows the three separate domains for chromosome 1 with the library DNA 
probe In Figure 2, two typical examples, namely, case 3 (A and B) and case 11 (C and 
D), are schematically represented The histograms demonstrate the frequency distribution in 
the single-target FISH, using the probes for lql2, lp36 and the library probe (Figure 2, A 
and C) The double-target FISH results, combining the centromere and telomere probes, 
are shown in Figure 2, В and D For case 3, the copy number for lql2 (disomy in 93% of 
the cells) was equal to the copy number for lp36 (disomy in 97% of the cells) Counting of 
the fluorescent domains after FISH with the library DNA probe in the interphase nuclei 
revealed also 95% of the nuclei with two domains (Figure 2A), in agreement with the 
number of FISH signals for the lq 12 and lp36 regions For case 11 (Figure 2, С and D), 
however, the imbalance between lq 12 (trisomy in 70% of the cells) and lp36 (disomy in 
91% of the cells) can be clearly illustrated Counting the chromosomal domains after FISH 
with the library DNA probe revealed three domains in about 50% of the nuclei of this case 
(Figure 2C) 
DNA Terraploid/Aneuploid TCCs (n=9) 
Single-target FISH in the flow cytometncally determined DNA tetraploid/aneuploid 
TCCs (DI = 1 3-3 2) revealed a more complex distribution of FISH spot numbers as 
detected in the DNA diploid TCCs (Table 1) The cases were selected on the basis of their 
chromosome I centromere copy number varying from one to nine 
For example, case 14 showed a trisomy for lql2 (in 79% of the cells), whereas two 
FISH signals for lp36 (in 70% of the cells) and three domains for the library DNA probe 
were detected In case 15, a heterogeneous population was detected for lql2, showing a 
tetrasomy in 38% of the cells and a trisomy in 41% of the cells, while an evident trisomy 
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Figure 1. Remin oj double-targit (Α-H and K-N) and smgle-tai get (I, J, O, and P) FISH procedures 
in interphase nutlet of case 11 (Α-D), case 17 (L-H), case 20 (1 ,Jj, case 21 (K-N), and case 22 (O and 
P) using probes far chromoòome 1 The nuclei were counterstained with 4',6-diamidino-2-phenyl-
indole (DAPl) In A and B, and in С and D, two double-target FISH reactions demonstrate the 
o\errepresenlation of the centromere (A) as compared to the telomere region (B and C, arrows) in a 
diploid TCC Furthermore, nuclei showing two IISH signals for the telomere (C, arrows) displayed 
three discrete and separate chromosome 1 domains with the library DNA probe (D) In E and F, and 
in G and H, two double-taiget FISH reactions ¡n an aneuploul TCC (case 17, DI=1 7) illustrate that 
four copies of the centróme/e (E) are combined with three copies of the telomere (F, arrows), whereas 
four chromosomal domains (II) contain onl\ three telomere regions (G. arrows), demonstrating the 
imbalance between these three chromosome 1 targets In I and J, isso nuclei of с cuse 20 show five FISH 
spots /or the centro/nei e (I) and four FISH spots for the telomere region (J) in single-target FISH 
reactions In К and L two nuclei of case 21 ¡Hastíate the imbalance between the number of centro-
meres (large arrows), whuh ¡ire one (K) and ruo (L) and the numlier of telomeres (small arrows), 
showing fise signals pir nmleus Tliese two photographs are double-exposures of the double-target 
FISH reactions In M and N, a double-target FISH reaction demonstrates that the nuclei having five 
spots for the telomere probe (M, arrows), also show Jη e chio/nosomal domains (N) In О and P, the 
nuclei of case 22 demolisti ate the imbalance between centromere (O, eight and nine spots /nucleus), 
and telomere (P, three and four spots/nucleus) 
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for ІрЗб in 81% of the cells was detected, as well as three domains for chromosome 1. 
Also, in case 16, an overrepresentation of lq 12 was observed (35% pentasomy and 37% 
tetrasomy), as compared to the trisomy for the lp36 target (in 68% of the cells). 
In two of three cases with a tetrasomy for lql2 (cases 18 and 19), we could not detect 
an imbalance between the three chromosome 1 targets However, in the other case (case 
17), an imbalance between lp36 as compared to both lql2 and the chromosomal domain 
probe was detected Figure 2, E and F, schematically illustrates the frequency distnbu-tions 
of the single target FISH with the three probes (E) and the double-target FISH, using lp36 
and lql2 (F) These data show the tetrasomy for lql2 in 81% of the cells, and the trisomy 
for lp36 in 85% of the cells The maximum number of chromosomal domains was four (in 
24% of the cells), while the largest cell population (43%) showed three domains Figure 1, 
E and F, shows the tetrasomy for lq 12 and the trisomy for lp36 in a double-target FISH 
experiment, whereas in Figure 1, G and H, the imbalance between the telomere sites and 
the chromosomal domains of case 17 is illustrated 
In case 20, containing a heterogeneous population of cells, the main numbers of FISH 
signals for lql2 were six (in 50% of the cells) and five (in 24% of the cells), while for 
lp36 the main copy numbers were four (in 59% of the cells) and three (in 30% of the 
cells) (Figure I, I and J) 
In case 21, evident monosomy (in 41% of the cells) and disomy (in 51% of the cells) 
for the chromosome 1 centromere were detected, whereas the copy number for lp36 targets 
was five (in 74% of the cells) (Figure 2, G and H) Counting the number of chromosome 1 
domains revealed a broad distribution, varying from two to five fluo-rescent regions per 
nucleus, with no evident peak fraction The imbalance between centromere and telomere for 
this case is illustrated in Figures 1, К and L In Figure IK, an interphase nucleus shows a 
monosomy for lql2 and a pentasomy for the lp36 target Also, in the nuclei with a disomy 
for lql2, a pentasomy for lp36 was detected (Figure IL) Evaluation of these nuclei in 
double-target FISH, using the hbiary DNA probe and the telomere probe, demonstrated 
that the copy number ot these targets were in balance, as is illustrated in Figures 1, M and 
N 
Case 22 demonstrated an evident heterogeneous population of cells, in which the 
maximum number of FISH signals for lq 12 was nine (in 20% of the cells), but also cells 
with eight (in 36% of the cells), seven (in 17% of the cells), and two (in 12% of the cells) 
FISH signals were observed (Figure 10) In contrast, the maximum number of FISH 
signals for the telomeric target lp36 was four (in 70% of the cells) (Figure IP) 
Discussion 
FISH using centiomeric associated ìepetitive DNA piobes, is a powerful technique for 
the detection of numerical chromosome aberrations in the interphase nuclei of tumors 
(Poddighe et al, 1992) Recently, studies were published that compared the results of 
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interphase cytogenetics with conventional karyotyping analyses of cell lines derived from 
solid tumors and of neoplastic cells from bone marrow and peripheral blood (Smit et al, 
1990, Poddighe et al. 1991) This combined approach has become a rapid procedure for the 
detection of numerical and structural chromosome aberrations, such as translocations, and 
for identification and subsequent characterization of marker chromosomes; statistical 
evaluations are also possible (Rappold et al, 1984; Cremer et al, 1988b, Nederlof et al, 
1989, Smit et al, 1990, Poddighe et al, 1991). A combination of a centramene and a 
telomenc associated DNA probe, specific for chromosome 1, was described (Van Dekken 
et al, 1989) and was used to investigate structural chromosome aberrations in more detail. 
The FISH method using library DNA probes visualizes whole individual human 
chromosomes as discrete territories in interphase nuclei and can thus be of value in the 
analysis of structural chromosome changes of solid tumors (Rappold et al, 1984, Burns et 
al, 1985, Lichter et al, 1988a, 1988b, Cremer et al, 1988b). In the present study, we 
applied a combination of a centramene associated, a telomenc associated and a library 
DNA probe for chromosome 1 to examine the feasibility of detecting numerical and 
structural aberrations in solid tumors by means of such probes in combination with FISH. 
Analyzing flow cytometrically determined DNA diploid TCCs, we have found that in all 
cases in which three FISH signals for the lql2 target were detected (six of 13 cases), two 
signals for the lp36 target were observed Furthermore, all cases with an over-representa-
tion of the centramene region, as compared to the telomenc region, showed three separate 
domains for chromosome 1, suggesting the presence of an additional large part of chromo-
some 1 in these TCCs 
Structural changes in chromosome 1 were recognized in bladder cancers by means of 
karyotyping These aberrations were characterized by breakpoints in the proximal regions 
of the chromosome arms In case of FCM near-diploid TCCs, +lp- and lq+ chromo-
somes have been reported frequently (Kovacs, 1985, Smeets et al, 1987a) The lq + 
chromosomes, with one or two duplications of part of the long arm, are rather common in 
such tumors and, it the break has occurred in the heterochromatin, one or two interstitial 
C-bands may be piesent on the long aim (Atkin et al, 1986) If we compare our data with 
the conventional cytogenetic analyses, the structural chromosome aberration in the 6 diploid 
cases with an imbalance between centramele and telomere most probably represents +lp- . 
Analysis of the (ìm)balance between lq 12 and lp36 in the tetraploid/aneuploid TCCs 
results is more complex because of the heterogeneous nature of these tumors. Also, the 
interpretation of the results obtained by FISH with the library DNA probe proved to be 
difficult because of overlap of the individual domains in the nuclei However, comparison 
of the number of lp36 and lql2 signals showed in six of nine cases an evident overrepre-
sentation of 1 q 12 whereas in two cases a balance between both targets was detected In the 
cases analyzed with the library DNA probe, the number of FISH domains was equal to the 
number of 1 q 12 targets In this respect the balance between 1 q 12 and chromosomal 
domains, as well as overrepresentation of lq 12 as compared to lp36, are comparable to 
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Figure 2. Evaluation of FISH reactions with the three different probes for chromosome I in case 3 (A 
and B), case II (C and D), case 17 (E and F), and case 21 (G and H) A, C, E, and G, demonstrate 
the frequency distributions of the number of hybridization spots obtained after a single-target FISH 
procedure. Two hundred nuclei were counted. • • probe lql2; ^ S probe ¡p36; (Ξ3 chromosome 
1 library DNA probe. In B, D, F, and H, percentages of FISH spot numbers detected in interphase 
nuclei after the double-target procedure with the probes for the telomere (lp36) and the centromere 
(lql2) are shown. One hundred nuclei were counted. 
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results in the DNA diploid TCCs Only in one tetraploid/aneuploid TCC (case 21, DI=2 0) 
was a strong underrepresentation of lql2 as compared to lp36 observed This case was 
selected from a group of 21 tetraploid/aneuploid TCCs, of which it appeared to be the only 
tetraploid/aneuploid tumor sample with a high percentage of cells containing one FISH 
signal for lq 12 per nucleus (41%) 
It is generally accepted that tetraploidization is a crucial step in the progression of many 
solid tumors (Kovacs, 1985, Shackney et al, 1989), in which random as well as nonrandom 
loss of chromosomes could lead to selection and growth of aneuploid or tetraploid tumors. 
In DNA diploid TCCs, we observed gain of lq 12 We have to realize that the cases with a 
trisomy for lq 12 were selected from a series of 28 cases and occur at a frequency of about 
20% (Hopman et al, 1991) In the tetraploid/aneuploid TCCs, gain of lql2 is difficult to 
determine since the DNA index ranged from 1 3-3 2 However, in four cases (cases 15, 16, 
20, and 22), the copy number was higher, as was expected on basis of the DI In the latter 
cases, the copy number for lp36 is in concordance with the DI However, on the basis of 
the limited number of the tetraploid /aneuploid cases, we could speculate about selective 
gain of lq 12 or loss of lp36 on the basis of tetraploidization Only in case 20 (DI = 1 8) did 
we detect a ratio of FISH signals between lql2 and lp36 of 6/4, which could be the result 
of tetraploidization 
Abnormalities involving both the long arm (q) and the short arm (p) of chromosome 1 
have been observed in many types of human tumors (Atkm, 1985, Olah et al, 1989), 
including hematological disorders, lymphomas, childhood tumors (including Wilms' tumor 
and neuroblastoma) colorectal, bieast and ovarian cancers, and carcinoma of the cervix 
uteri (Sandberg et al, 1988, Olah el al, 1989) Furthermore, abnormalities involving 
chromosome 1 are implicated in tumor progression and in in vitro immortalization of 
human colorectal adenoma cell lines These abnormalities can either involve deletions of the 
short arm of chromosome 1 or formation of an isochromosome l(q) resulting in 3 or 4 
copies of the long arm of chromosome 1 in each cell (Paraskeva, 1989) On the other hand, 
loss of genes on chromosome l(q) allows cells to escape cellular senescence, which appears 
to be an important step in carcinogenesis (Sugarawa et al, 1990) 
The piesent study demonstrates the routine utility of the FISH methods to assess 
structural aberrations in interphase nuclei of solid tumors It is to be expected that in 
future with the use of regional-specific, single copy DNA probes, a more precise definition 
of breakpoints and ot the chromosomal regions involved in deletion, translocation, 
duplication, or amplification can be achieved 
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Abstract 
The purpose of this study was to compare the outcome of RFLP analysis and interphase 
cytogenetics on transitional cell carcinomas (TCCs) of the urinary bladder, to obtain more 
insight into the mechanism and genetic background of progression of TCC 
TCC DNA samples, obtained from tumors of different stage and grade, were screened 
for loss of heterozygosity for chromosome loci 9q34, l lp l5 , 16q22-24, 17pl3, and 18q21 
In situ hybridization (ISH) was performed on serial frozen tissue sections of the same 
tumors Centromere associated DNA probes for the chromosomes 1, 7, 9, 10, 11, 16, 17 
and 18 were used to determine chromosome ploidy, numerical chromosome aberrations, the 
imbalance between chromosomes, and heterogeneity of aberrations within one tumor 
The results demonstrate a good correlation between RFLP and ISH approaches It 
shows that loss of heterozygosity (LOH) for chromosome locus 9q34 in early phases of 
TCC development is most probably due to loss of the complete chromosome 9, since ISH 
using the centromeric probe for this chromosome showed in all but one of these cases an 
underrepresentation No correlations were found for the loci on chromosomes l ip, 16q, 
17p and 18q, suggesting either an interstitial deletion or LOH in combination with a 
duplication of (a part of) that chromosome in the aneuploid cases 
Introduction 
Transitional cell carcinoma (TCC) is the most common form of urinary bladder cancer, 
comprising a heterogeneous group with markedly different neoplastic features (Cummings, 
1980) Approximately two thuds of the patients with TCC finally present recurrences, of 
which ten to twenty five percent will be of higher grade or stage (Tribukait et al, 1982) 
Currently, the most important predictors of the behaviour of TCCs are histological stage 
and grade The DNA ploidy, as determined by flow cytometry (FCM), may have additional 
value to predict the biological behaviour of the tumor (Pauwels et al, 1987) For example, 
FCM has revealed that noninvasive (pTa) TCCs are predominantly DNA diploid, while 
invasive behaviour of these malignancies is highly correlated with DNA aneuploidy or 
tetraploidy (Tribukait et al, 1986, Blomjous et al, 1988, Koss et al, 1989) 
Although conventional karyotyping allows the identification of chromosomal aber-
rations, characteristic for bladder cancer, involving chromosomes 1, 7, 9, and 11, the 
technique is generally hampered by difficulties such as low mitotic index, poor banding 
quality, or limited number of analyzable cells (Gibas et al, 1984, 1986, Atkin et al, 1985, 
Kovacs, 1985, Sandberg et al, 1986, 1988, Smeets et al, 1987a, 1987b, Vanni et al, 1988, 
Teyssier, 1989) 
Recently, interphase cytogenetics using centromere-associated DNA probes has been 
shown to enable a routine screening of tumor cells in both single cell suspensions (Cremer 
et al, 1988, Hopman et al 1988a, Devilee et al, 1988b, Nederlof et al, 1989, Raap et al, 
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1990; Lichter et al, 1991, Poddighe et al, 1991, 1992b) and sections of frozen tissues or 
formalin-fixed, paraffin-embedded tissues (Naoumov et al, 1988; Hopman et al, 1990, 
1992, Arnoldus et al, 1991, Poddighe et al, 1992a). For TCCs the most striking findings 
seem a primary loss of chromosome 9 in diploid tumors, and gain of chromosomes 1 and 7 
in aneuploid tumors (Hopman et al. 1988b, 1989, 1991). 
Comparison of tumor DNA and constitutional DNA for polymorphic markers by restric­
tion fragment length polymorphism (RFLP) analysis allows the detection of loss of 
heterozygosity (LOH) at specific chromosomal loci LOH at chromosomal regions in tumor 
tissue may indicate a deletion of putative tumor suppressor genes (Fearon et al, 1990b). 
RFLP analyses have shown allelic loss on 9q, 1 lp, 16q, 17p, and 18q being involved in 
various human cancers, including urinary bladder cancers (Tsai et al, 1990, Olumni et al, 
1990; Presti et al, 1991, Proctor et al, 1991; Sidranski et al, 1991, 1992). 
In earlier studies we used centiomere associated DNA probes for chromosomes 1, 7, 9, 
and 11 in ISH, because of the apparant correlation of changes in these chromosomes and 
TCC (Gibas et al. 1984, 1986, Sandberg, 1986; Sidranski et al, 1991, 1992; Presti et al, 
1991) Chromosomes 10. 16 and 18 were examined as controls and for the determination of 
chromosome ploidy 
Screening of 24 TCCs by RFLP analysis and ISH with the probes described above was 
done in view of the following questions a) is there a correlation between imbalance of 
different chromosome copy numbers and selective LOH7 ; b) is underrepresentation of 
certain chromosomes, as detected by ISH, con elated with LOH of markers on that same 
chromosome'' , c) although the DNA probes for ISH detect only centromeric regions, can 
the ISH approach be used instead of or as an adjunct to the LOH approach in a clinical and 
routine setting to detect (numerical) chromosome aberrations? , d) how is the under­
representation ot chromosome 9 followed during the process of tetiaploidization by ISH and 
RFLP9 , e) to what extent do both techniques overlap, and thus reveal the same informati­
on? ; f) can heterogeneity of chiomosome aberrations be detected in TCC by means of ISH 
and how does such heterogeneity influence the RFLP results? Answers to these questions 
may result in a better definition of the indication and application of each of these tech­
niques 
Materials and Methods 
Sample Selection and Preparation for ISH 
The tissue samples studied weie selected for their tumoi cell content, which was at least 
60-70%. Classification of histological stage and grade (I-III) was performed in paraffin 
sections. 
For this study 24 frozen tissue samples of TCC were selected on which both ISH and 
RFLP techniques could be performed For ISH, 5 μιη sections were mounted on organo-
silane coated slides, air dried and stored at room temperature. For RFLP analysis, 20 μνη 
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sections were collected and stored at -20°C Also, peripheral blood lymphocytes (PBLs) 
were collected of the same patients for RFLP analysis 
Pretreatment of Frozen Sections 
Prior to the ISH procedure, the sections were fixed in 70% ethanol/1% formaldehyde 
for 20 mm at -20°C After subsequent washings in phosphate buffered saline (PBS)/0 05% 
Tween-20, and water for 5 min at room temperature, the slides are incubated for 15 mm at 
37°C in 100 μ% pepsin per ml 0 01 N HCl Then the slides were rinsed in five dip washes 
of water and five dip washes of PBS, and dehydrated in an ascending alcohol series After 
air-drying, the sections were post-fixed in 1% formaldehyde/PBS for 10 min at room 
temperature 
ON A Probes for ISH 
The centromere associated DNA probes pUCl 77 (Cooke et al, 1979), p7t 1 (Waye et 
al, 1987b), pHUR98 (Moyzis et al, 1987), pHUR195 (Moyzis et al, 1987), plO 1 (Devilee 
et al, 1988a), pLCllA (Waye et al, 1987a), pl7H8 (Waye et al, 1986) and LI 84 (Devilee 
et al, 1986) were used for the detection of target sequences on chromosomes 1, 7, 9, 16, 
10, 11, 17, and 18, lespectively The probes were labeled by nick-translation with biotin-
11-dATP, according to the supplier's instructions (Boehrmger, Mannheim, Germany) 
In Situ Hybridization 
The DNA probes described above were hybridized to the (tumor-)cell preparations at a 
probe concentration of 1 ng/μΙ hybridization mixture, containing 60% formamide-2x 
standard sodium citrate (SSC) 10% dextransulfate, pH 7 0 Under these stringent condi­
tions, 15 μ\ of the hybridization mixture was applied to the slides under a coverslip (18 χ 
18 mm) Denaturation of probe and target DNA was performed simultaneously by heating 
the slides in a moist chainbei to 70°C for 3 mm After hybridization for 2 to 16 hours at 
37°C, the coverslips were removed by immersing the slides in 2xSSC, pH 7 0 at 42CC 
Posthybridization washing steps were performed twice in 60% formamide-2xSSC, pH 7 0 
for 5 min and twice in 2xSSC, pH 7 0 for 5 mm at 42°C 
Immunocytochemical detection of the hybridized DNA probes was performed as 
previously described (Hopman et al 1992) with mouse anti-biotin (Dakopatts, Glostrup, 
Denmark), biotin-labeled horse anti mouse IgG (Vector, Burhngame, CA), and a final in­
cubation with the avidin-biotin-labelled peroxidase complex (Vectastain Elite ABC Kit, 
Vector) All immuno-cylochemical steps were performed for 30 mm at 37°C The DNA 
probe was visualized with 0 5 mg/ml 3,3 diaminobenzidin tetrahydrochlonde (DAB, 
Sigma), 0 65% imidazole (Merck, Darmstadt. Germany), 0 015% H 2 0 2 (Merck), in PBS 
for 3 mm at pH 7 8, and the signal was amplified with CuSO„ (0 5% in 0 9% NaCl) for 3 
mm The slides were counterstained with hematoxylin and mounted in Permount (Fisher 
Scientific, New Jersey, NJ) 
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Evaluation of ¡SH Results 
The reproducibility and validity of a protocol to detect chromosome copy numbers by 
ISH in 5 μιτι routinely processed tissue sections have been described elsewere (Poddighe et 
al, 1992a). 
Evaluation of the preparations was done according to criteria as described before 
(Hopman et al, 1990; Poddighe et al, 1992a). A disadvantage of the use of tissue sections 
is, that, due to truncation of a significant number of nuclei, the number of ISH signals per 
nucleus will be underestimated as compared to the actual copy number of the target 
chromosome (Naoumov et al, 1988; Hopman et al, 1990; Arnoldus et al, 1991). Therefore, 
we evaluated separately within each section the tumor area, normal tissue and stromal cells, 
since no simple correction factors for truncation of nuclei are sofar available. In diploid 
tumors the true chromosome copy number is detectable in about 50% of the nuclei, so that 
monosomy or trisomy can be determined conclusively. However, with increasing nuclear 
size the true chromosome copy number will be increasingly underestimated. 
Hybridization with different probes on the same tumor areas in parallel sections enables 
the study of imbalance in chromosome copy number and, as a result, the specific loss of 
chromosomes. 
The TCCs were classified as diploid or aneuploid on basis of the mean number of ISH 
signals of at least six of the eight DNA probes. 
DNA Isolation and Southern Blot Analysis 
High molecular weight DNA was isolated from frozen tissue samples of the 24 TCCs, 
and from whole blood samples of the same patients as described (Miller et al, 1988). Ten 
^g of DNA digested with the appropriate restriction endonuclease was separated on a 0.8% 
agarose gel and transferred to Hybond N+ (Amersham). Blots were hybridized to the 
following radioactive labelled probes: EFD126 (Nakamura et al, 1987) for 9q34, c-H-ras 
(Pulciano et al, 1982) for l lpl5. PV962 (Mansouri et al. 1988) and 79.2.23 (Bufton et al, 
1986) for 16q22, 144D6 (Schwartz et al, 1988) for 17pl3, and 15.65 (Fearon et al, 1990a) 
for 18q21. 
Results 
Table 1 summarizes the RFLP and ISH results for each of the 24 TCCs. These were 
ranged according to their chromosome ploidy as determined on basis of ISH. Case nos. 1 to 
13 were classified as chromosome diploid, case nos. 14 to 21 as aneuploid, and case nos. 
22 to 24 as heterogeneous, i.e., mixed diploid and aneuploid. 
RFLP analysis. 
DNA isolated from these 24 TCCs was examined by Southern blotting for LOH for 
regions on chromosomes 9q, Юр, l ip, 16q, 17p, and 18q. In thirteen patients we found 24 
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Table 1. A summary of the RFLP and ISH results for the 24 Tiansitional Cell Carcinomas. 
For ISH we used the centromere-associated DNA probes for chromosomes 1, 7, 9, 10, 11, 
16, 17, and 18. Abbreviations: NI=probe is not informative, nd=not done, + means no 
LOH; - means LOH. 
RFLP analysis ISH analysis 
case grade/stage chromosomal locus detected on chrom. numerical 
No ploidy aberration(s) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Gl / pTa 
Gl / pTa 
G l / p T a 
G1 / pTa 
G1-2 / pTa 
G l - 2 / pTa 
G2 / pTa 
G2 / p T 1 
G2 / p T I 
G2 / p T I 
G2 / p T 1 
G3 / p T 3 
G3 / pT3 
G2-3 / pTa 
G2 / p T 1 
G2 / p T 1 
G2 / p T I 
G 1 - 2 / P T 1 - 2 
G3 / p T 2 
G3 / p T > 2 
G3 / p T 3 
G1-2 / p T a 
G1-2 / p T a 
G3 / p T > 2 
9q 
+ 
+ 
-
+ 
+ 
-
+ 
-
-
+ 
+ 
-
NI 
NI 
+ 
-
NI 
+ 
+ 
NI 
NI 
-
-
11p 
+ 
+ 
+ 
+ 
+ 
-
NI 
+ 
-
+ 
NI 
+ 
+ 
+ 
+ 
+ 
-
NI 
+ 
NI 
NI 
+ 
-
+ 
16q 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
+ 
+ 
17p 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
NI 
NI 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
+ 
-
18q 
+ 
NI 
+ 
NI 
+ 
+ 
-
NI 
NI 
NI 
+ 
nd 
nd 
NI 
+ 
-
-
+ 
NI 
NI 
nd 
nd 
+ 
+ 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
diploid 
tnploid 
triploid 
tetraploid 
hexaploid 
tetraploid 
tetraploid 
tetraploid 
tnploid 
tetraploid 
/ diploid 
tetraploid 
/ diploid 
tetraploid 
/ diploid 
None 
-9, -17 
-9 
-9, -17 
-10 
-9 
-9, -18 
-9 
+ 7, -9 
•18 
None 
-9 
None 
-9 
+ 1,-9 
+ 1,-9 
-9, -9 
None 
-18 
-9, -17 
None 
+ 1 , -9 , -9 
/ + 1 , -9 
None 
-9,-9,-17,-
/ - 9 , -17 
126 
number of ISH signals per nucleus 
5 » 7 « 9 
number of ISH signals per nucleus 
Figure 1. Frequency distribution patterns of m situ hybridization signals obtained with different 
centromere-associated DNA probes for chromosome 1 ( ^Ш ) , chromosome 9 ( а й ) , chromosome 11 
( ~ ) , chromosome 17 ( l^J ) , and chromosome 18 ( E73 ) on frozen tissue sections ofTCCs A) 
case no. 1, representing a diploid tumor with no numerical aberrations. B) represents case no 3, 
showing an underrepresentation for chromosome 9. C) Aneuploid tumor, case no. 16, demonstrating 
an overrepresentation for chromosome centromere 1, and loss for the centromeric target of 
chromosome 9. D) case no. 17, representing a highly aneuploid tumor with a mean chromosome copy 
number of six. Note that in the distribution patterns for the analyzed chromosomes an 
underrepresentation of the real copy number occurs due to truncation of nuclei in the five micrometer 
thick sections 
cases of LOH for one or more markers. The most frequent allelic loss was seen for the 
marker on chromosome 9q. Of nineteen informative cases (79%) we found LOH of the 
9q34 locus in nine tumors (47%). For the chromosome l ip marker we found that 21% of 
the nineteen informative cases (79%) had allelic loss. Although the 16q marker was 
informative in all 24 tumors, only three cases (12,5%) showed LOH for this locus. For the 
marker on 17p twenty-two cases (92%) were informative, of which five cases (23%) had 
LOH. Finally, the marker on 18q was less informative (60%), and demonstrated allelic loss 
in three cases (25%). 
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ISH analysis 
Evaluation of the ISH reactions on frozen tissue sections of the 24 TCCs with the eight 
centromeric DNA probes revealed that 18 out of 24 cases showed 27 times loss or gain of 
ISH signals as compared to the mean chromosome ploidy (determined according the criteria 
described in M & M sections) A gain of ISH signals was observed for chromosome 1 in 
three cases (12,5%), and for chromosome 7 in one case (4%). Loss of ISH signals as 
compared to the modal ISH number was most frequently found for chromosome 9, showing 
15 cases (62,5%) with a numerical loss The centromeric probe for chromosome 10 
demonstrated in one case (4%) an loss, while for the chromosomes 17 and 18 in three cases 
(respectively 12,5% and 13%) loss of ISH signals was observed For chromosome 16 no 
numerical aberrations were detected 
Chromosome diploid rumois 
Numerical chromosome aberrations were detected in ten out of 13 diploid TCCs (Table 
1, case nos 1-13) In eight cases a loss for chromosome 9 was observed. In two cases an 
additional loss of chromosome 17 was detected One case (no. 4) demonstrated a loss for 
chromosome 10, whereas case no 6 showed loss of chromosome 18, next to a loss for 
chromosome 9. Loss of chromosome 18 was also observed in case no. 9 Figure 1A shows 
Figure 2. In situ hybridization on frozen tumor tissue sections with centromere-associated DNA probes 
for chromosome 11 (A), chromosome 9 (B and F), and chromosome 1 (E and I) Southern blot 
hybridizations of tumor (T) and constitutional (C) DNA, digested with Taql, and hybridized to 
polymorphic probes for 9q34 (C, G, and J), and lip]5 (D, H, and K) Α-D represent a chromosome 
diploid TCC (case no 3) A and В demonstrate a tumor area in serial sections, showing two ISH 
signals for the probe for chromosome 11 (A), while the centromere probe for chromosome 9 
demonstrates one ISH signal m the same tumor area (В) С and D demonstrate Southern blot analyses 
for case no 1 and 3 For the 9q34 probe case no I retained this locus in the tumor (C lane I J, while 
case no 3 demonstiated LOH (С lane 3) Both case nos 1 and 3 were heterozygous for the lip 
probe CD lane 2 and 4, respecliveh) and demonstrated no LOH (D lanes 1 and 3) E-Η represent a 
chromosome aneuploid TCC (case 17) A represéntame tumor area, in which most nuclei contain five 
to sa ISH signals with the probe for chromosome 1 (E) The arrow indicates a nucleus with eight ISH 
signals In F the same tumor area in a serial section is hybridized with the probe for chromosome 9, 
showing a mean ISH copy number of four Southern blot analyses of case nos 16 and ¡7 for the 9q34 
probe re\eiled that tumor DNA from case 16 showed LOH (G lane 3), whereas case no 17 retained 
the 9q34 locus (G lane 2) For ¡he Up probe both tumors were informative (H lanes 2 and 4) Case 
no 17 demonstrated LOH (H lane I), and case 16 no LOH for this locus (H lane 3) I-K represent a 
heterogeneous tumor (case 24) In I, the tumor tissue section was hybridized with the centromere DNA 
probe for chromosome I The heterogeneity of the tumor is demonstrated In the left area the nuclei 
contain nunnly two ISH signal·, while in the right area the nuclei contain three and four ISH signals 
In J, Taql digested DNA from case nos 24 and 6 was hybridized with the 9q34 probe, demonstrating 
in both cases LOH (J lanes I and 3) Case no 24 showed no LOH with the lip probe (K lane 1), 
whereas case no 6 demonstrated LOH for this locus (K lane 3) 
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the quantitative evaluation of the hybridization signals of case no 1 for the centromere-
associated DNA probes for chromosomes 1 9, 11, 17, and 18 In this particular case the 
mean number of ISH signals for the chromosomal probes was two in about 45-50% of the 
nuclei, and one in 28 42% of the nuclei Therefore, this case was classified as a chrom-
osome diploid tumor Figure IB represents case no 3, in which a significant loss of 
chromosome 9 was detected, since 68% of the nuclei contain only one ISH signal for the 
chromosome 9 probe In about 55% of the nuclei of this case two ISH signals for the other 
chromosomes were detected Figure 2, A- and B, shows tumor areas of this diploid case 
(no 3), hybridized with the probe for chromosome 11 (Figure 2A), showing two ISH 
signals, and the probe for chromosome 9 (Figure 2B), showing one ISH signal in a high 
frequency of the cells 
The RFLP results for the case nos 1 and 3 are shown in Figure 2C and D, on which Taql 
digested DNA is hybridized to a probe for 9q and lip, îespectively Tumor DNA from 
case 3 showed LOH for the 9q probe (Figure 2C), whereas for the lip probe no LOH was 
observed (Figure 2D) 
Chromosome aneuploid tumors 
Screening of the eight chromosome aneuploid tumors (cases no 14-21) with the eight 
centromere-associated DNA probes revealed a profound heterogeneity with respect to the 
chromosome copy numbers In five cases an underrepresentation for chromosome 9, as 
compared to the other chromosomes, was detected In two cases (case nos 15 and 16) an 
overrepresentation for chromosome 1 was observed An additional loss for chromosome 17, 
next to loss of chmmosome 9, was detected in case no 20 Case no 19 showed a loss for 
chromosome 18 as the only numerical aberration 
Figure 1С shows the frequency distribution of case no 16 by evaluating the ISH signals 
in 200 nuclei in serial sections, showing a mean between 3 0 and 3 3 for the copy number 
of chromosomes 7, 11, 16, 17 and 18, and a modal copy number of four ISH signals per 
nucleus For chromosome 1 the mean copy number was 3 9, and modal copy number was 
five to six ISH signals per nucleus, representing a relative overrepresentation or gain of this 
chromosome The mean and modal copy number for chromosome 9 were 2 4 and 2, 
respectively, demonstrating an underrepresentation or loss of this chromosome 
The frequency distribution of ISH signals for the chromosomes 1, 9, 11, 17, and 18 of 
case no 17 is shown in Figure ID The mean copy number for the chromosomes 1, 11, 
17, and 18 was between 5 6 and 5 9, and a modal copy number of six ISH signals per 
nucleus For chromosome 9 the mean copy number was 3 6, with a modal copy number of 
four, representing a loss of two copies of this chromosome Figure 2E-F represent a part of 
the tumor of case 17 where the nuclei contain 5/6 ISH signals (with a maximum ISH copy 
number of 9) for chromosome 1 (Figure 2E), whereas for chromosome 9 the nuclei contain 
3/4 ISH signals (with a maximum ISH copy number of 6)(Figure 2F) 
Southern blots of tumor and constitutional DNA trom case nos 16 and 17 are shown in 
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Figure 2G and H, hybridized to the 9q and l ip probe, respectively. For the 9q probe, case 
no 16 demonstrates LOH, while case no 17 is not informative (Figure 2G). For the l ip 
probe, case no 16 retains the l ip allele, whereas case no 17 revealed LOH (Figure 2H). 
Heterogeneous rumois 
Evaluation of ISH signals for the cases no. 22-24 revealed extensive chromosome 
heterogeneity, both between ISH signals for the eight different DNA probes in the 
individual tumor cells, as well as between different tumor areas in the same case of TCC. 
Therefore, we have classified these three cases as being heterogeneous. In two cases (case 
nos. 22 and 24) loss for the centiomere of chromosome 9 was detected after screening of 
serial sections with the eight centiomere-associated DNA piobes. In the tctraploid tumor 
areas, we observed an ISH copy number for chromosome 9 of maximum two. indicated as 
an apparent loss ot two copies of chromosome 9 (Table 1) Figure 21 demonstrates the 
tumor heterogeneity of ISH signals within case no. 24, in which one part of the TCC 
contains 3 or 4 ISH signals for the chromosome 1 probe, while in another part of the TCC 
mainly 1 or 2 ISH signals for the same probe are found 
Figure 2J and К demonstrates the RFLP results of DNA from this tumor hybridized to 
the 9q and lip probe Although LOH for the 9q locus was concluded, the heterogeneity of 
the tumor DNA is reflected by the faint band in the blot (arrow in Figure 2J) 
Discussion 
Several investigations have demonstrated that centromere associated DNA probes can be 
applied in ISH techniques to determine numerical chromosome aberrations in interphase 
nuclei of tumors (for reviews, see Raap et al, 1990, Poddighe et al, 1992a). Other studies 
have compared the results of interphase cytogenetics with those of conventional karyotyping 
of neoplastic cells from leukemia or cell lines derived from solid tumors (Nederlof et al, 
89, Poddighe et al, 1991) Such a combined approach is particularly suited to determine or 
confirm structural chromosome aberrations, such as translocations, and to identify and 
characterize maikei chiomosomes 
In this study we have applied ISH to hozen tissue sections of TCCs and compared these 
results with those of RFLP analyses of the same tumor cases. In Table 2 we summarized 
these results per chromosome, in order to see whether a correlation exists between an 
underrepresentation, as detected by ISH, and LOH of a marker on that same chromosome. 
The most characteristic numerical aberration as detected by ISH in the 24 TCCs was a 
loss for chromosome 9 in 15 out of 24 cases, as compared to the mean chromosome ploidy 
as determined with the panel of 8 centromenc probes These observations strongly confirm 
other published data (Hopman et al, 1988b, 1989, 1991), where the cytogenetic obser­
vations concerning loss of chromosome 9 in low-giade, low-stage TCCs were confirmed by 
the ISH approach Also, the frequent occurrence of loss of chromosome 9 in early stages of 
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CHROMOSOME 9 (η = 191 
RFLP 
LOH 
ISH loss 8 
no ISH loss 1 
no LOH N 
4 12 
6 7 
CHROMOSOME 11 (n = 19) 
RFLP 
LOH 
0 
4 
no LOH N 
0 0 
15 19 
CHROMOSOME 16 (n = 21) 
RFLP 
LOH 
0 
3 
no LOH N 
0 0 
18 21 
N 10 19 15 19 
CHROMOSOME 17 (n - 2 2 ) CHROMOSOME 18 (n = 12) 
RFLP RFLP 
LOH no LOH N 
ISH loss 1 
no ISH loss 4 
3 4 
14 18 
LOH no LOH N 
18 21 
N 17 22 12 
Table 2. Two-way tables demonstrating the comparison of both RFLP and ISH analyses per 
chromosome In brackets are given the number of cases, on which both techniques revealed results 
This means informative for the RFLP analysis, and évaluable for ISH Loss means underrepresentation 
for that particular chromosome as delected by ISH, no loss means within the ploidy range as detected 
by ISH with the other centromere associated DNA probes 
TCC is in agreement with the observation of Tsai et al (1990), who showed that LOH of 
markers on chromosome 9q could be detected in 67% of the informative cases Comparison 
of the ISH results with the RFLP analyses of the same tumors in this study, revealed a high 
concordance for LOH and chromosomal loss as detected by ISH (Table 2). For the 13 
chromosome diploid cases studied, the ISH approach showed monosomy for chromosome 9 
in 8 cases The process of tetraploidization is a generally accepted concept in tumor 
progression (Shackney et al, 1989, Fearon et al, 1990b) In the aneuploid TCCs the 
apparent loss of two copies of chromosome 9 strongly indicates that the loss of one copy of 
this chromosome occurred before tetraploidization took place This confirms our previous 
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suggestion that loss of chromosome 9 is a primary or early event in carcinogenesis of the 
urinary bladder (Hopman et al, 1991), and that it is conserved during the process of tumor 
progression and invasion 
The loss of chromosome 9 as detected by ISH is most probably not limited to a small 
part of 9q Because this DNA target is situated in the heterochromatin on 9q, close to the 
centromere, only a complete loss of this heterochromatin region would result in a complete 
disappearance of the chromosome 9 signal Deletion of either 9q or 9p would preserve a 
part of this target sequence, resulting in positive, but less intense or less extended ISH 
signals Therefore, candidate genes that may play a relevant role in the oncogenesis of the 
urinary bladder can be located on both arms of chromosome 9. Recently, Cairns et al 
(1993) published a study, using 13 polymorphic markers for chromosome 9 in order to map 
the region of deletion in human bladder carcinomas Their results suggest that the target 
locus of a putative tumor suppressor gene involved in bladder carcinoma is located at the 
region between 9p 12-13 and 9q22 In our RFLP analysis we used a polymorphic marker 
located at 9q34. This may explain our observation that in four cases (Nos. 2, 4, 7, and 15) 
an ISH loss for chromosome 9, but no LOH with RFLP analysis was observed. 
For the other chromosomes studied, we found no correlation between LOH and centra-
mene loss The biological meaning of these observations could be that in those cases where 
LOH was found, but no loss was observed by ISH for that particular chromosome, an 
interstitial deletion, chromosomal rearrangement, or duplication of a part of that chromo-
some was involved As far as heterogeneity is concerned, ISH analysis on tissue sections is 
a more specific approach as compared to RFLP or karyotyping, since it is possible to 
evaluate results at the individual cell level, while Southern blot analysis provides a quan-
titative but integral overview of changes that dominate within the tumor This means that by 
RFLP analysis the genomic heterogeneity that might exist between subclones of neoplastic 
cells remains undetected. Furthermore, by ISH a numerical chromosome aberration can be 
observed, which is not possible by the RFLP approach Therefore, ISH can be applied in a 
clinical setting on a large scale basis for the analysis of tumors. The use of centromere-
associated probes enables the detection of numerical chromosome aberrations. The develop-
ment and application of region specific cosmid probes should increase the clinical applica-
bility of ISH 
Recently, Matsumuia et al (1992) showed that LOH of 17p in breast tumors correlated 
with 17 centromere and 17p loss, as detected by ISH, indicating that for breast tumors ISH 
can be used as a relevant clinical parameter. Therefore, we suggest that the ISH and RFLP 
techniques can be applied as complementary approaches for the study of clinical tumor 
material 
The approach as described in this paper, combining both Southern blotting and ISH, has 
the advantage that more insight into the two mechanisms of LOH and chromosomal 
evolution of tumors can be obtained A further step, however, could be the use of both 
centramene and cosmid probes of the same chromosome 
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Summary and Future Directions 
Interphase cytogenetics by in situ hybridization (ISH) techniques, allows the detection of 
specific nucleic acid sequences in morphologically preserved interphase cells or tissue 
sections The copy number of a specific chromosome in the nucleus can be determined by 
counting the number of signals after ISH, using specific DNA probes In this study 
chromosome specific DNA probes were applied in order to detect chromosome aberrations 
in tumor cells in a routine setting 
In hematological malignancies, chromosome banding techniques play an important role 
in the detection of genetic aberrations Since the chromosome aberrations are mostly well-
characterized, these banding techniques are used in diagnosis and determining prognosis 
Although a growing number of chromosomal abnormalities in solid tumors are being 
reported, cytogenetical analysis of solid tumors is still limited due to technical difficulties, 
such as low mitotic index, neccessity of cultunng the tumor cells, leading to induced 
changes in DNA content, low banding quality and fuzzy chromosomes 
Chapter 1 reviews the clinical applications and results obtained by single and multicolor 
ISH techniques in tumors Information on the different DNA probe types that are available 
for the detection of chromosomal abnormalities in inteiphase cells is presented A summary 
is given of the results obtained with these probes in different types of tumors, revelling 
both numencal and structural chromosome aberrations in metaphase spreads and interphase 
nuclei 
In the three subsequent chapters the ISH technique was applied to interphase nuclei of 
leukemias These studies were performed in order to investigate whether interphase 
cytogenetics can be applied as a routine diagnostic tool in addition to the existing karyo-
typing proceduies 
Chapter 2 describes numei ical chromosome aberrations in hematological cancers as 
detected by non radioactive ISH prc^euilres, using centromere-specific DNA probes for 
chromosomes 1 7, 8, 9, 10. 11, 16, 17, 18, X and Y In seven out of fifteen randomly 
selected cases with leukemia numerical aberrations for one or two chromosomes were 
demonstrated Comparison of the ISH results with classical karyotyping revealed that seven 
numerical chromosome aberrations were detected by both techniques, whereas in five 
instances an aberration was only found with ISH Furthermore, double target ISH using 
centromeric associated DNA piobes demonstrated translocations between two chromosomes 
in two cases Using the ISH appioach on inteiphase nuclei allowed the identification of 
non-characterized marker chromosomes, found by classical cytogenetic analysis Therefore, 
interphase cytogenetics using chromosome specific repetitive centromeric probes may be an 
additional tool for studying both numencal and stiuctural chromosomal aberrations of 
leukemias 
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Chapter 3 descibes a novel approach to determine the presence of chromosomal aberra­
tions in progenitor cells of bone marrow By using this method, a numerical chromosome 
aberration, as detected by both karyotyping and interphase cytogenetics, can be used as a 
marker for the aberrant cells After in vitro culturing of the bone marrow samples in agar, 
the ISH technique was applied Since our approach retains the cytological architecture of 
the agar assay, it allows discrimination between chromosomal aberrations detected in the 
clonogenic and non clonogenic cells With this new technique, the presence of the cytoge­
netic aberration in clonogenic cells can be detected at the interphase level. 
The application of this new ISH approach is demonstrated in a study of the diversity of 
acute myeloid leukemia (AML) during preleukemic phase, active disease, remission, and 
under in vitro culture conditions (Chapter 4) Firstly, in long-term liquid cultures of these 
leukemias upto 10 20 days, the numerical ISH marker was present in all clusters, which 
were morphologically typical for a leukemic growth pattern Since no residual normal 
clonogenic cells could be detected, it showed that not all leukemias appear to have the 
reported selective growth advantage for normal progenitor cells ih long term liquid 
cultures Secondly, two AML patients with a numerical ISH marker were studied both at 
presentation and during remission In both cases the marker was not present in the colonies 
nor in the clusters Therefore despite the abnormal growth patterns, the cultured progeni­
tors may well be residual normal cells Alternatively, they could have originated from a 
preleukemic clone without abnormal karyotype In both cases a low percentage (maximally 
6%) of abnormal bone marrow or peripheral blood cells were detected by ISH during 
remission Consequently, remissions in these patients could have been partially or complete­
ly of clonal origin Finally, one patient with trisomy for chromosome 10 as marker was 
analyzed during myelodysplasia phase and after transformation to AML During both 
stadia uniform but abnormal appearing cell clusters were cultered However, these clusters 
were either disomic or tnsomic for chromosome 10, indicating that a subclone within an 
abnormal growing preleukemic cell line might have been present 
The second part of this thesis deals with interphase cytogenetic analyses of a solid type 
of malignancy, ι e the transitional cell carcinoma (TCC) of the urinary bladder As already 
mentioned before, karyotyping analyses of solid tumors are hampered by different technical 
aspects, while also the flow cytometric (FCM) analysis of such lesions poses several 
problems 
Chapter 5 compares the nuclear DNA content of 53 TCCs of the urinary bladder as 
determined by FCM to chromosome ploidy as detected by ISH Therefore, DNA probes 
specific for the centromeric region ot chromosomes 1 and 18 were used In about 25% of 
the FCM diploid tumors evident chiomosome 1 aberrations were found by ISH, while in a 
few cases an aberration for chromosome 18 was detected FCM aneuploid cases with a 
DNA-index of 1 2 to 3 2 exhibited a profound heterogeneity In these TCCs the ratio 
between chromosomes 1 and 18 varied in a wide range, resulting in cases that showed more 
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ISH signals for chromosome 1 as compared to chromosome 1·8 or the opposite. Also minor 
cell populations showing polyploidization and giant cells containing numerous ISH signals 
could be detected It is concluded that interphase cytogenetics by ISH enables a fast 
screening of numerical chromosome aberrations and detection of different cell populations 
within one tumor that is apparently homogeneous after FCM analyses. 
Structural chromosome aberrations, such as +lp- and duplication of lq, are frequently 
encountered chromosomal anomalies in bladder cancer Similarly, extra chromosome 1 
copy numbers were detected by ISH in FCM diploid and aneuploid cases. Chapter 6 
therefore concentrates on structural chromosome 1 aberrations in 22 TCCs. For this 
purpose, a centromenc (lq 12) and a telomeric (lp36) DNA probe, as well as a library 
DNA probe from sorted human chromosome 1 were applied in single- and double-target 
ISH procedures. All FCM diploid TCCs, which showed three ISH signals for lql2, had 
two ISH signals for lp36. Since the library DNA probe showed three separate domains in 
the nuclei of these cases, the additional copy for lql2 could be explained as an extra 
chromosome lp-, containing the lql2 target In the FCM tetraploid and aneuploid tumors 
the results were more complex In several cases we observed an overrepresentation of lql2 
as compared to lp36, also suggesting the presence of extra copies of lp- chromosomes. 
Chapter 7 compares RFLP analyses and interphase cytogenetics in 24 TCCs in order to 
obtain an impression of the degiee of overlap of both techniques The tumor DNA samples 
were screened for loss of heterozygosity (LOH) for chromosome loci 9q34, l lp l5 , 16q22-
24, I7pl3, and 18q21 ISH was performed on serial frozen tissue sections with centromer-
ic-associaled DNA probes for chromosomes 1, 7, 9, 10, 11, 16, 17 and 18 to determine 
chiomosome aneuploidy, numerical chromosome aberrations, imbalance between chromo-
somes, and heterogeneity of those aberrations within the tumor The results demonstrate a 
good correlation between both approaches, showing that LOH for chromosome locus 9q34 
is mainly due to loss of the complete chromosome 9, since ISH with the centromenc probe 
for this chromosome showed in almost the same cases an underrepresentation No correla-
tions were found for the loci on chromosomes lip, 16q, 17p and 18q, suggesting either an 
interstitial deletion or LOH in combination with a duplication of (a part of) that particular 
chromosome in the aneuploid cases 
Future Directions 
The approach of interphase cytogenetics using ISH techniques has not yet reached the 
end ol its possibilities with regard to its technical developments and applications in the 
tumor analysis The approaches, as desciibed in this thesis, allow mainly the identification 
of numencal changes ol specific chiomosomes Most of the repetitive DNA sequences 
applied so tar lecognize targets located in the centromenc or heterochromatin regions of the 
respective chromosomes 
Interphase cytogenetics can be applied to monitor patients tor minimal residual disease. 
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Especially in hematological malignancies, where a vast knowledge of chromosomal 
aberrations exists, interphase cytogenetics will be carried out in the near future for 
diagnosis and monitoring 
In solid tumor diagnosis, wheie classical cytogenetic analyses are hampered by technical 
difficulties, interphase cytogenetics may reveal information of subclonal populations with 
chromosomal aberrations For example, in FCM near-diploid bladder tumors, we found 
that about 25% of these tumors contain numerical chromosome aberrations. 
Counting of hybridization signals is a crucial part of the evaluation of chromosomal 
changes in interphase nuclei. Heterogeneity of tumor cell populations, and variety of spot 
morphology may often lead to interpretation problems Furthermore, the number of ISH 
signals for a specific chromosome probe is not neccessaraly in agreement with the copy 
number of that paiticular chromosome, since most solid tumors consist of complex 
karyotypes with complex marker chromosomes The use of chromosome specific DNA 
libraries will facilitate the detection of numerical and structural chromosomal aberrations. 
This technique, known as chromosome in situ suppression (CISS or chromosome painting) 
hybridization, has already general applications for the identification of complex chromo-
some translocations in metaphase spreads The application of this technique for interphase 
cytigenetics is limited, since the staining patterns are difficult to interpret 
Another development in ISH is based on the combination of ratio-labeled DNA probes 
with digital imaging devices, like CCD cameras This enables the simultaneous detection of 
up to twelve distinctly painted chromosomes, both in metaphase spreads and interphase 
nuclei However, for the analysis of a tumor cell sample, previous knowledge of the 
expected chromosomal aberrations is required in such analyses 
A new approach to analyse tumor samples for unknown chromosomal changes has been 
described, termed as reverse chromosome painting. The principle of this technique is that 
isolated tumor DNA serves as probe in a CISS hybridisation to normal metaphase chromo-
some spreads Evaluation of signal intensities may reveal amplified sequences, but also loss 
of chromosomal material A further improvement of this technique for the detection of 
small differences of DNA sequences, is the so-called compaiative genomic hybridization 
(CGH) technique In this appioach, the labeled tumor DNA competes with differently 
labeled control genomic DNA for the same targets Hybridized tumor and control DNA 
sequences are detected by different fluorochromes. The resulting fluorescence ratios for 
each chromosome should reflect the relative copy number of the homologous sequences 
containing the two genomic DNAs 
The detection of chromosome target sites in both frozen or paraffin-embedded tissue 
sections allows the study of chromosome aneuploidy within the context of a variety of 
histological and morphological parameters The question whether progression of the tumor 
has given rise to cytogenetically distinct foci of cells becomes amenable for analysis, 
although further developments of the ISH approaches are necessary before applying in a 
routine setting. 
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To conclude, detailed genetic characterization of tumor cell populations by means of 
ISH techniques has already found its application in tumor pathology, especcially by the use 
of repetitive DNA probes Double (or multiple) target ISH may be applied in order to 
detect chromosome imbalances and tumor heterogeneity. Furthermore, it is to be expected 
that in combination with other molecular techniques, such as immunophenotyping, Southern 
blotting and PCR, the identification of chromosomal abnormalities and genetic imbalances 
in the tumor genome will help in the search for oncogenes and tumor suppressor genes 
specifically involved in certain tumor types Such improved and combined approaches could 
then increase our knowledge of tumor progression, and subsequently improve tumor 
diagnosis. 
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Samenvatting 
De interfase cytogenetica, gebruik makend van de in situ hybridisatie (ISH) technieken, 
biedt de mogelijkheid om specifieke nucleinezuur-sequenties te detecteren in interfase cellen 
of weefselcoupes Het kopie-aantal van een specifiek chromosoom in de kern kan worden 
bepaald door het aantal signalen te tellen na ISH met behulp van specifieke DNA probes In 
deze studie zijn chromosoom-specifieke DNA probes toegepast om routinematig chromo-
soom-afwijkingen in tumorcellen te detecteren 
Bij kwaadaardige hematologische ziekten spelen chromosoom bandenngstechnieken een 
belangrijke rol in de detectie van genetische afwijkingen Aangezien de meeste chromosoom 
afwijkingen thans goed gekaraktenseeid zijn worden deze bandenngstechnieken gebruikt 
bij het vaststellen van de diagnose en prognose Hoewel steeds meer chromosomale 
afwijkingen in solide tumoren bekend worden, zijn cytogenetische analyses van solide 
tumoren beperkt als gevolg van technische problemen, zoals een lage delingscapaciteit van 
de tumorcellen, slechte banderingskwahteit en vage chromosoom-contouren Ook kan de 
noodzaak van het kweken van de cellen leiden tot geïnduceerde veranderingen in DNA 
samenstelling 
Hoofdstuk 1 geeft een overzicht van de klinische toepassingen en resultaten, zoals 
verkregen met behulp van enkel- en meerkleurige ISH technieken in verscheidene tumor 
typen Informatie omtient de verschillende typen DNA probes die beschikbaar zijn voor de 
detectie van chromosomale afwijkingen in interfase cellen wordt gevolgd door een 
samenvatting van de resultaten zoals verkregen met deze probes Deze betreffen zowel 
numerieke als structurele chromosoom-veranderingen in metafase preparaten en in interfase 
kernen Tevens wordt aangegeven hoe deze gegevens ertoe bijdragen de tumordiagnose te 
vergemakkelijken 
In de drie daarop volgende hoofdstukken wordt de toepassing beschreven van de ISH 
techniek toegepast op interfase kernen van leukemieen Dit onderzoek werd gestart om uit 
te zoeken in hoeverre de interfase cytogenetica kan worden toegepast als een routinematig 
diagnostisch hulpmiddel naast de bestaande karyotypenngsprocedures 
Hoofdstuk 2 beschrijft de detectie van numerieke chromosoom veranderingen in 
hematologische maligniteiten met behulp van ISH procedures, gebruik makend van 
centromeer specifieke DNA probes voor de chromosomen 1, 7, 8, 9, 10, 11, 16, 17, 18, X 
en Y In zeven van de vijftien willekeurig gekozen gevallen van leukemie zijn numerieke 
veranderingen voor een of twee chromosomen aangetoond Vergelijking van de ISH 
resultaten met de klassieke karyotypering het zeven maal een numerieke chromosoom 
afwijking zien, die door beide technieken werd aangetoond, terwijl vijfmaal een afwijking 
alleen met ISH werd gevonden Verder toonde de dubbel ISH procedure met twee 
verschillende centromeer geassocieerde DNA piobes translocaties tussen twee chromosomen 
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aan in twee gevallen. Met behulp van de ISH benadering op interfase kernen bleek het 
verder mogelijk niet-gekarakteriseerde markerchromosomen, zoals verkregen met de 
klassieke cytogenetische analyse, te karakteriseren. Daardoor kan de interfase cytogenetica 
met behulp van chromosoom-specifieke, repetitieve centromeer-probes additionele informa-
tie opleveren bij de bestudering van numerieke en structurele chromosomale veranderingen 
in leukemieën. 
In Hoofdstuk 3 is een nieuwe benadering beschreven voor de bestudering van chromo-
somale veranderingen in progenitor cellen in beenmerg. Daarvoor kan een numerieke 
chromosoom verandei ing, zoals aangetoond met zowel karyotypering als interfase cytoge-
netica, als merker voor de afwijkende cellen worden gebruikt. Na in vitro kweek van 
beenmerg cellen in agar kan de ISH techniek worden toegepast met behoud van de 
cytologische informatie van het agar assay. Hierdoor is het mogelijk een onderscheid te 
maken tussen chromosomale veranderingen in de kolonievormende en niet-kolonievormende 
cellen in kweek. Met deze nieuwe benadering kan de aanwezigheid van de cytogenetische 
afwijking in de klonogene cel worden aangetoond op interfase niveau. 
De betekenis van deze nieuwe ISH benadering is aangetoond door de bestudering van de 
biologische verscheidenheid van acute myeloïde leukemie (AML) gedurende de preleu-
kemische fase, de aktieve ziekte, tijdens remissie, en onder in vitro kweek condities 
(Hoofdstuk 4). In lange termijn cultures van deze leukemieën (10-20 dagen) is de nume-
rieke chromosomale verandering aanwezig in alle celklusters, die morfologisch kenmerkend 
zijn voor het leukemische groeipatroon. Aangezien er geen residuale normale klonogene 
cellen konden worden aangetoond, blijkt dat niet voor alle leukemieën het beschreven 
selectieve groeivooideel van normale progenitor cellen optreedt. Twee AML patiënten met 
een numerieke ISH meiker werden bestudeerd zowel ten tijde van eerste presentatie als ook 
na remissie van de ziekte. In beide gevallen was de merker niet aanwezig in de kolonies of 
in de klusters, hetgeen wijst op een normaal karakter van de gekweekte progenitor cellen. 
Ook is het mogelijk dat ze ontstaan zijn uit een preleukemische celkloon met een normaal 
karyotype. In beide gevallen is een laag percentage (maximaal 6%) van abnormale beenmerg-
en perifere bloedcellen gedetecteerd met ISH tijdens remissie. Dit betekent dat de remissies 
in deze patiënten partieel of compleet klonaal kunnen zijn geweest. Tenslotte is één patiënt 
met een trisomie vooi chromosoom 10 als merker geanalyseerd tijdens de myelodysplasti-
sche fase en na transformatie tot AML. Tijdens beide stadia zijn gelijke, maar abnormaal 
ogende celklusters gekweekt. Echter, de celclusters vertoonden hetzij een disomie hetzij een 
trisomie voor chromosoom 10. Dit duidt erop dat een subkloon in een abnormaal groeiende 
preleukemische kloon aanwezig kan zijn geweest. 
Het tweede deel van dit proefschrift beschrijft de toepassing van de interfase cyto-
genetica op een solide tumor, namelijk het overgangscel-carcinoom (TCC) van de urine 
blaas. Zoals al eerder genoemd, worden karyotypering-analyses van solide tumoren 
belemmerd door verschillende technische aspecten, terwijl ook de flowcytometrische (FCM) 
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analyses van dergelijke afwijkingen verscheidene problemen met zich meebrengen 
In Hoofdstuk 5 is de DNA inhoud van 53 TCCs, zoals bepaald met behulp van FCM, 
vergeleken met de chromosoom-ploidie, zoals die bepaald wordt met behulp van de ISH 
procedure Daarvoor zijn DNA probes specifiek voor het centromeer gebied van de 
chromosomen 1 en 18 gebruikt In ongeveer 25% van de FCM diploide tumoren zijn 
chromosoom 1 afwijkingen gevonden met ISH, terwijl in enkele gevallen een afwijking 
voor chromosoom 18 gedetecteeid is De FCM aneuploide gevallen met een DNA index 
van 1 2 tot 3 2, toonden een hoge mate van heterogeniteit In deze TCCs varieerde de ratio 
tussen de chromosomen 1 en 18 aanzienlijk, resulterend in gevallen die meer ISH signalen 
voor chromosoom 1 vertoonden in vergelijking tot signalen voor chromosoom 18, en 
omgekeerd Ook werden kleine celpopulaties waargenomen waarbij polyploidisenng was 
opgetreden, en reuzecellen met zeer vele ISH signalen De interfase cytogenetica kan een 
snelle screening van numeiieke chromosoom afwijkingen mogelijk maken en verschillende 
celpopulaties detecteren binnen eén tumor die aanvankelijk homogeen leek zoals bepaald 
met behulp van FCM 
Structurele chromosoom afwijkingen, zoals + lp- en duplicatie van lq, zijn vaak 
waargenomen chromosomale veranderingen bij blaaskanker Ook extra kopie-aantallen voor 
chromosoom 1 zijn met ISH gedetecteerd in zowel FCM diploide als aneuploide tumoren 
Hoofdstuk 6 beschrijft een studie naar structurele chromosoom 1 veranderingen in 22 
TCCs Daarvoor zijn centromeer (lql2) en telomeer (lp36) DNA probes, evenals een 
DNA chromosoom 1 bank gebruikt in enkel en dubbel-target ISH procedures Alle FCM 
diploide TCCs, die drie ISH signalen per kern voor lql2 bevatten, toonden twee ISH 
signalen voor lp36 Aangezien de chromosoom 1 bank drie apaite domeinen in de kernen 
van deze gevallen toonde, kon het additionele signaal voor 1 q 12 worden verklaard als een 
extra chromosoom lp-, dat het lql2 target bevat In de FCM tetraploide en aneuploide 
tumoren waren de resultaten complexer In enkele gevallen werd een overrepresentatie van 
lql2 ten opzichte van lp36 waargenomen, hetgeen eveneens de aanwezigheid van extra 
kopie-aantallen van lp- suggereert 
In Hoofdstuk 7 zijn de resultaten van RFLP analyses en die van de interfase cyto-
genetica op 24 TCCs met elkaar vergeleken De tumor DNA samples, verkregen uit 
tumoren van verschillende gradatie en stadia, werden gescreend op verlies van heterozygo-
tie voor de chromosoom gebieden 9q34, Upl5, 16q22-24, I7p 13 en 18q21 ISH werd op 
seriecoupes van vnesmateiiaal van dezeltde tumoren uitgevoerd Centromeer-geassocieerde 
DNA probes voor de chromosomen 1, 7 9 10, 11, 16, 17 en 18 werden gebruikt om 
chromosoom ploidy, numerieke chromosoom afwijkingen, imbalans tussen chromosomen en 
heterogeniteit van afwijkingen binnen eenzelfde tumor te bepalen Er bleek een goede 
correlatie te bestaan tussen de RFLP en ISH benadering, waaibij het verlies van heterozy-
gotie voor het chromosoom locus 9q34 in de vroege fase van de TCC-ontwikkeling 
vooi namelijk het gevolg is van verlies van het complete chiomosoom 9, aangezien ISH met 
de centromeer probe vooi dit chromosoom in bijna alle gevallen een ondervertegenwoordi-
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ging het zien. Voor de loei op chromosomen lip, 16q, 17p, en 18q werd geen correlatie 
tussen beide benaderingen gevonden. Het gevonden verlies van heterozygotie kan duiden op 
een interstitiele deletie, maar ook verlies van heterozygotie in combinatie met een duplicatie 
van (een deel van) het betreffende chromosoom in de aneuploide gevallen. 
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Het verlies van chromosoom 9q is een belangrijke vroege gebeurtenis bij 
het ontstaan van het overgangscelcarcinoom van de unneblaas 
(Dit proefschrift) 
BIJ het in combinatie gebruiken van glucose-oxidase- en peroxidase-gecon-
jugeerde antilichamen in de immunocytochemie wordt onvoldoende 
rekening gehouden met het ontstaan van peroxides door auto-oxidatie van 
DAB. 
(Kuhlmann WD et al, Histochemistry (1986) 85 13-17) 
Cellen met een abnormaal chromosoomaantal zijn focaal al aanwezig in 
intraepithelial afwijkingen graad 1 van de cervix uteri 
(NKB KWF-project no 92-34) 
4 De ontwikkeling van geautomatiseerde systemen voor ISH signaal analyse 
resulteert in een schijnbaar objectieve benadering van de werkelijkheid door 
het niet geobjectiveerd zijn van de selectiecriteria 
Bij de interpretatie van in situ hybridisatie resultaten op weefselcoupes is het 
aansnij-effect ondergeschikt aan het behoud van de weefsel-architektuur. 
De in situ detectie van DNA of RNA sequenties dient, evenals immunocyto-
chemie, een vaste plaats in de diagnostiek te krijgen. 
Prenatale diagnostiek van de menselijke geaardheid is irrelevant en maat-
schappelijk ongewenst. 
De toegankelijkheid van klassieke muziek wordt verminderd doordat de cd-
booklets zelden in het Nederlands verschijnen. 
Het lot van het stedelijk knooppunt Arnhem-Nijmegen wordt tijdens de slag 
om Eist beslist. 
Voor de wetenschapper geldt: Onbegrepen maakt onbemind. 
Een Sardijn in Nederland is als een peper in hutspot. 
Voorzitters zijn vaak ook lijders. 
Schrijven is zilver, schrappen is goud. 
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